Update May 17 - May 23, 2021, Dr. Peter J. Lansberg MD, PhD

Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics

COVID-19 publications - Week 20 2021 1133 Publications

PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected]

Reliable on-line resources for Covid 19

WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker Retracted papers AAN - Neurology resources COVID-19 risk tools - Apps COVID-19 resources (Harvard) Web app for SARS-CoV2 mutations COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF) COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins) COVID-19 calculators (Medscap)

Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known or Suspected COVID-19 (ASA, 2020) OSHA Guidance on Preparing the Workplace for COVID-19 (2020) Policy for Sterilizers, Disinfectant Devices, and Air Purifiers (FDA, 2020) Breast Cancer Patient Triage Guidelines (CPBCC, 2020) clinical guidance for adult Belgian patients with suspected or confirmed COVID-19 National Covid-19 Testing Action Plan (Rockefeller Foundation) ASE issues Echo-cardiography guidance

Trials & Registries CAPACITY European registry COVID 19 patients WHO launches global megatrial FDA launches Convalescent plasma trial Lets Beat Covid-19 Survey to help plan hospital services COVID IBD registry Google mobility reports per country COVID 19 World's largest trial of potential coronavirus treatments rolled out across the UK Pregnancy Registry (US) ICNARC report on COVID-19 in critical care - NHS April 24 COVID-19 Human Genetics - Biobanks COVID19 settings of transmission database COVID-19 prevention network Covid-Plex trial - (plasma exchange & convalescent plasma trial)

The Covid-Plex trial is an investigator initiated, multicenter, parallel-group, open-label randomized clinical trial aiming to randomize patients with severe COVID-19 to standard care or standard care plus plasmapheresis and convalescent plasma.

If you are interested to participate Please contact Wladimir Szpirt, Nicholas Carlson Anders, or Perner Bo Feldt-Rasmussen. Depts. Of Intensive Care Therapy and Nephrology, Copenhagen University Hospital Rigshospitalet, Denmark

Covid-Plex trial

Mainstream Media New York Times - Corona update U.S. experts press calls for China to allow inquiries into the pandemic’s origins. As Covid Rampages Across Nepal, Workers Pay the Price London protest anti vaccine passports Early analysis suggests that another mRNA vaccine is safe Facebook Takes on Superspreaders A surge of cases in Malaysia is partly linked to prayer gatherings. Why Apple and Google’s Virus Alert Apps Had Limited Success

Washington Post - Corona update Doctors prepare to ration care as covid surge leaves Malaysia in ‘total lockdown’ Barbershop offers coronavirus shots, in addition to cuts and shaves. Vietnam detects highly contagious new coronavirus variant as infections surge Everything you need for the return of travel 30 observations from my first vaccinated flight Explaining HIPAA: No, it doesn’t ban questions about your vaccination status

Guardian - Corona update America in the Time of Covid review – a devastating analysis Students in England call for 30% Covid discount on tuition fees End of England Covid lockdown on 21 June increasingly in doubt Vietnam says new Covid variant is hybrid of India and UK strains Some long Covid sufferers in England waiting months for treatment Key Articles

1. COVID-19 reinfection: a rapid systematic review of case reports and case series. J. Investig. Med. 2021; Wang J, Kaperak C, Sato T, Sakuraba A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006572 With millions having had COVID-19 or received a SARS-CoV-2 vaccine, re- infections are likely to occur. This review explored a total of 17 cases with confirmed re-infections. The majority experiences similar symptom severity (11/16). Worse symptoms occurred in 2/16 patients, and 2/16 patients experienced milder symptoms. One immunocompromised patient suffered fatal outcomes after a second infection.

2. Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection. Int J Infect Dis 2021; Vicenti I, Gatti F, Scaggiante R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34022329 A single vaccination in patients with a history of a mild or asymptomatic SARS- C0V-2 infection resulted in a significantly greater antibody plasma titer than uninfected patients who completed two vaccinations with the BNT162b2 (Pfizer) vaccine.

3. Vitamin D in the Covid-19 era: a review with recommendations from a G.I.O.S.E.G. expert panel. Endocrine 2021:1-7Ulivieri FM, Banfi G, Camozzi V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999367 The Glucocorticoid-Induced Osteoporosis Skeletal Endocrinology Group (G.I.O.S.E.G) has formulated recommendations regarding the use of vitamin D in COVID-19 patients. The G.I.O.S.E.G appointed an expert panel to evaluate the current evidence on vitamin D and a published summary of their findings in this recommendations paper.

4. Coronary microvascular dysfunction pathophysiology in COVID-19. Microcirculation 2021:e12718Yin J, Wang S, Liu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013612

5. Prevalence and risk factors of thrombotic events on patients with COVID- 19: a systematic review and meta-analysis. Thromb J 2021; 19:32Xiong X, Chi J, Gao Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011381

6. Secondary Immune Thrombocytopenic Purpura Triggered by COVID-19. Cureus 2021; 13:e14505Watts A, Raj K, Gogia P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007758

7. Clinical outcomes and quality of life of COVID-19 survivors: A follow-up of 3 months post hospital discharge. Respir. Med. 2021; 184:106453Todt BC, Szlejf C, Duim E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34010740

8. Genetic susceptibility of COVID-19: a systematic review of current evidence. Eur. J. Med. Res. 2021; 26:46SeyedAlinaghi S, Mehrtak M, MohsseniPour M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016183

9. Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals. Int J Infect Dis 2021; Sasikala M, Shashidhar J, Deepika G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022331

10. Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology. J Thromb Haemost 2021; Nazy I, Sachs UJ, Arnold DM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018298

11. Uncurtaining the effect of COVID-19 in diabetes mellitus: a complex clinical management approach. Environ. Sci. Pollut. Res. Int. 2021:1- 8Kashyap S, Bala R, Madaan R, Behl T. http://www.ncbi.nlm.nih.gov/pubmed/? term=34021454

12. Statins in COVID-19 infection: A rehash of old themes or truly a new hope? J. Clin. Lipidol. 2021; Jia X, Virani SS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994121

13. Cerebral venous thrombosis in COVID-19. Diabetes Metab Syndr 2021; 15:1039-1045Ghosh R, Roy D, Mandal A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015627

14. [Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination]. Neurologia 2021; Avendaño-Solá C, Cámara R, Castellanos M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994625

15. Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor. Front Chem 2021; 9:661230Al-Karmalawy AA, Dahab MA, Metwaly AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017819

Basic Science (49 articles) 1. Sequence and structural analysis of COVID-19 E and M proteins with MERS virus E and M proteins-A comparative study. Biochem Biophys Rep 2021; 26:101023Aldaais EA, Yegnaswamy S, Albahrani F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013072 2. Global characterization of B cell receptor repertoire in COVID-19 patients by single-cell V(D)J sequencing. Brief. Bioinform. 2021; Jin X, Zhou W, Luo M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015809 3. DeepImmuno: deep learning-empowered prediction and generation of immunogenic peptides for T-cell immunity. Brief. Bioinform. 2021; Li G, Iyer B, Prasath VBS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009266 4. Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID- 19. Brief. Bioinform. 2021; Tomazou M, Bourdakou MM, Minadakis G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009288 5. In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor. Brief. Bioinform. 2021; Zhang Y, He X, Zhai J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013346 6. High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies. Cell 2021; Garrett ME, Galloway J, Chu HY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010620 7. SARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium. Cell Stem Cell 2021; Eriksen AZ, Møller R, Makovoz B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022129 8. Modeling the binding of protoporphyrin IX, verteporfin, and chlorin e6 to SARS-CoV-2 proteins. Chem Heterocycl Compd (N Y) 2021:1-9Koifman OI, Lebedeva NS, Gubarev YA, Koifman MO. http://www.ncbi.nlm.nih.gov/pubmed/? term=34007082 9. Computational Approaches to Discover Novel Natural Compounds for SARS- CoV-2 Therapeutics. ChemistryOpen 2021; 10:593-599Rampogu S, Lee G, Kulkarni AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010501 10. Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity. Comput. Biol. Med. 2021; 134:104459Das D, Podder S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020127 11. Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking. Comput. Biol. Med. 2021; 134:104468Elghoneimy LK, Ismail MI, Boeckler FM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34015671 12. QSAR modeling and pharmacoinformatics of SARS coronavirus 3C-like protease inhibitors. Comput. Biol. Med. 2021; 134:104483Ishola AA, Adedirin O, Joshi T, Chandra S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020129 13. Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach. Comput. Biol. Med. 2021; 134:104451Roy S, Sharma B, Mazid MI et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020131 14. Converging global crises are forcing the rapid adoption of disruptive changes in drug discovery. Drug Discov Today 2021; Mark Treherne J, Langley GR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015541 15. Avoiding culture shock with the SARS-CoV-2 spike protein. Elife 2021; 10Hale BG. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003114 16. Molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses of pangolin origin. Embo j 2021:e107786Niu S, Wang J, Bai B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018203 17. Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patients. Emerg Microbes Infect 2021:1-19Wang X, Lam JY, Chen L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003073 18. Analysis of Emerging Variants in Structured Regions of the SARS-CoV-2 Genome. Evol. Bioinform. Online 2021; 17:11769343211014167Ryder SP, Morgan BR, Coskun P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017166 19. SARS-CoV-2 suppresses mRNA expression of selenoproteins associated with ferroptosis, endoplasmic reticulum stress and DNA synthesis. Food Chem. Toxicol. 2021:112286Wang Y, Huang J, Sun Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023458 20. Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor. Front Chem 2021; 9:661230Al-Karmalawy AA, Dahab MA, Metwaly AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017819 21. Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs. Front Chem 2021; 9:638187Tito A, Colantuono A, Pirone L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996744 22. Commentary: Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID- 19 Treatment. Front. Immunol. 2021; 12:682195Carvalho JL, Silva-Carvalho AE, Garcez EM, Saldanha-Araujo F. http://www.ncbi.nlm.nih.gov/pubmed/? term=33995424 23. Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm. Front. Immunol. 2021; 12:642860Kozma GT, Mészáros T, Bakos T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995361 24. SARS-CoV-2 Switches 'on' MAPK and NFκB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression. Front. Pharmacol. 2021; 12:631879Goel S, Saheb Sharif-Askari F, Saheb Sharif Askari N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995033 25. Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery. Front. Pharmacol. 2021; 12:660710Li X, Peng T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017257 26. Profiling Ribonucleotide and Deoxyribonucleotide Pools Perturbed by Remdesivir in Human Bronchial Epithelial Cells. Front. Pharmacol. 2021; 12:647280Li Y, Zhang HX, Luo WD et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33995062 27. Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries. Genomics 2021; 113:2158-2170Wang R, Chen J, Gao K, Wei GW. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004284 28. Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients. Hum Genomics 2021; 15:29Wulandari L, Hamidah B, Pakpahan C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001248 29. Analyzing host-viral interactome of SARS-CoV-2 for identifying vulnerable host proteins during COVID-19 pathogenesis. Infect Genet Evol 2021:104921Das JK, Roy S, Guzzi PH. http://www.ncbi.nlm.nih.gov/pubmed/? term=34004362 30. Differential host circRNA expression profiles in human lung epithelial cells infected with SARS-CoV-2. Infect Genet Evol 2021:104923Yang M, Qi M, Xu L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004360 31. Genomic Variation, Origin Tracing and Vaccine Development of SARS-CoV-2: A Systematic Review. Innovation (N Y) 2021:100116Li T, Huang T, Guo C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997827 32. Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19. Int J Cardiol 2021; Li XT, Zhang MW, Zhang ZZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000358 33. Epigallocatechin Gallate Inhibits the Uridylate-Specific Endoribonuclease Nsp15 and Efficiently Neutralizes the SARS-CoV-2 Strain. J. Agric. Food Chem. 2021; Hong S, Seo SH, Woo SJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34015930 34. Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery. J Biomol Struct Dyn 2021:1-28Arunkumar M, Gunaseelan S, Kubendran Aravind M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014150 35. A large-scale computational screen identifies strong potential inhibitors for disrupting SARS-CoV-2 S-protein and human ACE2 interaction. J Biomol Struct Dyn 2021:1-14Singh A, Dhar R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33998954 36. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in early stage of COVID-19. J. Clin. Invest. 2021; Ahn JH, Kim J, Hong SP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003804 37. Functional characterization of CD4+ T cell receptors crossreactive for SARS- CoV-2 and endemic coronaviruses. J. Clin. Invest. 2021; 131Dykema AG, Zhang B, Woldemeskel BA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33830946 38. HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children. J. Clin. Invest. 2021; 131Porritt RA, Paschold L, Rivas MN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33705359 39. Genome-wide screening of SARS-CoV-2 infection-related genes based on the blood leucocytes sequencing dataset of patients with COVID-19. J Med Virol 2021; Gao X, Liu Y, Zou S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34009691 40. Evaluation of the relationship between KIM-1 and suPAR levels and clinical severity in COVID-19 patients: A different perspective on suPAR. J Med Virol 2021; Kerget B, Kerget F, Aksakal A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34019703 41. Glycosylation is a key in SARS-CoV-2 infection. J. Mol. Med. (Berl.) 2021; Reis CA, Tauber R, Blanchard V. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023935 42. Calendulaglycoside A Showing Potential Activity Against SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics, and SAR Studies. J Tradit Complement Med 2021; Zaki AA, Ashour A, Elhady SS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34026584 43. Discrete and continuum models of COVID-19 virus, formal solutions, stability and comparison with real data. Math Comput Simul 2021; Abdel-Gawad HI, Abdel-Gawad AH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007097 44. The intersection of COVID-19 and cancer: signaling pathways and treatment implications. Mol. Cancer 2021; 20:76Zong Z, Wei Y, Ren J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001144 45. In silico Studies on the Interaction Between Mpro and PLpro From SARS-CoV- 2 and Ebselen, its Metabolites and Derivatives. Mol Inform 2021; Nogara PA, Omage FB, Bolzan GR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018687 46. Do gene-environment interactions play a role in COVID-19 distribution? The case of Alpha-1 Antitrypsin, air pollution and COVID-19. Multidiscip Respir Med 2021; 16:741Murgia N, Corsico AG, D'Amato G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012547 47. Joint Segmentation and Detection of COVID-19 via a Sequential Region Generation Network. Pattern Recognit 2021; 118:108006Wu J, Zhang S, Li X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002101 48. Exploring SARS-CoV-2 Spikes Glycoproteins for Designing Potential Antiviral Targets. Viral Immunol 2021; Kamel NA, El Wakeel LM, Aboshanab KM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018828 49. Northern pig-tailed macaques ( Macaca leonina) infected with SARS-CoV-2 show rapid viral clearance and persistent immune response. Zool Res 2021; 42:350-353Song TZ, Zheng HY, Han JB et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33998182

Biomarkers - Genetics (112 articles)

1. Persistence of Elevated Procalcitonin in a Patient with Covid-19 Uncovering a Diagnosis of Medullary Thyroid Carcinoma. AACE Clin Case Rep 2021; Laura G, Salvatore D, Giorgio P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997278 2. The Value and Institutional Impact of an In-System Laboratory Testing During the COVID-19 Pandemic. Acad Pathol 2021; 8:23742895211010253Kaul K, Singh K, Sabatini L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997276 3. VA-Wide, Multicenter Verification Study of the Cepheid Xpert SARS-CoV-2 Assay. Acad Pathol 2021; 8:23742895211011911Obeidat M, Frank AR, Icardi MS, Klutts JS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997277 4. Sensitive Detection of SARS-CoV-2 Using a SERS-Based Aptasensor. ACS Sens 2021; Chen H, Park SG, Choi N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34019385 5. Predictive Value of C-reactive Protein, Lactate Dehydrogenase, Ferritin and D- dimer Levels in Diagnosing COVID-19 Patients: a Retrospective Study. Acta Inform Med 2021; 29:45-50Kaftan AN, Hussain MK, Algenabi AA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012213 6. Sampling Methods and Risk Stratification Regarding Environmental Contamination by SARS-CoV-2. Acta Med Port 2021; Mendes M, Andrade Oliveira A, Pires O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014160 7. Influence of vitamin D status on hospital length of stay and prognosis in hospitalized patients with moderate to severe COVID-19: a multicenter prospective cohort study. Am. J. Clin. Nutr. 2021; Reis BZ, Fernandes AL, Sales LP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020451 8. Presence of SARS-CoV-2 Viral RNA in Aqueous Humor of Asymptomatic Individuals. Am. J. Ophthalmol. 2021; Koo EH, Eghrari AO, Dzhaber D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022227 9. Emerging point-of-care biosensors for rapid diagnosis of COVID-19: current progress, challenges, and future prospects. Anal. Bioanal. Chem. 2021:1- 23Rasmi Y, Li X, Khan J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008124 10. Comparative evaluation of six nucleic acid amplification kits for SARS-CoV-2 RNA detection. Ann. Clin. Microbiol. Antimicrob. 2021; 20:38Wu S, Shi X, Chen Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022903 11. Sequence and structural analysis of COVID-19 E and M proteins with MERS virus E and M proteins-A comparative study. Biochem Biophys Rep 2021; 26:101023Aldaais EA, Yegnaswamy S, Albahrani F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013072 12. HRPZyme Assisted Recognition of SARS-CoV-2 infection by Optical Measurement (HARIOM). Biosens. Bioelectron. 2021; 187:113280Ahmad M, Sharma P, Kamai A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020221 13. Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil. BMC Genomics 2021; 22:371Franceschi VB, Caldana GD, de Menezes Mayer A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016042 14. Lack of association between vitamin D insufficiency and clinical outcomes of patients with COVID-19 infection. BMC Infect. Dis. 2021; 21:450Davoudi A, Najafi N, Aarabi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006228 15. SARS-CoV-2 PCR-positive and PCR-negative cases of pneumonia admitted to the hospital during the peak of COVID-19 pandemic: analysis of in-hospital and post-hospital mortality. BMC Infect. Dis. 2021; 21:458Gaipov A, Gusmanov A, Abbay A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016043 16. Association between fatality rate of COVID-19 and selenium deficiency in China. BMC Infect. Dis. 2021; 21:452Zhang HY, Zhang AR, Lu QB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011281 17. Shortcomings of SARS-CoV-2 genomic metadata. BMC Res. Notes 2021; 14:189Gozashti L, Corbett-Detig R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34001211 18. How do the UK public interpret COVID-19 test results? Comparing the impact of official information about results and reliability used in the UK, USA and New Zealand: a randomised controlled trial. BMJ Open 2021; 11:e047731Recchia G, Schneider CR, Freeman AL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016665 19. The value of anal swab RT-PCR for COVID-19 diagnosis in adult Indonesian patients. BMJ Open Gastroenterol 2021; 8Abdullah M, Sudrajat DG, Muzellina VN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011623 20. Prognostic value of bilirubin and drug interactions. BMJ Open Gastroenterol 2021; 8Ng A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006605 21. Lymphocyte/mean platelet volume ratio, a new marker; is it effective in predicting the prognosis of COVID-19 cases? Bratisl. Lek. Listy 2021; 122:413- 417Eraybar S, Yuksel M, Aygun H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34002615 22. COVID-19 biomarkers and their overlap with comorbidities in a disease biomarker data model. Brief. Bioinform. 2021; Gogate N, Lyman D, Bell A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015823 23. Canadian national COVID-19 genomics surveillance priorities for existing and emerging variants of concern. Can. Commun. Dis. Rep. 2021; 47:139-141. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012337 24. SARS-CoV-2 seroprevalence among blood donors in Québec, and analysis of symptoms associated with seropositivity: a nested case-control study. Can. J. Public Health. 2021:1-11Lewin A, Therrien R, De Serres G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999398 25. Developing a SARS-CoV-2 Antigen Test Using Engineered Affinity Proteins. ChemRxiv 2021; Kim S, Yee EH, Miller EA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013166 26. Evaluation of High-Sensitivity Cardiac Troponin T Levels in Japanese Patients Recently Recovered From Coronavirus Disease 2019. Circ. J. 2021; Ide S, Hayama H, Asai Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994409 27. Biochemistry tests in hospitalized COVID-19 patients: Experience from a canadian tertiary care centre. Clin. Biochem. 2021; Rutledge AC, Choi YH, Karp I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022172 28. Hematological profile and biochemical markers of COVID-19 non-survivors: A retrospective analysis. Clin Epidemiol Glob Health 2021; 11:100770Bairwa M, Kumar R, Beniwal K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997479 29. Excess Soluble fms-like Tyrosine Kinase 1 Correlates With Endothelial Dysfunction and Organ Failure in Critically Ill Coronavirus Disease 2019 Patients. Clin Infect Dis 2021; 72:1834-1837Dupont V, Kanagaratnam L, Goury A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32672790 30. Coronavirus Disease 2019 Patients in Earlier Stages Exhaled Millions of Severe Acute Respiratory Syndrome Coronavirus 2 Per Hour. Clin Infect Dis 2021; 72:e652-e654Ma J, Qi X, Chen H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32857833 31. Biomarker Research and Development for Coronavirus Disease 2019 (COVID- 19): European Medical Research Infrastructures Call for Global Coordination. Clin Infect Dis 2021; 72:1838-1842Oldoni E, van Gool A, García Bermejo L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33091118 32. Serum Antibody Profile of a Patient With Coronavirus Disease 2019 Reinfection. Clin Infect Dis 2021; 72:e659-e662To KK, Hung IF, Chan KH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32966566 33. The Role of Computed Tomography and Real-Time Polymerase Chain Reaction in the Diagnosis and Prognostication of COVID-19. Cureus 2021; 13:e14424Roberts JT, Hrushka JM, Krider SO, Nguyen QD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996292 34. Impact of pre-infection HbA1c levels on COVID-19 prognosis:systematic review and meta-analysis. Diabetes Metab Res Rev 2021:e3476Prattichizzo F, de Candia P, Nicolucci A, Ceriello A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34018307 35. Multiple detection and spread of novel strains of the SARS-CoV-2 B.1.177 (B.1.177.75) lineage that test negative by a commercially available nucleocapsid gene real-time RT-PCR. Emerg Microbes Infect 2021:1-19Amato L, Jurisic L, Puglia I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019466 36. Association between Thyroid Function and Prognosis of COVID-19: A Retrospective Observational Study. Endocr. Res. 2021:1-8Lang S, Liu Y, Qu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014139 37. Vitamin D in the Covid-19 era: a review with recommendations from a G.I.O.S.E.G. expert panel. Endocrine 2021:1-7Ulivieri FM, Banfi G, Camozzi V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999367 38. Endocrine and metabolic aspects of Covid-19. Endokrynol. Pol. 2021; Pawlikowski M, Winczyk K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010445 39. Clinical evaluation of rapid point-of-care antigen tests for diagnosis of SARS- CoV-2 infection. Eur J Clin Microbiol Infect Dis 2021:1-7Koeleman JGM, Brand H, de Man SJ, Ong DSY. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021840 40. Genetic susceptibility of COVID-19: a systematic review of current evidence. Eur. J. Med. Res. 2021; 26:46SeyedAlinaghi S, Mehrtak M, MohsseniPour M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016183 41. The diagnostic accuracy of seven commercial molecular in vitro SARS-CoV-2 detection tests: a rapid meta-analysis. Expert Rev Mol Diagn 2021; Ulhaq ZS, Soraya GV. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015984 42. Comparative evaluation of a dual-target real-time RT-PCR assay for COVID-19 diagnosis and assessment of performance in pooled saliva and nasopharyngeal swab samples. Expert Rev Mol Diagn 2021; Yip CCY, Leung KH, Ng ACK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014785 43. CRISPR-Based COVID-19 Testing: Toward Next-Generation Point-of-Care Diagnostics. Front Cell Infect Microbiol 2021; 11:663949Ganbaatar U, Liu C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996635 44. Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1). Front. Immunol. 2021; 12:593595Choreño-Parra JA, Jiménez-Álvarez LA, Cruz-Lagunas A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33995342 45. Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation. Front. Immunol. 2021; 12:675678Della-Torre E, Lanzillotta M, Campochiaro C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995419 46. High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients. Front. Immunol. 2021; 12:675679Greenbaum U, Klein K, Martinez F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995420 47. Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients. Front. Immunol. 2021; 12:659018Martín-Sánchez E, Garcés JJ, Maia C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012444 48. Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease. Front. Immunol. 2021; 12:671052Medjeral-Thomas NR, Troldborg A, Hansen AG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995410 49. SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs. Front. Immunol. 2021; 12:661052Xiang Q, Feng Z, Diao B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995382 50. A COVID-19 Test Triage Tool, Predicting Negative Results and Reducing the Testing Burden on Healthcare Systems During a Pandemic. Front Med (Lausanne) 2021; 8:563465Lundon DJ, Kelly BD, Nair S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996839 51. Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries. Genomics 2021; 113:2158-2170Wang R, Chen J, Gao K, Wei GW. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004284 52. Association between vitamin D level and prognostic factors among patients infected with SARS-CoV-2. Horm. Mol. Biol. Clin. Investig. 2021; Haghighi M, Ebadi SS, Soleimantabar H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34005841 53. Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients. Hum Genomics 2021; 15:29Wulandari L, Hamidah B, Pakpahan C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001248 54. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets. Immunity 2021; Dugan HL, Stamper CT, Li L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022127 55. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients. Immunobiology 2021; 226:152093Kisserli A, Schneider N, Audonnet S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022670 56. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID- 19. Infection 2021:1-9Pink I, Raupach D, Fuge J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021897 57. A brief, highly selective history of acute phase proteins as indicators of infection, inflammation and injury. Inflammopharmacology 2021; Powanda MC, Moyer ED. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019218 58. Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as per November 20, 2020. Int J Infect Dis 2021; Hayer J, Kasapic D, Zemmrich C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015523 59. Day by day symptoms following positive and negative PCR tests for SARS- CoV-2 in non-hospitalised health-care workers: a 90-day follow-up study. Int J Infect Dis 2021; Nielsen KJ, Vestergaard JM, Schlünssen V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022336 60. The complicated relationships of heparin-induced thrombocytopenia and platelet factor 4 antibodies with COVID-19. Int. J. Lab. Hematol. 2021; Favaloro EJ, Henry BM, Lippi G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000089 61. Radiologically Undetectable Latent Pulmonary Lymphocyte Infiltration Suggesting the Need for Early Glucocorticoid Therapy: An Autopsy Case of Rapidly Progressive COVID-19 Pneumonia with Lymphopenia. Intern Med 2021; Tanomogi N, Otani T, Araki J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994439 62. Phenome-wide and eQTL Associations of COVID-19 Genetic Risk Loci. iScience 2021:102550Moon C, Schilder BM, Raj T, Huang KL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34027315 63. RT-PCR diagnosis of COVID-19 from exhaled breath condensate: a clinical study. J Breath Res 2021; Sawano M, Takeshita K, Ohno H, Oka H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020435 64. Do Certain Biomarkers Predict Adverse Outcomes in Coronavirus Disease 2019? J. Clin. Med. Res. 2021; 13:195-203Narvel H, Sayed A, Narvel N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007357 65. Biochemical abnormalities in COVID-19: a comparison of white versus ethnic minority populations in the UK. J. Clin. Pathol. 2021; Taylor DR, Buchanan D, Al- Hasani W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011620 66. Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay. J Clin Virol 2021; 140:104869Perchetti GA, Pepper G, Shrestha L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023572 67. Ultra-precise label-free nanosensor based on integrated graphene with Au nanostars toward direct detection of IgG antibodies of SARS-CoV-2 in blood. J Electroanal Chem (Lausanne) 2021; 894:115341Alireza Hashemi S, Bahrani S, Mojtaba Mousavi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994897 68. ABO in Correlation to the Requirement of Mechanical Ventilation and Mortality in Critically Ill Patients With COVID-19. J Hematol 2021; 10:64-70Al-Ansari RY, Alshaer A, Al-Anazi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007367 69. Evaluation of SARS-CoV-2 RNA quantification by RT-LAMP compared to RT- qPCR. J Infect Chemother 2021; Minami K, Masutani R, Suzuki Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006453 70. Clinical and hematologic presentations of adults with COVID-19 patients in Jeddah: A case control study. J Infect Public Health 2021; 14:709-716Kamel FO, Magadmi RM, Alqutub ST et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020210 71. Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden. J Intern Med 2021; Castro Dopico X, Muschiol S, Christian M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34008203 72. COVID-19 reinfection: a rapid systematic review of case reports and case series. J. Investig. Med. 2021; Wang J, Kaperak C, Sato T, Sakuraba A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006572 73. Design of an effective piezoelectric microcantilever biosensor for rapid detection of COVID-19. J. Med. Eng. Technol. 2021:1-11Kabir H, Merati M, Abdekhodaie MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998955 74. A case report of super responder of critical COVID-19 pneumonia. J. Med. Invest. 2021; 68:192-195Kishaba T, Maeda A, Fukuoka S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994470 75. Evaluation of the prognostic role of NLR, LMR, PLR and LCR ratio in COVID-19 patients. J Med Virol 2021; Erdogan A, Can FE, Gönüllü H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019701 76. Genome-wide screening of SARS-CoV-2 infection-related genes based on the blood leucocytes sequencing dataset of patients with COVID-19. J Med Virol 2021; Gao X, Liu Y, Zou S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34009691 77. Evaluation of the relationship between KIM-1 and suPAR levels and clinical severity in COVID-19 patients: A different perspective on suPAR. J Med Virol 2021; Kerget B, Kerget F, Aksakal A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34019703 78. Assessment of salivary antibody response to BNT162b2 mRNA COVID-19 vaccination. J Med Virol 2021; Lapić I, Šegulja D, Rogić D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009653 79. Evaluation of six different rapid methods for nucleic acid detection of SARS- COV-2 virus. J Med Virol 2021; Mahmoud SA, Ganesan S, Ibrahim E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002401 80. Comparative evaluation of Panbio and SD Biosensor antigen rapid diagnostic tests for COVID-19 diagnosis. J Med Virol 2021; Pérez-García F, Romanyk J, Gutiérrez HM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002864 81. Rapid COVID-19 antigenic tests: Usefulness of a modified method for diagnosis. J Med Virol 2021; Reza S, Corentin D, Te-Din H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009649 82. Glycosylation is a key in SARS-CoV-2 infection. J. Mol. Med. (Berl.) 2021; Reis CA, Tauber R, Blanchard V. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023935 83. Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis. J Thromb Haemost 2021; Demelo- Rodriguez P, Farfán-Sedano AI, Pedrajas JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018658 84. Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis. JHEP Rep 2021:100303Kaur S, Hussain S, Kolhe K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997748 85. Microbiological Testing for Coronavirus Disease 2019. Jma j 2021; 4:67- 75Yamamoto K, Ohmagari N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997438 86. SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg. Lancet Reg Health Eur 2021; 4:100056Wilmes P, Zimmer J, Schulz J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33997830 87. Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: A case-control study. Life Sci 2021; 277:119634Karsli E, Sabirli R, Altintas E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015287 88. Selective and electronic detection of COVID-19 (Coronavirus) using carbon nanotube field effect transistor-based biosensor: A proof-of-concept study. Mater Today Proc 2021; Thanihaichelvan M, Surendran SN, Kumanan T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996512 89. Non-invasive Vocal Biomarker is Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Mayo Clin Proc Innov Qual Outcomes 2021; Maor E, Tsur N, Barkai G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007956 90. Personalized Prediction of Hospital Mortality in COVID-19 positive patients. Mayo Clin Proc Innov Qual Outcomes 2021; Rozenbaum D, Shreve J, Radakovich N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002167 91. A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection-SARS-CoV-2 as a Proof of Concept. mBio 2021; 12Rusanen J, Kareinen L, Szirovicza L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006662 92. Skin lesions in children during the first wave of the SARS-CoV-2 pandemic. Med Clin (Barc) 2021; Carazo Gallego B, Martín Pedraz L, Galindo Zavala R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016448 93. COVID-19 swab-related skull base injury. Med. J. Aust. 2021; Mistry SG, Walker W, Earnshaw J, Cervin A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008200 94. Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers. mSphere 2021; 6Murata T, Sakurai A, Suzuki M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34011679 95. Do gene-environment interactions play a role in COVID-19 distribution? The case of Alpha-1 Antitrypsin, air pollution and COVID-19. Multidiscip Respir Med 2021; 16:741Murgia N, Corsico AG, D'Amato G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012547 96. The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients. New Microbes New Infect 2021:100899Caruana G, Lebrun LL, Aebischer O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007453 97. Evaluation of oxidative stress level: total antioxidant capacity, total oxidant status and glutathione activity in patients with Covid-19. New Microbes New Infect 2021:100897Karkhanei B, Ghane ET, Mehri F. http://www.ncbi.nlm.nih.gov/pubmed/?term=34026228 98. SARS-CoV-2 IgG response in symptomatic and asymptomatic COVID-19- infected healthcare workers. Occup. Med. (Lond.) 2021; Cordova E, Bacelar B, Nieto F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008016 99. Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB. Open Med (Wars) 2021; 16:749-753Li W, Huang B, Shen Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013047 100. Distinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-19. Platelets 2021:1-11Chao Y, Rebetz J, Bläckberg A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33999778 101. The sex-related discrepancy in laboratory parameters of severe COVID-19 patients with diabetes: A retrospective cohort study. Prim. Care Diabetes 2021; Hammad MO, Alseoudy MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006475 102. Decreased availability of nitric oxide and hydrogen sulfide is a hallmark of COVID-19. Redox Biol 2021; 43:101982Dominic P, Ahmad J, Bhandari R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020311 103. [C-Reactive protein and SOFA scale: a simple score as early predictor of critical care requirement in patients with COVID-19 pneumonia in Spain.]. Rev. Esp. Anestesiol. Reanim. 2021; Vaquero-Roncero LM, Sánchez-Barrado E, Escobar-Macias D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994585 104. Serum ACE activity and plasma ACE concentration in patients with SARS- CoV-2 infection. Scand. J. Clin. Lab. Invest. 2021:1-4Henry BM, Benoit JL, Rose J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003706 105. Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis. Thromb J 2021; 19:32Xiong X, Chi J, Gao Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011381 106. Galectin-3: Can It Be A Diagnostic Tool For Pneumonia In COVID-19 Patients? Turk J Med Sci 2021; Kartal Baykan E, Şebin E, Karaşahin Ö et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013703 107. Comparison of SARS-CoV-2 indirect and direct RT-qPCR detection methods. Virol J 2021; 18:99Pearson JD, Trcka D, Lu S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001180 108. Frequency of HLA alleles among COVID-19 infected patients: Preliminary data from Saudi Arabia. Virology 2021; 560:1-7Naemi FMA, Al-Adwani S, Al-Khatabi H, Al-Nazawi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015620 109. ------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS. Wellcome Open Res 2021; 6:38Reyes L, M AS-G, Morrison T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997298 110. COVID-19 and hyperglycemia/diabetes. World J. Diabetes 2021; 12:642- 650Michalakis K, Ilias I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995851 111. Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients. World J. Diabetes 2021; 12:590- 602Rojas A, Lindner C, Gonzàlez I, Morales MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995847 112. Treatment refractive hypernatremia with mild COVID-19. Zeitschrift fur Gerontologie und Geriatrie 2021; Künzler T, Münzer T.

Children (36 articles) 1. Impact of the COVID-19 pandemic on parents' perception of health behaviors in children with overweight and obesity. Acad. Pediatr. 2021; Beck AL, Huang JC, Lendzion L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023488 2. COVID-19 in children at Strasbourg University Hospital: A retrospective study of the first 2months of the epidemic. Arch. Pediatr. 2021; Lavaine O, Spizzo J, Arbitre C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020861 3. Effect of Covid-19 quarantine on diabetes Care in Children. Clin Diabetes Endocrinol 2021; 7:9Gayoso M, Lim WY, Mulekar MS, Kaulfers AD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020722 4. Integrating Advocacy for Marginalized Children and Families Into Evidence- Based Care During COVID-19: Clinical Vignettes. Cogn. Behav. Pract. 2021; Bailin A, Burton S, Rego S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994768 5. Where There Is (No) Smoke, There Is Still Fire: a Review of Trends, Reasons for Use, Preferences and Harm Perceptions of Adolescent and Young Adult Electronic Cigarette Use. Curr Pediatr Rep 2021:1-5Gupta PS, Kalagher KM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996271 6. Mysterious multisystem inflammatory syndrome: Life-threatening disease in young people after SARS-CoV-2 infection causes concern. Deutsche Apotheker Zeitung 2021; 161Stahl V. 7. Early Childhood Educators' Wellbeing During the COVID-19 Pandemic. Early Child Educ J 2021:1-11Eadie P, Levickis P, Murray L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994770 8. Children in Monetary Poor Households: Baseline and COVID-19 Impact for 2020 and 2021. Econ Disaster Clim Chang 2021:1-16Fiala O, Delamónica E, Escaroz G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997601 9. Persistence of SARS-CoV-2-Specific IgG in Children 6 Months After Infection, Australia. Emerg Infect Dis 2021; 27Toh ZQ, Higgins RA, Do LAH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016252 10. Serum IgG levels in children 6 months after SARS-CoV-2 infection and comparison with adults. Eur. J. Pediatr. 2021; Bloise S, Marcellino A, Testa A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023936 11. Adolescent and Young Adult ME/CFS After Confirmed or Probable COVID-19. Front Med (Lausanne) 2021; 8:668944Petracek LS, Suskauer SJ, Vickers RF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996867 12. An Overview of Asthma and COVID-19: Protective Factors Against SARS-COV- 2 in Pediatric Patients. Front Pediatr 2021; 9:661206Liuzzo Scorpo M, Ferrante G, La Grutta S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996694 13. Health-Related Quality of Life in Italian Adolescents During Covid-19 Outbreak. Front Pediatr 2021; 9:611136Mastorci F, Piaggi P, Doveri C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996676 14. Survey on the Progression of Myopia in Children and Adolescents in Chongqing During COVID-19 Pandemic. Front Public Health 2021; 9:646770Wang W, Zhu L, Zheng S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33996724 15. Impact of Pediatric COVID-19 on Family Health-Related Quality of Life: A Qualitative Study from Latvia. Glob Pediatr Health 2021; 8:2333794x211012394Stars I, Smane L, Pucuka Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997124 16. Parents' willingness and attitudes concerning the COVID-19 vaccine: A cross- sectional study. Int J Clin Pract 2021:e14364Yılmaz M, Sahin MK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998108 17. Cutaneous manifestations associated with COVID-19 in children: A systematic review. J Family Med Prim Care 2021; 10:93-101Shah S, Akhade K, Ganguly S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017709 18. Delayed access to care and late presentations in children during the COVID-19 pandemic New Zealand-wide lockdown: A New Zealand Paediatric Surveillance Unit study. J. Paediatr. Child Health 2021; Duncanson M, Wheeler BJ, Jelleyman T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003540 19. Sleep disturbances in children with cystic fibrosis, primary ciliary dyskinesia and typically developing children during COVID-19 pandemic. J. Paediatr. Child Health 2021; Sismanlar Eyuboglu T, Aslan AT, Ramaslı Gursoy T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004018 20. Is there an increased incidence of orchiectomy in pediatric patients with acute testicular torsion during COVID-19 pandemic?-A retrospective multicenter study. J. Pediatr. Urol. 2021; Pogorelić Z, Milanović K, Veršić AB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994321 21. Skin lesions in children during the first wave of the SARS-CoV-2 pandemic. Med Clin (Barc) 2021; Carazo Gallego B, Martín Pedraz L, Galindo Zavala R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016448 22. "corona und Du" : A web-based information portal on mental health for children, adolescents and parents. Nervenheilkunde 2021; 40:333-340Elisabeth Piechaczek C, Primbs R, Comanns PM et al. 23. Burden and mental health problems of children and adolescents in Hamburg during the COVID-19 pandemic: Results of the COPSY study Hamburg. Nervenheilkunde 2021; 40:319-326Kaman A, Otto C, Adedeji A et al. 24. Child protection in times of Covid-19 pandemic: Empirical results of a nationwide survey of children and youth welfare authorities. Nervenheilkunde 2021; 40:312-318Mairhofer A, Peucker C, Pluto L, Van Santen E. 25. Changes in Pediatric Sports Injury Presentation During the COVID-19 Pandemic: A Multicenter Analysis. Orthop J Sports Med 2021; 9:23259671211010826Johnson MA, Halloran K, Carpenter C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997072 26. Multiple cardiovascular complications of COVID-19 infection in a young patient: a case report. Pan Afr. Med. J. 2021; 38:192Rasras H, Boudihi A, Hbali A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995798 27. [Not Available]. An Pediatr (Engl Ed) 2021; Esmel-Vilomara R, Dolader P, Sabaté- Rotes A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995537 28. COVID-19 in a child with severe propionic acidemia. Pediatr. Int. 2021; 63:606- 607Saad-Naguib M, Barbouth D, Thorson W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002470 29. Favipiravir use in children with COVID-19 and acute kidney injury: is it safe? Pediatr. Nephrol. 2021:1-6Ozsurekci Y, Oygar PD, Gürlevik SL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021797 30. Impacts of lockdown on dietary patterns among youths in China: the COVID- 19 Impact on Lifestyle Change Survey. Public Health Nutr. 2021:1-12Yu B, Zhang D, Yu W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33993895 31. Rapid Rise of Pediatric Telehealth During COVID-19 in a Large Multispecialty Health System. Telemed J E Health 2021; Howie F, Kreofsky BL, Ravi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999718 32. Changes in pediatric healthcare utilization in Hunan Province, China, during the COVID-19 pandemic: a multi-center cross-sectional study. Transl Pediatr 2021; 10:870-881Yan H, Li X, Lu X et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34012836 33. Analysis of mycoplasma pneumoniae infection among children with respiratory tract infections in hospital in Chengdu from 2014 to 2020. Transl Pediatr 2021; 10:990-997Zhang L, Lai M, Ai T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012847 34. A recently explored aspect of the iceberg named COVID-19: multisystem inflammatory syndrome in children (MIS-C). Turk Arch Pediatr 2021; 56:3- 9Haslak F, Yıldız M, Adrovic A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34013222 35. Childhood immunization during the COVID-19 pandemic in Texas. Vaccine 2021; Nuzhath T, Ajayi KV, Fan Q et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020814 36. Telemedicine in the COVID-19 era: Taking care of children with obesity and diabetes mellitus. World J. Diabetes 2021; 12:651-657Umano GR, Di Sessa A, Guarino S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995852

Clinical Features (57 articles)

1. Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19). Actas Dermosifiliogr. 2020; 111:734-742Carrascosa JM, Morillas V, Bielsa I, Munera- Campos M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012157 2. Cutaneous Manifestations in Patients With COVID-19: Clinical Characteristics and Possible Pathophysiologic Mechanisms. Actas Dermosifiliogr. 2021; 112:314-323González González F, Cortés Correa C, Peñaranda Contreras E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012165 3. Are Oral Mucosal Changes a Sign of COVID-19? A Cross-Sectional Study at a Field Hospital. Actas Dermosifiliogr (Engl Ed) 2021; Nuño González A, Magaletskyy K, Martín Carrillo P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994549 4. Changes of clinical characteristics of asymptomatic patients with positive SARS-Cov-2 nucleic acid test during treatment cycle and related risk factors. Am J Transl Res 2021; 13:3650-3657Li S, Li J, Cao D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017547 5. COVID-19 in children at Strasbourg University Hospital: A retrospective study of the first 2months of the epidemic. Arch. Pediatr. 2021; Lavaine O, Spizzo J, Arbitre C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020861 6. Clustering of COVID-19 Symptoms Among Iranian Patients: The Role of Preexisting Comorbidity on Latent Class Membership. Asia Pac. J. Public Health 2021:10105395211017755Moradi-Asl E, Adham D, Ghobadi H, Abbasi- Ghahramanloo A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018399 7. SARS-CoV-2 PCR-positive and PCR-negative cases of pneumonia admitted to the hospital during the peak of COVID-19 pandemic: analysis of in-hospital and post-hospital mortality. BMC Infect. Dis. 2021; 21:458Gaipov A, Gusmanov A, Abbay A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016043 8. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med 2021; 19:129Romero-Duarte Á, Rivera-Izquierdo M, Guerrero-Fernández de Alba I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011359 9. Tongue ulcer in a patient with COVID-19: a case presentation. BMC Oral Health 2021; 21:273Nejabi MB, Noor NAS, Raufi N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016110 10. Complicated case of COVID-19 disease with overlapping features of thrombotic thrombocytopenic purpura and haemophagocytic lymphohistiocytosis. BMJ Case Rep. 2021; 14Verma DP, Dandu H, Yadav G, Verma SP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011641 11. Diagnostic accuracy of subjective dyspnoea in detecting hypoxaemia among outpatients with COVID-19: a retrospective cohort study. BMJ Open 2021; 11:e046282Berezin L, Zhabokritsky A, Andany N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006036 12. Heterogeneity in COVID-19 patient volume, characteristics and outcomes across US Department of Veterans Affairs facilities: an observational cohort study. BMJ Open 2021; 11:e044646Bravata DM, Myers LJ, Perkins AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006034 13. OLFACTORY AND GUSTATORY DYSFUNCTIONS IN SARS-CoV-2 INFECTION. Brain Behav Immun Health 2021:100268Boscutti A, Delvecchio G, Pigoni A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34027497 14. Incidence and Clinical Features of Venous Thromboembolism in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan. Circ. J. 2021; Yamashita Y, Maruyama Y, Satokawa H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34011824 15. Quantitative assessment of retinal changes in COVID-19 patients. Clin. Exp. Optom. 2021:1-6Oren B, Aksoy Aydemır G, Aydemır E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016010 16. Profiling Cases With Nonrespiratory Symptoms and Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Mexico City. Clin Infect Dis 2021; 72:e655-e658Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vázquez A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32857829 17. Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United States. Clin Infect Dis 2021; 72:e558-e565Fried MW, Crawford JM, Mospan AR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32856034 18. Differential Cytokine Signatures of SARS-CoV-2 and Influenza Infection Highlight Key Differences in Pathobiology. Clin Infect Dis 2021; Karaba AH, Zhou W, Hsieh LL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013339 19. Cutaneous manifestations of infections: an update for general physicians. Clin Med (Lond) 2021; 21:174-176Morris-Jones R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34001567 20. Integrating Advocacy for Marginalized Children and Families Into Evidence- Based Care During COVID-19: Clinical Vignettes. Cogn. Behav. Pract. 2021; Bailin A, Burton S, Rego S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994768 21. Hypothermia is Associated With Poor Prognosis in Hospitalized Patients With Severe COVID-19 Symptoms. Cureus 2021; 13:e14526Maait Y, El Khoury M, McKinley L, El Khoury A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007774 22. Clinical characteristics and abnormal parameters evolution in patients with novel coronavirus infection: a case series of 272 cases in Guangzhou. Disaster Med Public Health Prep 2021:1-26Wang Y, Hu Z, Luo J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002684 23. Clinical features and prognostic factors in Covid-19: A prospective cohort study. EBioMedicine 2021; 67:103378de Bruin S, Bos LD, van Roon MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000622 24. Endocrine and metabolic aspects of Covid-19. Endokrynol. Pol. 2021; Pawlikowski M, Winczyk K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010445 25. Clinical outcomes of coronavirus disease 2019 (COVID-19) amongst HIV patients: a systematic literature review. Epidemiol Health 2021:e2021036Massarvva T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015893 26. Coronary artery ectasia in a child after arterial switch operation for transposition of the great arteries and suspected multisystem inflammatory syndrome in children associated with COVID-19: a case report. Eur Heart J Case Rep 2021; 5:ytab143Sobh M, Jensen-Kondering U, Voges I, Boroni Grazioli SB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013161 27. Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1). Front. Immunol. 2021; 12:593595Choreño-Parra JA, Jiménez-Álvarez LA, Cruz-Lagunas A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33995342 28. Geographical Variations in Host Predisposition to COVID-19 Related Anosmia, Ageusia, and Neurological Syndromes. Front Med (Lausanne) 2021; 8:661359Kumar AA, Lee SWY, Lock C, Keong NC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996863 29. Hearing Loss-a Camouflaged Manifestation of COVID 19 Infection. Indian J Otolaryngol Head Neck Surg 2021:1-5Dharmarajan S, Bharathi MB, Sivapuram K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996529 30. Maxillofacial Infections in Covid-19 Era-Actuality or the Unforeseen: 2 Case Reports. Indian J Otolaryngol Head Neck Surg 2021:1-4Sai Krishna D, Raj H, Kurup P, Juneja M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34026593 31. Making scents of loss of taste in COVID-19: Is self-reported loss of taste due to olfactory dysfunction? A prospective study using psychophysical testing. Int Forum Allergy Rhinol 2021; Le Bon SD, Payen L, Prunier L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013654 32. Clinical-radiological correlations in COVID-19-related venous thromboembolism: preliminary results from a multidisciplinary study. Int J Clin Pract 2021:e14370Wu MA, Colombo R, Arquati M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998752 33. Clinical presentation, outcomes and factors associated with mortality: a prospective study from three COVID-19 referral care centers in West Africa. Int J Infect Dis 2021; Jaspard M, Sow MS, Juchet S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000419 34. Day by day symptoms following positive and negative PCR tests for SARS- CoV-2 in non-hospitalised health-care workers: a 90-day follow-up study. Int J Infect Dis 2021; Nielsen KJ, Vestergaard JM, Schlünssen V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022336 35. Obstructive sleep apnea and COVID-19 clinical outcomes during hospitalization: a cohort study. J. Clin. Sleep Med. 2021; Mashaqi S, Lee-Iannotti J, Rangan P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019476 36. Detection of a second outbreak of chilblain-like lesions during COVID-19 pandemic through teledermatology. J Eur Acad Dermatol Venereol 2021; Giraud- Kerleroux L, Mongereau M, Cassius C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34014574 37. Frequent clinical and radiological manifestations of the Novel SARS-CoV-2: A review article. J Family Med Prim Care 2021; 10:122-126Alshoabi SA, Alhazmi FH, Abdulaal OM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017713 38. Cutaneous manifestations associated with COVID-19 in children: A systematic review. J Family Med Prim Care 2021; 10:93-101Shah S, Akhade K, Ganguly S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017709 39. Clinical outcomes of patients hospitalized for COVID-19 and evidence-based on the pharmacological management reduce mortality in a region of the Colombian Caribbean. J Infect Public Health 2021; 14:696-701García-Posada M, Aruachan-Vesga S, Mestra D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020208 40. Clinical and hematologic presentations of adults with COVID-19 patients in Jeddah: A case control study. J Infect Public Health 2021; 14:709-716Kamel FO, Magadmi RM, Alqutub ST et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020210 41. Clinical Characteristics of COVID-19: Risk Factors for Early Oxygen Requirement after Hospitalization. J Korean Med Sci 2021; 36:e139Suh HJ, Lee E, Park SW. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002553 42. A case report of super responder of critical COVID-19 pneumonia. J. Med. Invest. 2021; 68:192-195Kishaba T, Maeda A, Fukuoka S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994470 43. Interventions targeting non-symptomatic cases can be important to prevent local outbreaks: SARS-CoV-2 as a case study. J R Soc Interface 2021; 18:20201014Lovell-Read FA, Funk S, Obolski U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006127 44. SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg. Lancet Reg Health Eur 2021; 4:100056Wilmes P, Zimmer J, Schulz J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33997830 45. Skin lesions in children during the first wave of the SARS-CoV-2 pandemic. Med Clin (Barc) 2021; Carazo Gallego B, Martín Pedraz L, Galindo Zavala R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016448 46. A Novel Non-Invasive Device for the Assessment of Central Venous Pressure in Hospital, Office and Home. Med Devices (Auckl) 2021; 14:141-154Marcelli E, Cercenelli L, Bortolani B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012302 47. Clinical features of 50 cases of 2019 novel coronavirus in Bandar Abbas, Iran. Med. J. Islam. Repub. Iran 2021; 35:7Jarineshin H, Saljoughi F, Estabraghnia Babaki H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996658 48. Cutaneous hemorrhagic bullae in a patient with COVID-19: A case report. Med. J. Islam. Repub. Iran 2021; 35:15Karimi Alavije M, Karbalaie Niya MH, Sadeghzadeh-Bazargan A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33996666 49. Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers. mSphere 2021; 6Murata T, Sakurai A, Suzuki M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34011679 50. NSGA-II as feature selection technique and AdaBoost classifier for COVID-19 prediction using patient's symptoms. Nonlinear Dyn 2021:1-23Soui M, Mansouri N, Alhamad R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025034 51. Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB. Open Med (Wars) 2021; 16:749-753Li W, Huang B, Shen Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013047 52. Prevalence of anosmia and ageusia symptoms among long-term effects of COVID-19. Oral Dis 2021; Moraschini V, Reis D, Sacco R, Calasans-Maia MD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002923 53. Timing of onset of symptom for COVID-19 from publicly reported confirmed cases in Uganda. Pan Afr. Med. J. 2021; 38:168Ario AR, Mirembe BB, Biribawa C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995775 54. Ketoacidosis as a primary manifestation of COVID-19. Pediatr. Endocrinol. Diabetes Metab. 2021; Akbarizadeh M, Naderifar M, Ghanizadegan P, Akbarizadeh M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008395 55. Making sense of COVID-19: a longitudinal investigation of the initial stages of developing illness representations. Psychol. Health 2021:1-17Shiloh S, Peleg S, Nudelman G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998908 56. [Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry]. Rev Clin Esp 2020; 220:480- 494Casas-Rojo JM, Antón-Santos JM, Millán-Núñez-Cortés J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994573 57. Clinical characteristics and outcomes of 1,331 patients with COVID-19: HM Spanish Cohort. Rev. Esp. Quimioter. 2021; Cardinal-Fernández P, Garcia Cuesta E, Barberán J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008930

CNS (18 articles)

1. SARS-CoV-2 vaccines are not free of neurological side effects. Acta Neurol. Scand. 2021; Finsterer J, Scorza FA. http://www.ncbi.nlm.nih.gov/pubmed/? term=34002379 2. The need for psychological, caregiver-centered intervention in the time of COVID-19. Alzheimers Dement (N Y) 2021; 7:e12166Ortelli P, Ferrazzoli D, Versace V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013019 3. COVID-19-Induced Encephalitis: A Case Report of a Rare Presentation With a Prolonged Electroencephalogram. Cureus 2021; 13:e14476Miqdad MA, Enabi S, Alshurem M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007736 4. Unexplained worsening of parkinsonian symptoms in a patient with advanced Parkinson's disease as the sole initial presentation of COVID-19 infection: a case report. Egypt J Neurol Psychiatr Neurosurg 2021; 57:60Kamel WA, Ismail, II, Ibrahim M, Al-Hashel JY. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025113 5. Neurological consequences of neurovascular unit and brain vasculature damages: potential risks for pregnancy infections and COVID-19-babies. Febs j 2021; Rasile M, Lauranzano E, Mirabella F, Matteoli M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998773 6. Geographical Variations in Host Predisposition to COVID-19 Related Anosmia, Ageusia, and Neurological Syndromes. Front Med (Lausanne) 2021; 8:661359Kumar AA, Lee SWY, Lock C, Keong NC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996863 7. Adolescent and Young Adult ME/CFS After Confirmed or Probable COVID-19. Front Med (Lausanne) 2021; 8:668944Petracek LS, Suskauer SJ, Vickers RF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996867 8. Intracranial hypertension and visual loss following COVID-19: A case report. Indian J Ophthalmol 2021; 69:1625-1627Ilhan B, Cokal BG, Mungan Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011757 9. Contradictory Responses to the COVID-19 Pandemic in Amyotrophic Lateral Sclerosis Patients and Their Families and Caregivers in Japan. Intern Med 2021; 60:1519-1524Yanagihashi M, Sugisawa T, Fuchimoto M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994445 10. Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome requires cerebro-spinal-fluid studies. J. Neuroimmunol. 2021; 357:577609Finsterer J, Scorza FA, Scorza CA, Fiorini AC. http://www.ncbi.nlm.nih.gov/pubmed/? term=34023795 11. Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung. J. Neurol. 2021:1-6Bulfamante G, Bocci T, Falleni M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003372 12. COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2. J. Neurol. 2021:1-31Sriwastava S, Tandon M, Podury S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009454 13. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci 2021; 426:117486Frontera JA, Yang D, Lewis A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000678 14. Post-infectious neurologic complications in Covid-2019: a complex case report. J Nucl Med 2021; Tiraboschi P, Xhani R, Zerbi SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016729 15. COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies. Mult Scler Relat Disord 2021; 52:102939Garjani A, Middleton RM, Hunter R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010764 16. The course of COVID-19 infection in patients with multiple sclerosis-The experience of one center based on the population of Upper Silesia. Mult Scler Relat Disord 2021; 52:102984Nowak-Kiczmer M, Kubicka-Bączyk K, Niedziela N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000683 17. Lessons from the COVID-19 pandemic for improving outpatient neuropalliative care: A qualitative study of patient and caregiver perspectives. Palliat. Med. 2021:2692163211017383Macchi ZA, Ayele R, Dini M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006157 18. [Features of the morphological manifestations of COVID-19-associated with acute hemorrhagic necrotizing encephalopathy in adults]. Sud. Med. Ekspert. 2021; 64:52-55Ermilov VV, Barkanov VB, Barkanova ON, Filatov VE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013697

Coagulation (35 articles)

1. COVID-19: coagulation disorders and anticoagulant treatment in patients hospitalised in ICU. Anaesthesiol Intensive Ther 2021; Pluta J, Cieniewicz A, Trzebicki J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006056 2. COVID-19-associated central retinal vein occlusion treated with oral aspirin. BMJ Case Rep. 2021; 14Venkatesh R, Reddy NG, Agrawal S, Pereira A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011649 3. Complicated case of COVID-19 disease with overlapping features of thrombotic thrombocytopenic purpura and haemophagocytic lymphohistiocytosis. BMJ Case Rep. 2021; 14Verma DP, Dandu H, Yadav G, Verma SP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011641 4. Changes of coagulation function and risk of stroke in patients with COVID-19. Brain Behav 2021:e02185Qiu F, Wu Y, Zhang A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998177 5. Incidence and Clinical Features of Venous Thromboembolism in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan. Circ. J. 2021; Yamashita Y, Maruyama Y, Satokawa H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34011824 6. Thrombotic Events in COVID-19: Inquires About the Deleterious Procoagulant Effect of Corticosteroid Therapy. Clin. Appl. Thromb. Hemost. 2021; 27:10760296211020139Crisan-Dabija R, Burlacu A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018412 7. Complications in COVID-19 patients: Characteristics of pulmonary embolism. Clin Imaging 2021; 77:244-249Cau R, Pacielli A, Fatemeh H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34029929 8. Simultaneous bilateral mechanical thrombectomy in a patient with COVID-19. Clin. Neurol. Neurosurg. 2021; 206:106677Khanna O, Hafazalla K, Saiegh FA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020326 9. Acute Necrotizing Encephalopathy Associated With SARS-CoV-2 Exposure in a Pediatric Patient. Cureus 2021; 13:e15018Lazarte-Rantes C, Guevara-Castañón J, Romero L, Guillén-Pinto D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017667 10. Secondary Immune Thrombocytopenic Purpura Triggered by COVID-19. Cureus 2021; 13:e14505Watts A, Raj K, Gogia P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007758 11. Contemporary Catheter-Based Treatment Options for Management of Acute Pulmonary Embolism. Curr. Treat. Options Cardiovasc. Med. 2021; 23:44Singh M, Shafi I, Rali P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994774 12. Cerebral venous thrombosis in COVID-19. Diabetes Metab Syndr 2021; 15:1039- 1045Ghosh R, Roy D, Mandal A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34015627 13. Defective NET clearance contributes to sustained FXII activation in COVID-19- associated pulmonary thrombo-inflammation. EBioMedicine 2021; 67:103382Englert H, Rangaswamy C, Deppermann C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000623 14. Intracranial hypertension and visual loss following COVID-19: A case report. Indian J Ophthalmol 2021; 69:1625-1627Ilhan B, Cokal BG, Mungan Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011757 15. A Case Series of Life-Threatening Hemorrhagic Events in Patients with COVID- 19. Indian J Surg 2021:1-7Hajian A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994698 16. The complicated relationships of heparin-induced thrombocytopenia and platelet factor 4 antibodies with COVID-19. Int. J. Lab. Hematol. 2021; Favaloro EJ, Henry BM, Lippi G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000089 17. Severity of COVID-19 in Cancer patients versus patients without Cancer: A Propensity Score Matching Analysis. J. Cancer 2021; 12:3558-3565Liu C, Wang K, Li L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995633 18. Thrombotic Microangiopathy in a Patient With COVID-19 Infection and Metastatic Cholangiocarcinoma. J Hematol 2021; 10:83-88Sharma S, Pavuluri S, Srinivasan K, Ghouse M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007371 19. Impact of SARS-CoV-2 infection on acute intracerebral haemorrhage in northern Italy. J Neurol Sci 2021; 426:117479Sangalli D, Martinelli-Boneschi F, Versino M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004463 20. Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis. J Thromb Haemost 2021; Demelo- Rodriguez P, Farfán-Sedano AI, Pedrajas JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018658 21. Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology. J Thromb Haemost 2021; Nazy I, Sachs UJ, Arnold DM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018298 22. Practical Recommendations for the Management of Patients with ITP During the COVID-19 Pandemic. Mediterr. J. Hematol. Infect. Dis. 2021; 13:e2021032Rodeghiero F, Cantoni S, Carli G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007420 23. [High frequency of endoluminal thrombus in patients with ischaemic stroke following COVID-19]. Neurologia 2021; Gómez-Porro P, Cabal-Paz B, Valenzuela- Chamorro S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994626 24. Late pulmonary embolism in a patient with non-severe COVID-19: case report, value of antithrombotic prophylaxis and literature review. Pan Afr. Med. J. 2021; 38:185Maloumbi PBI, Hassouni A, Ibara-Onguema JR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995791 25. Several cases of arterial thrombosis of the limbs revealing asymptomatic and paucisymptomatic COVID-19 infection. Pan Afr. Med. J. 2021; 38:209Niang I, Thioub D, Ly M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995815 26. COVID-19 Induced Mesenteric Venous Infarction. Radiol Case Rep 2021; Calcagno E, Sogunro O, Nepal P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33995746 27. Comparison of the coagulopathies associated with COVID-19 and sepsis. Res Pract Thromb Haemost 2021; 5:e12525Campbell RA, Hisada Y, Denorme F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34027292 28. Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort study. Res Pract Thromb Haemost 2021; 5:e12521Weeks LD, Sylvester KW, Connors JM, Connell NT. http://www.ncbi.nlm.nih.gov/pubmed/? term=34013153 29. Veno-arterial thrombosis and microcirculation imaging in a patient with COVID-19. Respir Med Case Rep 2021; 33:101428Akin S, van Hooven D, Ince C, Jansen T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996436 30. [Features of the morphological manifestations of COVID-19-associated with acute hemorrhagic necrotizing encephalopathy in adults]. Sud. Med. Ekspert. 2021; 64:52-55Ermilov VV, Barkanov VB, Barkanova ON, Filatov VE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013697 31. Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report. Ther Adv Hematol 2021; 12:20406207211011353Gruden G, Beggiato E, Camerino E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995989 32. Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis. Thromb J 2021; 19:32Xiong X, Chi J, Gao Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011381 33. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine 2021; Welsh KJ, Baumblatt J, Chege W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006408 34. PERTinent new insights into venous thromboembolism risk and management in hospitalized patients with COVID-19. Vasc. Med. 2021:1358863x211012776Han H, Barnes GD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014133 35. Effect of aspirin on short-term outcomes in hospitalized patients with COVID- 19. Vasc. Med. 2021:1358863x211012754Sahai A, Bhandari R, Godwin M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010070

Complications (53 articles)

1. COVID-19: A Potential Trigger for Thyroid Dysfunction. Am. J. Med. Sci. 2021; Ashraf S, Imran MA, Ashraf S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34023311 2. Noninvasive ventilation and positional therapy in COVID-19: Case report and literature review. Anaesthesist 2021; Sellmann T, Maurer C, Thal SC. 3. COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies. Biomed. Pharmacother. 2021; 140:111685Hua S, Yang Y, Zou D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015585 4. The repurposed use of anesthesia machines to ventilate critically ill patients with coronavirus disease 2019 (COVID-19). BMC Anesthesiol. 2021; 21:155Bottiroli M, Calini A, Pinciroli R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34016056 5. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med 2021; 19:129Romero-Duarte Á, Rivera-Izquierdo M, Guerrero-Fernández de Alba I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011359 6. A rare case report of late-onset phytobezoar formation following laparoscopic sleeve gastrectomy: delayed redo bariatric surgery. BMC Surg. 2021; 21:254Aryannezhad S, Sadeghian Y, Shapoori P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022864 7. Preseptal cellulitis and infraorbital abscess as a complication of a routine COVID-19 swab. BMJ Case Rep. 2021; 14Fazekas B, Fazekas B, Darraj E, Jayakumar D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011639 8. Complicated case of COVID-19 disease with overlapping features of thrombotic thrombocytopenic purpura and haemophagocytic lymphohistiocytosis. BMJ Case Rep. 2021; 14Verma DP, Dandu H, Yadav G, Verma SP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011641 9. The emerging role of cellular senescence in complications of COVID-19. Cancer Treat Res Commun 2021; 28:100399Mohiuddin M, Kasahara K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023769 10. Complications in COVID-19 patients: Characteristics of pulmonary embolism. Clin Imaging 2021; 77:244-249Cau R, Pacielli A, Fatemeh H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34029929 11. Significantly Lower Case-fatality Ratio of Coronavirus Disease 2019 (COVID- 19) than Severe Acute Respiratory Syndrome (SARS) in Hong Kong-A Territory-Wide Cohort Study. Clin Infect Dis 2021; 72:e466-e475Lui GC, Yip TC, Wong VW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33005933 12. Non-intubated COVID-19 patients despite high levels of supplemental oxygen. Crit Care 2021; 25:170Chosidow S, Plantefève G, Fraissé M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001221 13. Myeloma Cast Nephropathy and COVID-19: A Case Report of Multiple Myeloma Presenting as Acute Kidney Injury in the Setting of COVID-19. Cureus 2021; 13:e14461Memon W, Popli K, Akram A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996321 14. COVID-19-Induced Encephalitis: A Case Report of a Rare Presentation With a Prolonged Electroencephalogram. Cureus 2021; 13:e14476Miqdad MA, Enabi S, Alshurem M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007736 15. Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review. Dermatol Ther (Heidelb) 2021:1-8Diez-Domingo J, Parikh R, Bhavsar AB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999370 16. Cerebral venous thrombosis in COVID-19. Diabetes Metab Syndr 2021; 15:1039- 1045Ghosh R, Roy D, Mandal A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34015627 17. Defective NET clearance contributes to sustained FXII activation in COVID-19- associated pulmonary thrombo-inflammation. EBioMedicine 2021; 67:103382Englert H, Rangaswamy C, Deppermann C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000623 18. Unexplained worsening of parkinsonian symptoms in a patient with advanced Parkinson's disease as the sole initial presentation of COVID-19 infection: a case report. Egypt J Neurol Psychiatr Neurosurg 2021; 57:60Kamel WA, Ismail, II, Ibrahim M, Al-Hashel JY. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025113 19. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration. Front. Immunol. 2021; 12:589095Chen R, Lan Z, Ye J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995341 20. Prediction of COVID-19 Hospital Length of Stay and Risk of Death Using Artificial Intelligence-Based Modeling. Front Med (Lausanne) 2021; 8:592336Mahboub B, Bataineh MTA, Alshraideh H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017839 21. COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities. Front Med (Lausanne) 2021; 8:672028Manansala M, Chopra A, Baughman RP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996868 22. Intracranial hypertension and visual loss following COVID-19: A case report. Indian J Ophthalmol 2021; 69:1625-1627Ilhan B, Cokal BG, Mungan Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011757 23. Orbital infarction syndrome secondary to rhino-orbital mucormycosis in a case of COVID-19: Clinico-radiological features. Indian J Ophthalmol 2021; 69:1627-1630Rao R, Shetty AP, Nagesh CP. http://www.ncbi.nlm.nih.gov/pubmed/? term=34011758 24. Rise of the phoenix: Mucormycosis in COVID-19 times. Indian J Ophthalmol 2021; 69:1563-1568Ravani SA, Agrawal GA, Leuva PA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011742 25. A Case Series of Life-Threatening Hemorrhagic Events in Patients with COVID- 19. Indian J Surg 2021:1-7Hajian A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994698 26. The complicated relationships of heparin-induced thrombocytopenia and platelet factor 4 antibodies with COVID-19. Int. J. Lab. Hematol. 2021; Favaloro EJ, Henry BM, Lippi G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000089 27. Length of Stay in ICU of Covid-19 patients in England, March - May 2020. Int J Popul Data Sci 2021; 5:1411Shryane N, Pampaka M, Aparicio-Castro A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007893 28. Severity of COVID-19 in Cancer patients versus patients without Cancer: A Propensity Score Matching Analysis. J. Cancer 2021; 12:3558-3565Liu C, Wang K, Li L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995633 29. A Simplified Comorbidity Evaluation Predicting Clinical Outcomes Among Patients With Coronavirus Disease 2019. J. Clin. Med. Res. 2021; 13:237- 244Kirby JJ, Shaikh S, Bryant DP et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34007362 30. Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease. J Clin Transl Hepatol 2021; 9:256-264Premkumar M, Kedarisetty CK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007808 31. Cancer, transplant, and immunocompromising conditions were not significantly associated with severe illness or death in hospitalized COVID-19 patients. J Clin Virol 2021; 140:104850Krasnow MR, Litt HK, Lehmann CJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022753 32. Logistical Challenge With Prehospital Use of High-Flow Nasal Oxygen Therapy in COVID-19-Induced Respiratory Distress: A Case Report. J. Emerg. Med. 2021; Kedzierewicz R, Derkenne C, Fraudin A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994257 33. Predictors of mortality and the need of mechanical ventilation in confirmed COVID-19 patients presenting to the emergency department in North India. J Family Med Prim Care 2021; 10:542-549Suresh S, Tiwari A, Mathew R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017785 34. Regional differences in COVID-19 ICU admission rates in the Kingdom of Saudi Arabia: A simulation of the new model of care under vision 2030. J Infect Public Health 2021; 14:717-723Alharbi AA, Alqassim AY, Gosadi IM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020211 35. Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study. J Infect Public Health 2021; 14:726-733Alrashed AA, Khan TM, Alhusseini NK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020213 36. Pulmonary Barotrauma in COVID-19 Patients With ARDS on Invasive and Non- Invasive Positive Pressure Ventilation. J. Intensive Care Med. 2021:8850666211019719Rajdev K, Spanel AJ, McMillan S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013825 37. Elective laparoscopic colectomy in a patient 3 weeks after coronavirus disease 2019 infection: a case report. J Med Case Rep 2021; 15:275Tateno Y, Harada K, Okamoto F, Katsuragawa H. http://www.ncbi.nlm.nih.gov/pubmed/? term=34006322 38. Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology. J Thromb Haemost 2021; Nazy I, Sachs UJ, Arnold DM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018298 39. Prevalence and impact of Clostridioides difficile infection among hospitalized patients with coranavirus disease 2019. JGH Open 2021; 5:622-625Allegretti JR, Nije C, McClure E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013064 40. Ventilated COVID-19 patients: A call to action. Laryngo- Rhino- Otologie 2021; 100:342Kessing R. 41. Invasive Fungal Sinusitis in Post COVID-19 Patients: A New Clinical Entity. Laryngoscope 2021; El-Kholy NA, El-Fattah AMA, Khafagy YW. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009676 42. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19. Liver Int 2021; Bütikofer S, Lenggenhager D, Garcia PDW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018314 43. Multisystem inflammatory syndrome associated with SARS-CoV-2 in a Japanese girl. Pediatr. Int. 2021; Baba T, Maruyama T, Katsuragi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009707 44. COVID-19 in a child with severe propionic acidemia. Pediatr. Int. 2021; 63:606- 607Saad-Naguib M, Barbouth D, Thorson W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002470 45. Weaning from Mechanical Ventilation in Patients with SARS-CoV-2 Infection after Prolonged Mechanical Ventilation: First Experience. Pneumologie 2021; 75:261-267Schäfer H, Michels IC, Bucher B et al. 46. Massive Emphysema Subcutis, pneumothorax, Pneumomediastinum and Pneumoperitoneum as Uncommon Complication of COVID-19 Pneumonia, a Rare Case. Radiol Case Rep 2021; Utomo SA, Notopuro F, Rosalina S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995744 47. Comparison of the coagulopathies associated with COVID-19 and sepsis. Res Pract Thromb Haemost 2021; 5:e12525Campbell RA, Hisada Y, Denorme F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34027292 48. Prediction of Extubation Failure in COVID-19. Respir. Care 2021; de Andrade Filho PH, de Assis Brasil ES, Costa LG et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34006593 49. Veno-arterial thrombosis and microcirculation imaging in a patient with COVID-19. Respir Med Case Rep 2021; 33:101428Akin S, van Hooven D, Ince C, Jansen T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996436 50. [COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult]. Rev. Esp. Anestesiol. Reanim. 2020; Elouardi Y, Houssam R, Zarrouki Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994586 51. Pneumomediastinum in COVID-19: A series of three cases and review of literature. SAGE Open Med Case Rep 2021; 9:2050313x211011807Machiraju PK, Alex NM, Safinaaz, Baby NM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017591 52. Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report. Ther Adv Hematol 2021; 12:20406207211011353Gruden G, Beggiato E, Camerino E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995989 53. Reusable Elastomeric Respirators in HealthCare. Workplace Health Saf. 2021; 69:291-292Pompeii L, Hines SE. http://www.ncbi.nlm.nih.gov/pubmed/? term=33998347

Cured – Recovered (26 articles)

1. Evaluation of High-Sensitivity Cardiac Troponin T Levels in Japanese Patients Recently Recovered From Coronavirus Disease 2019. Circ. J. 2021; Ide S, Hayama H, Asai Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994409 2. Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics. Clin Infect Dis 2021; Hirschtick JL, Titus AR, Slocum E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007978 3. Factors Associated with Readmission in the US Following Hospitalization with COVID-19. Clin Infect Dis 2021; Verna EC, Landis C, Brown RS, Jr. et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015106 4. Long COVID and the brain network of Proust's madeleine: targeting the olfactory pathway. Clin Microbiol Infect 2021; Guedj E, Lazarini F, Morbelli S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015528 5. Myopathic changes in patients with long-term fatigue after COVID-19. Clin. Neurophysiol. 2021; Agergaard J, Leth S, Pedersen TH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020890 6. Dead space estimates may not be independently associated with 28-day mortality in COVID-19 ARDS. Crit Care 2021; 25:171Morales-Quinteros L, Neto AS, Artigas A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001222 7. Fit again?! - How one can become physically active after COVID-19 infection. Deutsche Apotheker Zeitung 2021; 161. 8. Respiratory follow-up after hospitalization for COVID-19: who and when? Eur. J. Clin. Invest. 2021:e13603Riou M, Marcot C, Oulehri W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998683 9. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data. Front Med (Lausanne) 2021; 8:653516Salamanna F, Veronesi F, Martini L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017846 10. Intermittent Hypoxic Preconditioning: A Potential New Powerful Strategy for COVID-19 Rehabilitation. Front. Pharmacol. 2021; 12:643619Cai M, Chen X, Shan J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995053 11. Post-COVID Recovery Assessment Clinics: A Real Need of Time. Innov Pharm 2021; 12Raza MA, Aziz S, Shahzad S, Raza SM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007667 12. Normal adrenal and thyroid function in patients who survive COVID-19 infection. J. Clin. Endocrinol. Metab. 2021; Clarke SA, Phylactou M, Patel B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008009 13. Prevalence and cross states comparison of case fatality rate and recovery rate of COVID 19/SARS-COV-2 in India. J Family Med Prim Care 2021; 10:475-480AA ZA, Desai HD, Sharma K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34017773 14. COVID-19 reinfection: a rapid systematic review of case reports and case series. J. Investig. Med. 2021; Wang J, Kaperak C, Sato T, Sakuraba A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006572 15. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci 2021; 426:117486Frontera JA, Yang D, Lewis A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000678 16. Post-infectious neurologic complications in Covid-2019: a complex case report. J Nucl Med 2021; Tiraboschi P, Xhani R, Zerbi SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016729 17. Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute- Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome. J. Proteome Res. 2021; Holmes E, Wist J, Masuda R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009992 18. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 2021; 6:100122Augustin M, Schommers P, Stecher M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34027514 19. What's going on following acute covid-19? Clinical characteristics of patients in an out-patient rehabilitation program. NeuroRehabilitation 2021; Albu S, Zozaya NR, Murillo N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998551 20. Re-infection or Relapse of COVID-19 in Health Care workers; case series of 2 Patients from Pakistan. New Microbes New Infect 2021:100896Ahmed A, Sana F, Ikram A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996101 21. [The Long-COVID Syndrome - a New Clinical Picture after COVID-19 Infection]. Praxis (Bern 1994) 2021; 110:377-382Funke-Chambour M, Feldmeyer L, Hoepner R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019446 22. Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study. Respir. Med. 2021; 184:106435Frija-Masson J, Debray MP, Boussouar S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020126 23. Preexisting cardiorespiratory comorbidity does not preclude the success of multidisciplinary rehabilitation in post-COVID-19 patients. Respir. Med. 2021; 184:106470Maniscalco M, Fuschillo S, Ambrosino P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022502 24. Clinical outcomes and quality of life of COVID-19 survivors: A follow-up of 3 months post hospital discharge. Respir. Med. 2021; 184:106453Todt BC, Szlejf C, Duim E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010740 25. Pulmonary arterial hypertension post COVID-19: A sequala of SARS-CoV-2 infection? Respir Med Case Rep 2021; 33:101429Khan AW, Ullah I, Khan KS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996435 26. [The role of micronutrients in the comprehensive rehabilitation of patients with the novel coronavirus infection COVID-19]. Vopr. Pitan. 2021; 90:40- 49Marchenkova LA, Makarova EV, Yurova OV. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019347

Cardiovascular disease (53 articles)

1. Chloroquine- and Hydroxychloroquine-Induced Cardiomyopathy: A Case Report and Brief Literature Review. Am J Clin Pathol 2021; 155:793-801Nadeem U, Raafey M, Kim G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33316045 2. Prognostic value of right ventricular strain pattern on ECG in COVID-19 patients. Am J Emerg Med 2021; 49:1-5Barman HA, Atici A, Sahin I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34029783 3. Interpretation of myocardial injury subtypes in COVID-19 disease per fourth version of Universal Definition of Myocardial Infarction. Biomarkers 2021:1- 9Salbach C, Mueller-Hennessen M, Biener M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998352 4. Symptomatic sinus bradycardia due to electrolyte imbalances in syndrome of inappropriate antidiuretic hormone (SIADH) related covid-19: a case report. BMC Infect. Dis. 2021; 21:465Amir M, Renata A, Ratana LT. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020617 5. COVID-19-associated central retinal vein occlusion treated with oral aspirin. BMJ Case Rep. 2021; 14Venkatesh R, Reddy NG, Agrawal S, Pereira A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011649 6. Changes of coagulation function and risk of stroke in patients with COVID-19. Brain Behav 2021:e02185Qiu F, Wu Y, Zhang A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998177 7. Impact of ECG Characteristics on the Performance of an Artificial Intelligence Enabled ECG for Predicting Left Ventricular Dysfunction. Circ Arrhythm Electrophysiol 2021; 14:e009871Perez-Downes J, Fitzgerald P, Adedinsewo D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33993719 8. Incidence and Clinical Features of Venous Thromboembolism in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan. Circ. J. 2021; Yamashita Y, Maruyama Y, Satokawa H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34011824 9. Complications in COVID-19 patients: Characteristics of pulmonary embolism. Clin Imaging 2021; 77:244-249Cau R, Pacielli A, Fatemeh H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34029929 10. Simultaneous bilateral mechanical thrombectomy in a patient with COVID-19. Clin. Neurol. Neurosurg. 2021; 206:106677Khanna O, Hafazalla K, Saiegh FA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020326 11. Evidence-Based Approach to Out-of-Hospital Cardiac Arrest. Curr. Treat. Options Cardiovasc. Med. 2021; 23:43Kashef MA, Lotfi AS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994773 12. Contemporary Catheter-Based Treatment Options for Management of Acute Pulmonary Embolism. Curr. Treat. Options Cardiovasc. Med. 2021; 23:44Singh M, Shafi I, Rali P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994774 13. Cerebral venous thrombosis in COVID-19. Diabetes Metab Syndr 2021; 15:1039- 1045Ghosh R, Roy D, Mandal A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34015627 14. Prognostic value of right ventricular dilatation in patients with COVID-19: a multicentre study. Eur. Heart J. Cardiovasc. Imaging 2021; Soulat-Dufour L, Fauvel C, Weizman O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008835 15. A suicide attempt on a left ventricular assist device patient during COVID-19 pandemic: can we only blame the virus? A case report. Eur Heart J Case Rep 2021; 5:ytab144Jiménez-Blanco Bravo M, Zamorano Gómez JL, Del Prado Díaz S, Alonso Salinas GL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013162 16. Coronary artery ectasia in a child after arterial switch operation for transposition of the great arteries and suspected multisystem inflammatory syndrome in children associated with COVID-19: a case report. Eur Heart J Case Rep 2021; 5:ytab143Sobh M, Jensen-Kondering U, Voges I, Boroni Grazioli SB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013161 17. Incident atrial fibrillation and its risk prediction in patients developing COVID- 19: A machine learning based algorithm approach. Eur J Intern Med 2021; Lip GYH, Genaidy A, Tran G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34023150 18. Modelling sudden cardiac death risks factors in patients with coronavirus disease of 2019: the hydroxychloroquine and azithromycin case. Europace 2021; Montnach J, Baró I, Charpentier F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34009333 19. COVID-19 and Hypertension: The What, the Why, and the How. Front. Physiol. 2021; 12:665064Muhamad SA, Ugusman A, Kumar J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012410 20. Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19. Int J Cardiol 2021; Li XT, Zhang MW, Zhang ZZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000358 21. Admissions for and Quality of Care of ST-Segment-Elevation Myocardial Infarction in the Post COVID-19 Era in China. Int J Clin Pract 2021:e14379Ma J, Zhou S, Li N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022120 22. EXPRESS: COVID-19 AND STROKE â UNDERSTANDING THE RELATIONSHIP AND ADAPTING SERVICES. A GLOBAL WORLD STROKE ORGANISATION PERSPECTIVE. Int. J. Stroke 2021:17474930211006435Markus HS, Martins SCO. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003703 23. Early echocardiographic findings in patients hospitalized for COVID-19 pneumonia: a prospective, single center study. Intern Emerg Med 2021:1- 8Ceriani E, Marceca A, Lanfranchi A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34019253 24. Influence of coronavirus disease 2019 (COVID-19) on working flow, safety and efficacy outcome of mechanical thrombectomy for acute ischemic stroke with large vessel occlusion. Interv. Neuroradiol. 2021:15910199211018093Huo X, Sun X, Mo D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000867 25. Exploring the impact of the COVID-19 epidemic on the medical emergency calls and calls for cardiovascular diseases in Hangzhou, China. Ir. J. Med. Sci. 2021:1-5Chen J, Cheng YR, Fu XY et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34018158 26. Resilience in the Face of Adversity: The Cardiology Community Comes Together. J Am Coll Cardiol 2021; 77:2477-2479Henry TD, Garcia S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016260 27. International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19. J Am Coll Cardiol 2021; 77:2466-2476Kite TA, Ludman PF, Gale CP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016259 28. Inequities in Hypertension Control in the United States Exposed and Exacerbated by COVID-19 and the Role of Home Blood Pressure and Virtual Health Care During and After the COVID-19 Pandemic. J Am Heart Assoc 2021:e020997Bress AP, Cohen JB, Anstey DE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006116 29. Echocardiographic Correlates of In-Hospital Death in Patients with Acute COVID-19 Infection: The World Alliance Societies of Echocardiography (WASE-COVID) Study. J. Am. Soc. Echocardiogr. 2021; Karagodin I, Singulane CC, Woodward GM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023454 30. Suspected subclinical myocarditis detected by cardiac magnetic resonance imaging late post COVID-19 recovery. J Cardiol Cases 2021; Ghugre NR, Orbach A, Biswas L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007346 31. Statins in COVID-19 infection: A rehash of old themes or truly a new hope? J. Clin. Lipidol. 2021; Jia X, Virani SS. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994121 32. Thrombotic Microangiopathy in a Patient With COVID-19 Infection and Metastatic Cholangiocarcinoma. J Hematol 2021; 10:83-88Sharma S, Pavuluri S, Srinivasan K, Ghouse M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007371 33. Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study. J Infect Public Health 2021; 14:726-733Alrashed AA, Khan TM, Alhusseini NK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020213 34. Impact of SARS-CoV-2 infection on acute intracerebral haemorrhage in northern Italy. J Neurol Sci 2021; 426:117479Sangalli D, Martinelli-Boneschi F, Versino M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004463 35. Decline in Rehab Transfers Among Rehab-Eligible Stroke Patients During the COVID-19 Pandemic. J. Stroke Cerebrovasc. Dis. 2021; 30:105857Thau L, Siegal T, Heslin ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022581 36. The Essential Vulnerability of Human Cardiac Myocytes to SARS-CoV-2. JACC Basic Transl Sci 2021; 6:346-349Das M, Bristow MR, Chung MK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997520 37. Course and therapy of cardiovascular diseases during COVID-19 pandemic. Journal fur Kardiologie 2021; 28:10-13Burger AL, Kaufmann CC, Jäger B et al. 38. Practical Recommendations for the Management of Patients with ITP During the COVID-19 Pandemic. Mediterr. J. Hematol. Infect. Dis. 2021; 13:e2021032Rodeghiero F, Cantoni S, Carli G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007420 39. Coronary microvascular dysfunction pathophysiology in COVID-19. Microcirculation 2021:e12718Yin J, Wang S, Liu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013612 40. [Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination]. Neurologia 2021; Avendaño-Solá C, Cámara R, Castellanos M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994625 41. [High frequency of endoluminal thrombus in patients with ischaemic stroke following COVID-19]. Neurologia 2021; Gómez-Porro P, Cabal-Paz B, Valenzuela- Chamorro S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994626 42. Perception is not reality when risk stratifying adults with congenital heart disease for COVID-19. Open Heart 2021; 8Yuan S, Oechslin E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001656 43. Impact of the COVID-19 Lockdown on the Arrhythmic Burden of Patients with Implantable Cardioverter-Defibrillators. Pacing Clin. Electrophysiol. 2021; Sassone B, Virzì S, Bertini M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34022067 44. Late pulmonary embolism in a patient with non-severe COVID-19: case report, value of antithrombotic prophylaxis and literature review. Pan Afr. Med. J. 2021; 38:185Maloumbi PBI, Hassouni A, Ibara-Onguema JR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995791 45. Several cases of arterial thrombosis of the limbs revealing asymptomatic and paucisymptomatic COVID-19 infection. Pan Afr. Med. J. 2021; 38:209Niang I, Thioub D, Ly M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995815 46. Multiple cardiovascular complications of COVID-19 infection in a young patient: a case report. Pan Afr. Med. J. 2021; 38:192Rasras H, Boudihi A, Hbali A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995798 47. COVID-19 Induced Mesenteric Venous Infarction. Radiol Case Rep 2021; Calcagno E, Sogunro O, Nepal P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33995746 48. Veno-arterial thrombosis and microcirculation imaging in a patient with COVID-19. Respir Med Case Rep 2021; 33:101428Akin S, van Hooven D, Ince C, Jansen T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996436 49. Pulmonary arterial hypertension post COVID-19: A sequala of SARS-CoV-2 infection? Respir Med Case Rep 2021; 33:101429Khan AW, Ullah I, Khan KS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996435 50. [Cardiopulmonary resuscitation during the COVID-19 pandemic in Spain]. Rev. Esp. Anestesiol. Reanim. 2020; Aliaño Piña M, Ruiz C, Monedero P, Galán J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994587 51. [COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult]. Rev. Esp. Anestesiol. Reanim. 2020; Elouardi Y, Houssam R, Zarrouki Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994586 52. [Features of the morphological manifestations of COVID-19-associated with acute hemorrhagic necrotizing encephalopathy in adults]. Sud. Med. Ekspert. 2021; 64:52-55Ermilov VV, Barkanov VB, Barkanova ON, Filatov VE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013697 53. PERTinent new insights into venous thromboembolism risk and management in hospitalized patients with COVID-19. Vasc. Med. 2021:1358863x211012776Han H, Barnes GD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014133

Diagnosis (10 articles)

1. Predictive Value of C-reactive Protein, Lactate Dehydrogenase, Ferritin and D- dimer Levels in Diagnosing COVID-19 Patients: a Retrospective Study. Acta Inform Med 2021; 29:45-50Kaftan AN, Hussain MK, Algenabi AA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012213 2. Automatic COVID-19 disease diagnosis using 1D convolutional neural network and augmentation with human respiratory sound based on parameters: cough, breath, and voice. AIMS Public Health 2021; 8:240-264Lella KK, Pja A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017889 3. Emergency lower gastrointestinal endoscopy performed safely in a COVID-19 patient on extracorporeal membrane oxygenation (ECMO) with hemorrhagic shock. Clin. J. Gastroenterol. 2021:1-4Misumi Y, Fujii Y, Yaguchi A, Nonaka K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008112 4. The Role of Computed Tomography and Real-Time Polymerase Chain Reaction in the Diagnosis and Prognostication of COVID-19. Cureus 2021; 13:e14424Roberts JT, Hrushka JM, Krider SO, Nguyen QD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996292 5. Distinguishing Coronavirus Disease 2019 Patients From General Surgery Emergency Patients With the CIAAD Scale: Development and Validation of a Prediction Model Based on 822 Cases in China. Front Med (Lausanne) 2021; 8:601941Zhao B, Wei Y, Sun W et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33996842 6. A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): A consensus of Latin American experts. Int J Infect Dis 2021; Fay FF, Alvarez- Moreno CA, Bonvehi PE et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34022333 7. Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: A case-control study. Life Sci 2021; 277:119634Karsli E, Sabirli R, Altintas E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015287 8. Diagnosing COVID-19 disease using an efficient CAD system. Optik (Stuttg) 2021; 241:167199Shakarami A, Menhaj MB, Tarrah H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34028466 9. Simple hemogram to support the decision-making of COVID-19 diagnosis using clusters analysis with self-organizing maps neural network. Soft comput 2021:1-12Souza AA, Almeida DC, Barcelos TS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025211 10. COVID-19 Classification Based on Deep Convolution Neural Network Over a Wireless Network. Wirel Pers Commun 2021:1-21Shalaby WA, Saad W, Shokair M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994667

DM-MS-Obesity (15 articles)

1. Impact of the COVID-19 pandemic on parents' perception of health behaviors in children with overweight and obesity. Acad. Pediatr. 2021; Beck AL, Huang JC, Lendzion L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023488 2. Obesity - A Risk Factor for Psoriasis and COVID-19. Actas Dermosifiliogr (Engl Ed) 2021; Llamas-Velasco M, Ovejero-Merino E, Salgado-Boquete L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994548 3. COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies. Biomed. Pharmacother. 2021; 140:111685Hua S, Yang Y, Zou D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015585 4. Effect of Covid-19 quarantine on diabetes Care in Children. Clin Diabetes Endocrinol 2021; 7:9Gayoso M, Lim WY, Mulekar MS, Kaulfers AD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020722 5. Resurgence of COVID-19 and diabetes in India. Diabetes Metab Syndr 2021; 15:1037-1038Pal R, Bhadada SK, Misra A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34004526 6. Evaluation of perceived fears of COVID-19 virus infection and its relationship to health-related quality of life among patients with diabetes mellitus in Egypt during pandemic: a developing country single-center study. Diabetol Int 2021:1- 9Abdelghani M, Hamed MG, Said A, Fouad E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996370 7. Uncurtaining the effect of COVID-19 in diabetes mellitus: a complex clinical management approach. Environ. Sci. Pollut. Res. Int. 2021:1-8Kashyap S, Bala R, Madaan R, Behl T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021454 8. Review: Obesity and COVID-19: A Detrimental Intersection. Front. Endocrinol. (Lausanne) 2021; 12:652639Gammone MA, D'Orazio N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995281 9. Severity of COVID-19 and Treatment Strategy for Patient With Diabetes. Front. Endocrinol. (Lausanne) 2021; 12:602735Jin S, Hu W. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995267 10. Adolescent males suffered from reduced physical activity and increased BMI during COVID- 19 pandemic. Nutr. Metab. Cardiovasc. Dis. 2021; Maltoni G, Zioutas M, Deiana G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994065 11. Effect of COVID-19 pandemic on global Bariatric surgery PRActiceS - The COBRAS study. Obes. Res. Clin. Pract. 2021; Singhal R, Tahrani AA, Sakran N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994148 12. The sex-related discrepancy in laboratory parameters of severe COVID-19 patients with diabetes: A retrospective cohort study. Prim. Care Diabetes 2021; Hammad MO, Alseoudy MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006475 13. Optimizing diabetes mellitus care to improve COVID-19 outcomes in resource- limited settings in Africa. Ther Adv Infect Dis 2021; 8:20499361211009380Kyazze AP, Bongomin F, Ninsiima S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33996072 14. COVID-19 and hyperglycemia/diabetes. World J. Diabetes 2021; 12:642- 650Michalakis K, Ilias I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995851 15. Telemedicine in the COVID-19 era: Taking care of children with obesity and diabetes mellitus. World J. Diabetes 2021; 12:651-657Umano GR, Di Sessa A, Guarino S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995852

Education and training and science (61 articles)

1. University Students Perception of Online Education: Is Engagement Enough? Acta Inform Med 2021; 29:4-9Fyllos A, Kanellopoulos A, Kitixis P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012206 2. Pediatric Surgical Reentry Strategy Following the COVID-19 Pandemic: A Tiered and Balanced Approach. Am. Surg. 2021:31348211011125Pickens RC, Kao AM, Williams MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010059 3. "My Entire World Stopped": College Students' Psychosocial and Academic Frustrations during the COVID-19 Pandemic. Appl Res Qual Life 2021:1- 22Hagedorn RL, Wattick RA, Olfert MD. http://www.ncbi.nlm.nih.gov/pubmed/? term=33995688 4. Good Knowledge but Poor Practice Toward COVID-19 Among Indonesian Youth. Asia Pac. J. Public Health 2021:10105395211015048Fuady A, Khoe LC, Azzahra TB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998316 5. Maintaining Effective Supervision Systems for Trainees Pursuing a Behavior Analyst Certification Board Certification During the COVID-19 Pandemic. Behav Anal Pract 2021:1-11Ninci J, Čolić M, Hogan A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995855 6. Challenges in PhD education due to COVID-19 - disrupted supervision or business as usual: a cross-sectional survey of Swedish biomedical sciences graduate students. BMC Med. Educ. 2021; 21:294Börgeson E, Sotak M, Kraft J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022871 7. Knowledge and practice to prevent COVID-19 and its associated factors among pregnant women in Debre Tabor Town Northwest Ethiopia, a community-based cross-sectional study. BMC Pregnancy Childbirth 2021; 21:397Ayele AD, Mihretie GN, Belay HG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020600 8. The promise and perils of Unit 731 data to advance COVID-19 research. BMJ Glob Health 2021; 6Su Z, McDonnell D, Cheshmehzangi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016575 9. Prospective observational study of gender and ethnicity biases in respiratory protective equipment for healthcare workers in the COVID-19 pandemic. BMJ Open 2021; 11:e047716Carvalho CYM, Schumacher J, Greig PR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016664 10. A survey of Canadian emergency physicians' experiences and perspectives during the COVID-19 pandemic. Cjem 2021:1-9Gaucher N, Trottier ED, Côté AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999397 11. Emerging from Emergency Pandemic Pedagogy: A survey of Anatomical Educators in the United Kingdom and Ireland. Clin Anat 2021; Dulohery K, Scully D, Longhurst GJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998056 12. The Volunteers in Research programme: supporting COVID-19 research and improving medical training in parallel. Clin Med (Lond) 2021; 21:182- 188McKinnon T, Watson A, Richards L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34001569 13. Transdiagnostic vulnerability factors for behavioral health problems during COVID-19. Cogn. Behav. Ther. 2021; 50:179-184Rogers AH, Zvolensky MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018469 14. The Impact of COVID-19 on National Clinical Trials Network Breast Cancer Trials. Curr. Breast Cancer Rep. 2021:1-7Ndumele A, Park KU. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995839 15. Early Childhood Educators' Wellbeing During the COVID-19 Pandemic. Early Child Educ J 2021:1-11Eadie P, Levickis P, Murray L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994770 16. Family-School Cooperation: An Online Survey of Parents and Teachers of Young Children in Spain. Early Child Educ J 2021:1-9Otero-Mayer A, González- Benito A, Gutiérrez-de-Rozas B, Vélaz-de-Medrano C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007139 17. The Impacts of COVID-19 on Early Childhood Education: Capturing the Unique Challenges Associated with Remote Teaching and Learning in K-2. Early Child Educ J 2021:1-15Timmons K, Cooper A, Bozek E, Braund H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007140 18. M-learning in the COVID-19 era: physical vs digital class. Educ Inf Technol (Dordr) 2021:1-21Matzavela V, Alepis E. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994833 19. Technology-mediated teaching and learning process: A conceptual study of educators' response amidst the Covid-19 pandemic. Educ Inf Technol (Dordr) 2021:1-33Okoye K, Rodriguez-Tort JA, Escamilla J, Hosseini S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025205 20. Perceptions and lessons from web-based interviews for the reproductive endocrinology and infertility fellowship application cycle. Fertil. Steril. 2021; Hariton E, Raker CA, Frishman GN, Feinberg EC. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016437 21. Teaching and Learning in Times of COVID-19: Uses of Digital Technologies During School Lockdowns. Front. Psychol. 2021; 12:656776Pozo JI, Pérez Echeverría MP, Cabellos B, Sánchez DL. http://www.ncbi.nlm.nih.gov/pubmed/? term=33995217 22. Assessment of Knowledge, Attitude, and Practice of Security and Safety Workers Toward the COVID-19 Pandemic: A Cross-Sectional Study. Front Public Health 2021; 9:631717AlRasheed MM, Alsugair AM, Almarzouqi HF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996716 23. Research on International Cooperative Governance of the COVID-19. Front Public Health 2021; 9:566499Lin X, Yang H, Wu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996704 24. Determinants of Confidence in Overall Knowledge About COVID-19 Among Healthcare Workers in South Africa: Results From an Online Survey. Front Public Health 2021; 9:614858Manyaapelo T, Mokhele T, Sifunda S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996709 25. Using online information technology for deaf students during COVID-19: A closer look from experience. Heliyon 2021; 7:e06915Alshawabkeh AA, Woolsey ML, Kharbat FF. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013080 26. COVID-19-CT-CXR: A Freely Accessible and Weakly Labeled Chest X-Ray and CT Image Collection on COVID-19 From Biomedical Literature. IEEE Trans Big Data 2021; 7:3-12Peng Y, Tang Y, Lee S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997112 27. The age again in the eye of the COVID-19 storm: evidence-based decision making. Immun. Ageing 2021; 18:24Martín MC, Jurado A, Abad-Molina C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016150 28. Experimental Animal Models of Coronavirus Infections: Strengths and Limitations. Immune Netw. 2021; 21:e12Casel MAB, Rollon RG, Choi YK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996168 29. Resident-performed immediate sequential bilateral cataract surgery during the COVID-19 pandemic. Indian J Ophthalmol 2021; 69:1579-1584Chen TA, Chen SP, Ahmad TR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011745 30. Medical Student's Perspective Regarding Undergraduate Surgical Education with Special Reference to Pandemic. Indian J Surg 2021:1-5Ray I, Agarwal V, Agarwal T, Pande A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025052 31. COVID-19 Preparedness in a Thai International School: Emotional Health and Infection Control Practices. Infect Control Hosp Epidemiol 2021:1-6Narupaves N, Kulworasreth P, Manaanuntakul N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34016203 32. Knowledge About COVID-19, Beliefs and Vaccination Acceptance Against COVID-19 Among High-Risk People in Ho Chi Minh City, Vietnam. Infect Drug Resist 2021; 14:1773-1780Huynh G, Nguyen TV, Nguyen DD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012276 33. COVID-19 compliant and cost effective teaching model for King Abdulaziz University. Int J Inf Technol 2021:1-14Bardesi H, Al-Mashaikhi A, Basahel A, Yamin M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997602 34. Context, design and conduct of the longitudinal COVID-19 psychological research consortium study-wave 3. Int. J. Methods Psychiatr. Res. 2021:e1880McBride O, Butter S, Murphy J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021946 35. Teaching Effective Informed Consent Communication Skills in the Virtual Surgical Clerkship. J Am Coll Surg 2021; Pang JH, Finlay E, Fortner S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015451 36. Dental trainees' mental health and intention to leave their programs during the COVID-19 pandemic. J. Am. Dent. Assoc. 2021; Chi DL, Randall CL, Hill CM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023094 37. Impact of Body Mass Index on COVID-19-Related In-Hospital Outcomes and Mortality. J. Clin. Med. Res. 2021; 13:230-236Ullah W, Roomi S, Nadeem N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007361 38. Admissions to Medical School during the COVID-19 Era without the MCAT. J Med Educ Curric Dev 2021; 8:23821205211014898Corridon PR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997289 39. Integrating Distance Strategies to Meet the 2020 Summer Research Internship Competencies and Objectives. J Med Educ Curric Dev 2021; 8:23821205211006414Cortes-Rodríguez AM, Inostroza-Nieves Y, González F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997286 40. Survey of German medical students during the COVID-19 pandemic: attitudes toward volunteering versus compulsory service and associated factors. J. Med. Ethics 2021; Mihatsch L, von der Linde M, Knolle F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021060 41. Virtual Mega-Meetings: Here to Stay? J. Pathol. Inform. 2021; 12:11Hassell LA, Hassell HJG. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012715 42. Nursing students on the frontline: Impact and personal and professional gains of joining the health care workforce during the COVID-19 pandemic in Spain. J. Prof. Nurs. 2021; 37:588-597Martin-Delgado L, Goni-Fuste B, Alfonso-Arias C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016318 43. Nursing students' readiness and coping strategies for the Covid-19 pandemic in Turkey. J. Prof. Nurs. 2021; 37:553-561Sümen A, Adıbelli D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016314 44. COVID-19 Knowledge and Behavior Change among High School Students in Semi-Rural Georgia. J. Sch. Health 2021; Campbell K, Weingart R, Ashta J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997969 45. Love at First Click: Surgery Residency Websites in the Virtual Era. J Surg Educ 2021; Chinedozi I, Martin O, Hays N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34011477 46. The Japanese Medical Science Federation COVID-19 Expert Opinion English Version. Jma j 2021; 4:148-162Nangaku M, Kadowaki T, Yotsuyanagi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997449 47. Otolaryngology Residency Program Rankings and Social Media Usage: A Longitudinal Analysis. Laryngoscope 2021; Patro A, Carr S, Stevens MN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000091 48. COVID-19 research progress: Bibliometrics and visualization analysis. Med. J. Islam. Repub. Iran 2021; 35:20Okhovati M, Arshadi H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996671 49. Developing a Hybrid Four-Prong Approach to Anatomical Education During the COVID-19 Pandemic. Med Sci Educ 2021:1-7Cheng H, Esmonde-White C, Kassay AD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34026305 50. Knowledge about coronavirus disease 2019: Implication for dentists in Saudi Arabia. Niger. J. Clin. Pract. 2021; 24:747-752Nassar AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018985 51. A qualitative examination of graduating nurses' response to the Covid-19 pandemic. Nurs. Ethics 2021:969733021999772Lancaster RJ, Schmitt C, Debish M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013816 52. Reimagining care homes: can the COVID-19 pandemic act as a catalyst for enhancing staff status and education? Nurs. Older People 2021; Wild DJ, Szczepura A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008354 53. Deliberate practice and self-recorded demonstration of skill proficiency: One baccalaureate nursing school's response to the COVID-19 pandemic. Nurse Educ Pract 2021; 53:103071Palmer TJ, Chisholm LJ, Rolf CG, Morris CR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020118 54. Knowledge, risk perception and adherence to COVID-19 prevention advisory among police officers in Makurdi Metropolis Benue State, 2020. Pan Afr. Med. J. 2021; 38:199Okon UA, Onche C, Ajisegiri SW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995805 55. The Efficiency of Learning Methodology for Privacy Protection in Context- aware Environment during the COVID-19 Pandemic. Procedia Comput Sci 2021; 184:52-59Alawadhi R, Hussain T. http://www.ncbi.nlm.nih.gov/pubmed/? term=34025822 56. Radical investment in the curriculum in times of Covid-19: Can we question the anti-science discourses? Prospects (Paris) 2021:1-8Lopes AC. http://www.ncbi.nlm.nih.gov/pubmed/?term=34024945 57. Daily multidisciplinary COVID-19 meeting: Experiences from a French university hospital. Respir Med Res 2021; 79:100828Rolland-Debord C, Canellas A, Choinier P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023794 58. Research on Covid-19: a disruptive phenomenon for bibliometrics. Scientometrics 2021:1-15Fassin Y. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994601 59. Towards Post-pandemic Transformative Teaching and Learning: Case Studies of Microlearning Implementations in two Post-secondary Educational Institutions. SN Comput Sci 2021; 2:271Wang T, Towey D, Ng RY, Gill AS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997792 60. Improving Neurosurgery Education Using Social Media Case-Based Discussions: A Pilot Study. World Neurosurg X 2021; 11:100103Newall N, Smith BG, Burton O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997763 61. Knowledge, attitude and practices towards COVID-19 among higher education students in India: a cross sectional study. Z Gesundh Wiss 2021:1- 13Padmanaban S, Rajendran P, Davis P, Velayutham P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007782

Elderly (8 articles)

1. Impact of COVID-19 on motor vehicle injuries and fatalities in older adults in Ontario, Canada. Accid. Anal. Prev. 2021; 157:106195Rapoport MJ, Chee JN, Aljenabi N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020183 2. A review on the COVID-19-related psychological impact on older adults: vulnerable or not? Aging Clin. Exp. Res. 2021:1-15Parlapani E, Holeva V, Nikopoulou VA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999378 3. The impact of COVID-19 on the well-being and cognition of older adults living in the United States and Latin America. EClinicalMedicine 2021; 35:100848Babulal GM, Torres VL, Acosta D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997742 4. Spatio-temporal analysis of COVID-19 incidence rate using GIS: a case study- Tehran metropolitan, Iran. GeoJournal 2021:1-15Nasiri R, Akbarpour S, Zali AR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994652 5. COVID-19 Pandemic and Resilience of the Transnational Home-Based Elder Care System between Poland and Germany. J Aging Soc Policy 2021:1- 19Nowicka M, Bartig S, Schwass T, Matuszczyk K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016033 6. Relationship Between COVID-19, Euthanasia and Old Age: A Study from a Legal-Ethical Perspective. J Relig Health 2021:1-35Salinas Mengual J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014474 7. The Japanese Medical Science Federation COVID-19 Expert Opinion English Version. Jma j 2021; 4:148-162Nangaku M, Kadowaki T, Yotsuyanagi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997449 8. Reimagining care homes: can the COVID-19 pandemic act as a catalyst for enhancing staff status and education? Nurs. Older People 2021; Wild DJ, Szczepura A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008354

Epidemiology (87 articles)

1. COVID-19: breaking down a global health crisis. Ann. Clin. Microbiol. Antimicrob. 2021; 20:35Mallah SI, Ghorab OK, Al-Salmi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006330 2. Learning where to look for COVID-19 growth: Multivariate analysis of COVID- 19 cases over time using explainable convolution-LSTM. Appl Soft Comput 2021; 109:107469Yudistira N, Sumitro SB, Nahas A, Riama NF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994895 3. Coincidence of pollen season and coronavirus disease 2019 pandemic: less time outdoors - lesser allergy symptoms in 2020. Asia Pac Allergy 2021; 11:e16Sözener Z, Öztürk B, Aydın Ö et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34007826 4. New strategy to control covid-19 pandemic using lead/lag compensator. Biomed. Signal Process. Control 2021; 68:102669Hadi MA, Amean ZM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995561 5. Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil. BMC Genomics 2021; 22:371Franceschi VB, Caldana GD, de Menezes Mayer A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016042 6. Lessons learned from the investigation of a COVID-19 cluster in Creil, France: effectiveness of targeting symptomatic cases and conducting contact tracing around them. BMC Infect. Dis. 2021; 21:457de Laval F, Grosset-Janin A, Delon F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011278 7. Identification of transmission chains and clusters associated with COVID-19 in Tunisia. BMC Infect. Dis. 2021; 21:453Safer M, Letaief H, Hechaichi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011266 8. Real time surveillance of COVID-19 space and time clusters during the summer 2020 in Spain. BMC Public Health 2021; 21:961Rosillo N, Del-Águila- Mejía J, Rojas-Benedicto A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34016076 9. Epidemiological trends in COVID-19 pandemic: prospective critical appraisal of observations from six countries in Europe and the USA. BMJ Open 2021; 11:e045782Velicu MA, Furlanetti L, Jung J, Ashkan K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010140 10. The current second wave and COVID-19 vaccination status in India. Brain Behav Immun 2021; Chakraborty C, Ranjan A, Bhattacharya M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022371 11. Canadian national COVID-19 genomics surveillance priorities for existing and emerging variants of concern. Can. Commun. Dis. Rep. 2021; 47:139-141. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012337 12. Seasonality of coronaviruses and other respiratory viruses in Canada: Implications for COVID-19. Can. Commun. Dis. Rep. 2021; 47:132-138Lagacé- Wiens P, Bullard J, Cole R, Van Caeseele P. http://www.ncbi.nlm.nih.gov/pubmed/? term=34012336 13. SARS-CoV-2 seroprevalence among blood donors in Québec, and analysis of symptoms associated with seropositivity: a nested case-control study. Can. J. Public Health. 2021:1-11Lewin A, Therrien R, De Serres G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999398 14. Time-dependent probability distribution for number of infection in a stochastic SIS model: case study COVID-19. Chaos Solitons Fractals 2021; 147:110983Otunuga OM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994678 15. COVID-19 in Punjab, India: Epidemiological patterns, laboratory surveillance and contact tracing of COVID-19 cases, March-May 2020. Clin Epidemiol Glob Health 2021:100769Sharma S, Goel K, Kurup KK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997478 16. Droplets and Aerosols Generated by Singing and the Risk of Coronavirus Disease 2019 for Choirs. Clin Infect Dis 2021; 72:e639-e641Bahl P, de Silva C, Bhattacharjee S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32945338 17. Severe Acute Respiratory Syndrome Coronavirus 2 Surveillance in Decedents in a Large, Urban Medical Examiner's Office. Clin Infect Dis 2021; 72:e580- e585Brouwer AF, Myers JL, Martin ET et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32877923 18. Coronavirus Disease 2019 Patients in Earlier Stages Exhaled Millions of Severe Acute Respiratory Syndrome Coronavirus 2 Per Hour. Clin Infect Dis 2021; 72:e652-e654Ma J, Qi X, Chen H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32857833 19. American Politics and the Spread of Severe Acute Respiratory Syndrome Coronavirus 2. Clin Infect Dis 2021; 72:e608-e609Wasfy JH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32940672 20. Insights on Coronavirus Disease 2019 Epidemiology From a Historic Cruise Ship Quarantine. Clin Infect Dis 2021; 72:e458-e459Yamagishi T, Doi Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=32798226 21. Epidemiology, Outcomes, and Associated Factors of Coronavirus Disease 2019 (COVID-19) Reverse Transcriptase Polymerase Chain Reaction- Confirmed Cases in the San Pedro Sula Metropolitan Area, Honduras. Clin Infect Dis 2021; 72:e476-e483Zuniga-Moya JC, Norwood DA, Romero Reyes LE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32803236 22. Novel SARS-CoV-2 variants: the pandemics within the pandemic. Clin Microbiol Infect 2021; Boehm E, Kronig I, Neher RA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015535 23. The Fourth Wave? COVID-19 and consecutive cognitive impairment. Deutsche Medizinische Wochenschrift 2021; 146:671-676Berlit P, Frölich L, Förstl H. 24. Resurgence of COVID-19 and diabetes in India. Diabetes Metab Syndr 2021; 15:1037-1038Pal R, Bhadada SK, Misra A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34004526 25. Mathematical Modeling and Covid-19 Forecast in Texas, USA: a prediction model analysis and the probability of disease outbreak. Disaster Med Public Health Prep 2021:1-27Hassan MN, Mahmud MS, Nipa KF, Kamrujjaman M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006346 26. SARS-CoV-2 Superspread in Fitness Center, Hong Kong, China, March 2021. Emerg Infect Dis 2021; 27Chu DKW, Gu H, Chang LDJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004137 27. Effect of meteorological factors and Air Quality Index on the COVID-19 epidemiological characteristics: an ecological study among 210 countries. Environ. Sci. Pollut. Res. Int. 2021; Vali M, Hassanzadeh J, Mirahmadizadeh A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34024000 28. Using excess deaths and testing statistics to determine COVID-19 mortalities. Eur. J. Epidemiol. 2021:1-14Böttcher L, D'Orsogna MR, Chou T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002294 29. Multiple House Occupancy is Associated with Mortality in Hospitalised Patients with Covid-19. Eur. J. Public Health 2021; Bruce E, Carter B, Quinn TJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999142 30. Meteorological and human mobility data on predicting COVID-19 cases by a novel hybrid decomposition method with anomaly detection analysis: a case study in the capitals of Brazil. Expert Syst Appl 2021:115190da Silva TT, Francisquini R, MC VN. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025047 31. Global Healthcare Resource Efficiency in the Management of COVID-19 Death and Infection Prevalence Rates. Front Public Health 2021; 9:638481Breitenbach MC, Ngobeni V, Aye GC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996718 32. Occupational Characteristics and Management Measures of Sporadic COVID- 19 Outbreaks From June 2020 to January 2021 in China: The Importance of Tracking Down "Patient Zero". Front Public Health 2021; 9:670669Feng M, Ling Q, Xiong J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996733 33. Estimating the Instantaneous Asymptomatic Proportion With a Simple Approach: Exemplified With the Publicly Available COVID-19 Surveillance Data in Hong Kong. Front Public Health 2021; 9:604455Li C, Zhao S, Tang B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012950 34. Urgent Considerations on the Relationship Between the Advance of Covid-19 in Indigenous Territories in Brazil and the Impacts of Monoepistemic Public Policies. Front Sociol 2021; 6:623656Herbetta A, Pocuhto T, Pimentel Da Silva MDS, Guajajara C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012988 35. Preventing the next pandemic and tackling antiscience: an interview with Peter Hotez. Future Microbiol. 2021; 16:539-541Hotez P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998265 36. [COVID-19 on migrants and ethnic minorities]. Gac. Sanit. 2020; Rodríguez- García-de-Cortázar A, Leralta-Piñán O, Jiménez-Pernett J, Ruiz-Azarola A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994254 37. COVID-19 and future pandemics: a global systems approach and relevance to SDGs. Global Health 2021; 17:59Thoradeniya T, Jayasinghe S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020654 38. The first 100 days: how has COVID-19 affected poor and vulnerable groups in India? Health Promot. Int. 2021; Johri M, Agarwal S, Khullar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002217 39. COVID-19: facts, figures, estimated relationships and analysis. Indian Econ Rev 2021:1-42Ray R, Kumar S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34024930 40. Hypothesis: SARS-CoV-2 transmission is predominated by the short-range airborne route and exacerbated by poor ventilation. Indoor Air 2021; Li Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002888 41. Correlation of Racial Effect with Severity of Disease and In-Hospital Outcome in Individuals Diagnosed with COVID-19. Int J Clin Pract 2021:e14383Alotaibi AR, Ezzeldin T, Siddiqui IA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022105 42. The massive attack of COVID-19 in India is a big concern for Bangladesh: The key focus should be given on the interconnection between the countries. Int. J. Health Plann. Manage. 2021; Daria S, Asaduzzaman M, Shahriar M, Islam MR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014016 43. The density paradox: Are densely-populated regions more vulnerable to Covid-19? Int. J. Health Plann. Manage. 2021; Moosa IA, Khatatbeh IN. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002898 44. SARS-CoV-2 sero-prevalence among general population and healthcare workers in India, December 2020 - January 2021. Int J Infect Dis 2021; Murhekar MV, Bhatnagar T, Thangaraj JWV et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34022338 45. The COVID-19-Related Lockdown in Qatar: Associations Among Demographics, Social Distancing, Mood Changes, and Quality of Life. Int J Ment Health Addict 2021:1-17Megreya AM, Latzman RD, Al-Ahmadi AM, Al-Dosari NF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994887 46. Controlling epidemic diseases based only on social distancing level: General case. ISA Trans. 2021; Dias S, Queiroz K, Araujo A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016439 47. Can virus-virus interactions impact the dynamics of the covid-19 pandemic? J Biomol Struct Dyn 2021:1-5Hendaus MA, Jomha FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998968 48. Biochemical abnormalities in COVID-19: a comparison of white versus ethnic minority populations in the UK. J. Clin. Pathol. 2021; Taylor DR, Buchanan D, Al- Hasani W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011620 49. Emerging role of air pollution and meteorological parameters in COVID-19. J Evid Based Med 2021; Zhao C, Fang X, Feng Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003571 50. Clinical spectrum and outcome of patients visiting coronavirus screening centre in North India and clinical predictors for COVID-19. J Family Med Prim Care 2021; 10:454-461Singla N, Gowda R, Mohindra R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017770 51. Household transmission but without the community-acquired outbreak of COVID-19 in Taiwan. J Formos Med Assoc 2021; Hsu CY, Wang JT, Huang KC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994234 52. COVID-19 preventive behaviours in White British and Black, Asian and Minority Ethnic (BAME) people in the UK. J Health Psychol 2021:13591053211017208Breakwell GM, Fino E, Jaspal R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33993789 53. BNT162b2 mRNA Covid-19 vaccine effectiveness in the prevention of SARS- CoV-2 infection: a preliminary report. J Infect Dis 2021; Bianchi FP, Germinario CA, Migliore G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007998 54. Shifting patterns of respiratory virus activity following social distancing measures for COVID-19 in South Korea. J Infect Dis 2021; Park S, Michelow IC, Choe YJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009376 55. The use of double border-screening strategy in the surveillance and prevention of COVID-19. J Infect Public Health 2021; 14:757-758Baddal B, Sanlidag T, Uzun B, Uzun Ozsahin D. http://www.ncbi.nlm.nih.gov/pubmed/? term=34022733 56. Comparative analysis of TOPSIS, VIKOR and COPRAS methods for the COVID- 19 Regional Safety Assessment. J Infect Public Health 2021; 14:775-786Hezer S, Gelmez E, Özceylan E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022737 57. Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden. J Intern Med 2021; Castro Dopico X, Muschiol S, Christian M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34008203 58. Control with uncertain data of socially structured compartmental epidemic models. J. Math. Biol. 2021; 82:63Albi G, Pareschi L, Zanella M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023964 59. SARS-CoV-2: The Second Wave in Europe. J Med Internet Res 2021; 23:e22431Fokas AS, Kastis GA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33939621 60. Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China. J Virus Erad 2021; 7:100040Kong X, Liu F, Wang H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996143 61. Prisons need to be included in global and national vaccinations effort against COVID-19. Lancet Reg Health Eur 2021; 4:100088Neufeld M, Alves da Costa F, Ferreira-Borges C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997833 62. SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg. Lancet Reg Health Eur 2021; 4:100056Wilmes P, Zimmer J, Schulz J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33997830 63. Potential lessons from the Taiwan and New Zealand health responses to the COVID-19 pandemic. Lancet Reg Health West Pac 2020; 4:100044Summers J, Cheng HY, Lin HH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013216 64. Settings of virus exposure and their implications in the propagation of transmission networks in a COVID-19 outbreak. Lancet Reg Health West Pac 2020; 4:100052Wong NS, Lee SS, Kwan TH, Yeoh EK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013218 65. Intrafamilial Spread of COVID-19 Infection Within Population in Bosnia and Herzegovina. Mater Sociomed 2021; 33:4-9Salihefendic N, Zildzic M, Huseinagic H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012342 66. A structured model for COVID-19 spread: modelling age and healthcare inequities. Math. Med. Biol. 2021; James A, Plank MJ, Binny RN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002201 67. Small-scale spatial distribution of COVID-19-related excess mortality. MethodsX 2021; 8:101257Gibertoni D, Sanmarchi F, Adja KYC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996519 68. Predictive modelling for COVID-19 outbreak control: lessons from the navy cluster in Sri Lanka. Mil Med Res 2021; 8:31Wijesekara N, Herath N, Kodituwakku K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001251 69. Implementation of integrated supportive supervision in the context of coronavirus 19 pandemic: its effects on routine immunization and vaccine preventable surveillance diseases indicators in the East and Southern African countries. Pan Afr. Med. J. 2021; 38:164Bello IM, Lebo E, Shibeshi ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995771 70. Ban of Religious Gatherings during the COVID-19 Pandemic: Impact on Christian Church Leaders' Well-Being in Ghana. Pastoral Psychol. 2021:1- 13Osei-Tutu A, Kenin A, Affram AA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34002100 71. Community incidence rates of COVID-19 and the severity of care home outbreaks in the City of Hull, England. Public Health Pract (Oxf) 2021:100139Aigbogun N, Greensmith M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34027507 72. Demographic factors associated with COVID-19-related death in Palestine. Public Health Pract (Oxf) 2021; 2:100145Maraqa B, Al-Shakhra K, Alawneh M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34027510 73. A two-phase dynamic contagion model for COVID-19. Results Phys 2021:104264Chen Z, Dassios A, Kuan V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002126 74. Predictability of COVID-19 worldwide lethality using permutation-information theory quantifiers. Results Phys 2021; 26:104306Fernandes LHS, Araujo FHA, Silva MAR, Acioli-Santos B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002129 75. A new SEIAR model on small-world networks to assess the intervention measures in the COVID-19 pandemics. Results Phys 2021; 25:104283Li J, Zhong J, Ji YM, Yang F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996400 76. Volatility estimation for COVID-19 Daily Rates using Kalman Filtering Technique. Results Phys 2021:104291Masum Bhuiyan MA, Mahmud S, Islam MR, Tasnim N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34026472 77. Modeling the underestimation of COVID-19 infection. Results Phys 2021; 25:104271Nakamoto I, Zhang J. http://www.ncbi.nlm.nih.gov/pubmed/? term=34002127 78. An improved SIR model describing the epidemic dynamics of the COVID-19 in China. Results Phys 2021; 25:104289Zhu WJ, Shen SF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996402 79. [Epidemiology of COVID-19 in Mexico: from the 27th of February to the 30th of April 2020]. Rev Clin Esp 2020; 220:463-471Suárez V, Suarez Quezada M, Oros Ruiz S, Ronquillo De Jesús E. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994571 80. Differential risk for COVID-19 in the first wave of the disease among Spaniards and migrants from different areas of the world living in Spain. Rev Clin Esp (Barc) 2021; 221:264-273Guijarro C, Pérez-Fernández E, González-Piñeiro B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998512 81. The socio-economic determinants of COVID-19: A spatial analysis of German county level data. Socioecon. Plann. Sci. 2021:101083Ehlert A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007090 82. Bayesian spatio-temporal joint disease mapping of Covid-19 cases and deaths in local authorities of England. Spat Stat 2021:100519Sahu SK, Böhning D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996424 83. A population-based study on mortality among Belgian immigrants during the first COVID-19 wave in Belgium. Can demographic and socioeconomic indicators explain differential mortality? SSM Popul Health 2021; 14:100797Vanthomme K, Gadeyne S, Lusyne P, Vandenheede H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997246 84. A family of Gamma-generated distributions: Statistical properties and applications. Stat. Methods Med. Res. 2021:9622802211009262Pourreza H, Jamkhaneh EB, Deiri E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006148 85. SNS Big Data Analysis Framework for COVID-19 Outbreak Prediction in Smart Healthy City. Sustain Cities Soc 2021; 71:102993El Azzaoui A, Singh SK, Park JH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996386 86. How many more? Under-reporting of the COVID-19 deaths in Brazil in 2020. Trop Med Int Health 2021; Kupek E. http://www.ncbi.nlm.nih.gov/pubmed/? term=34008266 87. REal-time Assessment of Community Transmission (REACT) of SARS-CoV-2 virus: Study protocol. Wellcome Open Res 2020; 5:200Riley S, Atchison C, Ashby D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997297

Gastro-enterology (18 articles) 1. Significant liver injury during hospitalization for COVID-19 is not associated with liver insufficiency or death. Clin Gastroenterol Hepatol 2021; Chew M, Tang Z, Radcliffe C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004326 2. Emergency lower gastrointestinal endoscopy performed safely in a COVID-19 patient on extracorporeal membrane oxygenation (ECMO) with hemorrhagic shock. Clin. J. Gastroenterol. 2021:1-4Misumi Y, Fujii Y, Yaguchi A, Nonaka K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008112 3. Correlation of Severity of COVID-19 Disease With Gastrointestinal Manifestations and Liver Injury - A North Brooklyn Community Hospital Experience: A Retrospective Cohort Study. Cureus 2021; 13:e14543Deane K, Singh A, Sarfraz A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017658 4. Gastrointestinal Symptoms in Association With Hypokalemia Can Be a Predictor of Inferior Outcomes in COVID-19. Cureus 2021; 13:e14466Wong Wai Cheong N, Meyyur Aravamudan V, Venkatachalam J, Kuthiah N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996325 5. Evolution of the emotional impact in patients with early Inflammatory Bowel Disease during and after Covid-19 lockdown. Gastroenterol. Hepatol. 2021; Sempere L, Bernabeu P, Cameo J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34023470 6. COVID-19 and Endoscopy. Gastroenterol Hepatol (N Y) 2020; 16:519- 524Srinivasan S, Sundaram S, Sharma P. http://www.ncbi.nlm.nih.gov/pubmed/? term=34017224 7. Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic. Inflamm. Bowel Dis. 2021; 27:940-946Grossberg LB, Pellish RS, Cheifetz AS, Feuerstein JD. http://www.ncbi.nlm.nih.gov/pubmed/?term=32619010 8. COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies. Inflamm. Bowel Dis. 2021; Squire JD, Gonzalez-Estrada A, Caldera F, Farraye FA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33999204 9. Innovation in IBD Care During the COVID-19 Pandemic: Results of a Cross- Sectional Survey on Patient-Reported Experience Measures. Inflamm. Bowel Dis. 2021; 27:864-869Taxonera C, Alba C, Olivares D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32812035 10. Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation. J. Clin. Exp. Hepatol. 2021; Choudhary NS, Dhampalwar S, Saraf N, Soin AS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994708 11. Rapid Recovery in COVID-19 Patients with Chronic Hepatitis B Virus Infection Treated with Tenofovir Disoproxil Fumarate. J Clin Transl Hepatol 2021; 9:269- 273Chen X, Liu D, Yang D, Zheng X. http://www.ncbi.nlm.nih.gov/pubmed/? term=34007810 12. Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease. J Clin Transl Hepatol 2021; 9:256-264Premkumar M, Kedarisetty CK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007808 13. Thrombotic Microangiopathy in a Patient With COVID-19 Infection and Metastatic Cholangiocarcinoma. J Hematol 2021; 10:83-88Sharma S, Pavuluri S, Srinivasan K, Ghouse M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007371 14. Medication adherence and complementary therapy usage in inflammatory bowel disease patients during the coronavirus disease 2019 pandemic. JGH Open 2021; 5:585-589Barnes A, Andrews J, Spizzo P, Mountifield R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013059 15. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19. Liver Int 2021; Bütikofer S, Lenggenhager D, Garcia PDW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018314 16. Patient perspective on safety of elective gastrointestinal endoscopy during the COVID-19 pandemic. Tech Innov Gastrointest Endosc 2021; Taneja V, El-Dallal M, Bilal M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007972 17. Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options. Therap. Adv. Gastroenterol. 2021; 14:17562848211012595Bourgonje AR, van Linschoten RCA, West RL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995584 18. Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID- 19 infection treatment. World J. Gastroenterol. 2021; 27:1905-1919Chinnici CM, Russelli G, Bulati M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007129

Guidelines (10 articles)

1. Patch Testing During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC). Actas Dermosifiliogr. 2020; 111:650-654Carrascosa JM, Pastor-Nieto MA, Ruiz-González I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012155 2. COVID-19 Vaccination of Allergic Patients in Conjunction with allergen immunotherapy (AIT) – A position paper of the Association of German Allergists (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI). Allergologie 2021; 44:339-348Klimek L, Pfaar O, Hamelmann E et al. 3. Reorganisation of GP surgeries during the COVID-19 outbreak: analysis of guidelines from 15 countries. BMC Fam. Pract. 2021; 22:96Tsopra R, Frappe P, Streit S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000985 4. Diagnosis and Management of Osteoporosis During COVID-19: Systematic Review and Practical Guidance. Calcif. Tissue Int. 2021:1-12Hampson G, Stone M, Lindsay JR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003337 5. EBCOG position statement on COVID-19 vaccination for pregnant and breastfeeding women. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021; Martins I, Louwen F, Ayres-de-Campos D, Mahmood T. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020833 6. The age again in the eye of the COVID-19 storm: evidence-based decision making. Immun. Ageing 2021; 18:24Martín MC, Jurado A, Abad-Molina C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016150 7. Broad guidelines for primary care practitioners/standalone private health facilities/frontline healthcare facilities in view of COVID-19 pandemic. J Family Med Prim Care 2021; 10:1-9Raina SK, Kumar R, Kumar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017693 8. Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology. J Thromb Haemost 2021; Nazy I, Sachs UJ, Arnold DM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018298 9. The Japanese Medical Science Federation COVID-19 Expert Opinion English Version. Jma j 2021; 4:148-162Nangaku M, Kadowaki T, Yotsuyanagi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997449 10. Communicating personalized risks from COVID-19: guidelines from an empirical study. R Soc Open Sci 2021; 8:201721Freeman ALJ, Kerr J, Recchia G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996117

Imaging (21 articles)

1. Real‑time COVID-19 diagnosis from X-Ray images using deep CNN and extreme learning machines stabilized by chimp optimization algorithm. Biomed. Signal Process. Control 2021; 68:102764Hu T, Khishe M, Mohammadi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995562 2. Detection of COVID-19 in X-ray images by classification of bag of visual words using neural networks. Biomed. Signal Process. Control 2021; 68:102750Nabizadeh-Shahre-Babak Z, Karimi N, Khadivi P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007303 3. Can we estimate cytokine storm from initial computed tomography images of Coronavirus disease-2019 patients? Bratisl. Lek. Listy 2021; 122:405-412Ozturk C, Gungor O, Koc F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002614 4. Image of the month: Diagnostic and therapeutic challenges in the management of ectopic ACTH syndrome: a perfect storm of hypercortisolism, hyperglycaemia and COVID-19. Clin Med (Lond) 2021; 21:231-234Rehman T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001576 5. The Role of Computed Tomography and Real-Time Polymerase Chain Reaction in the Diagnosis and Prognostication of COVID-19. Cureus 2021; 13:e14424Roberts JT, Hrushka JM, Krider SO, Nguyen QD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996292 6. Role of High Resolution Computed Tomography chest in the diagnosis and evaluation of COVID -19 patients -A systematic review and meta-analysis. Eur J Radiol Open 2021; 8:100350Ishfaq A, Yousaf Farooq SM, Goraya A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007865 7. Case Report: Behavioral Unresponsiveness in Acute COVID-19 Patients: The Utility of the Motor Behavior Tool-Revised and (18)F-FDG PET/CT. Front. Neurol. 2021; 12:644848Vijiala S, Epiney JB, Jöhr J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995248 8. Teaching and Learning in Times of COVID-19: Uses of Digital Technologies During School Lockdowns. Front. Psychol. 2021; 12:656776Pozo JI, Pérez Echeverría MP, Cabellos B, Sánchez DL. http://www.ncbi.nlm.nih.gov/pubmed/? term=33995217 9. COVID-19-CT-CXR: A Freely Accessible and Weakly Labeled Chest X-Ray and CT Image Collection on COVID-19 From Biomedical Literature. IEEE Trans Big Data 2021; 7:3-12Peng Y, Tang Y, Lee S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997112 10. Clinical-radiological correlations in COVID-19-related venous thromboembolism: preliminary results from a multidisciplinary study. Int J Clin Pract 2021:e14370Wu MA, Colombo R, Arquati M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998752 11. Echocardiographic Correlates of In-Hospital Death in Patients with Acute COVID-19 Infection: The World Alliance Societies of Echocardiography (WASE-COVID) Study. J. Am. Soc. Echocardiogr. 2021; Karagodin I, Singulane CC, Woodward GM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023454 12. Suspected subclinical myocarditis detected by cardiac magnetic resonance imaging late post COVID-19 recovery. J Cardiol Cases 2021; Ghugre NR, Orbach A, Biswas L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007346 13. Frequent clinical and radiological manifestations of the Novel SARS-CoV-2: A review article. J Family Med Prim Care 2021; 10:122-126Alshoabi SA, Alhazmi FH, Abdulaal OM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017713 14. Point-of-care ultrasonography in the initial characterization of patients with COVID-19. Med Clin (Engl Ed) 2021; 156:477-484Tung-Chen Y, Algora-Martín A, Llamas-Fuentes R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007877 15. [High frequency of endoluminal thrombus in patients with ischaemic stroke following COVID-19]. Neurologia 2021; Gómez-Porro P, Cabal-Paz B, Valenzuela- Chamorro S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994626 16. Diagnosing COVID-19 disease using an efficient CAD system. Optik (Stuttg) 2021; 241:167199Shakarami A, Menhaj MB, Tarrah H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34028466 17. Using Deep Learning Model for Adapting and Managing COVID-19 Pandemic Crisis. Procedia Comput Sci 2021; 184:558-564Alodat M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025823 18. Typical Covid-19 case with primary pneumomediastinum in a 37 year old male. Radiol Case Rep 2021; Jafari R, Cegolon L, Dehghanpoor F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995745 19. Lung Ultrasound Score to Predict Outcomes in COVID-19. Respir. Care 2021; Trias-Sabrià P, Molina-Molina M, Aso S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34006594 20. Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study. Respir. Med. 2021; 184:106435Frija-Masson J, Debray MP, Boussouar S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020126 21. Risk factors for persistent abnormality on chest radiographs at 12-weeks post hospitalisation with PCR confirmed COVID-19. Respir Res 2021; 22:157Wallis TJM, Heiden E, Horno J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020644

Immune response (44 articles) 1. Global dynamics of SARS-CoV-2/cancer model with immune responses. Appl Math Comput 2021:126364Elaiw AM, Al Agha AD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002102 2. DeepImmuno: deep learning-empowered prediction and generation of immunogenic peptides for T-cell immunity. Brief. Bioinform. 2021; Li G, Iyer B, Prasath VBS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009266 3. B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV. Cell 2021; Scheid JF, Barnes CO, Eraslan B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015271 4. Decay of Fc-dependent antibody functions after mild to moderate COVID-19. Cell Rep Med 2021:100296Lee WS, Selva KJ, Davis SK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997824 5. Developing a SARS-CoV-2 Antigen Test Using Engineered Affinity Proteins. ChemRxiv 2021; Kim S, Yee EH, Miller EA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013166 6. SARS-CoV2 IgG antibody: Seroprevalence among health care workers. Clin Epidemiol Glob Health 2021; 11:100766Prakash O, Solanki B, Sheth J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997477 7. The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors. Clin Epidemiol Glob Health 2021; 11:100763Wardhani SO, Fajar JK, Nurarifah N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997476 8. Excess Soluble fms-like Tyrosine Kinase 1 Correlates With Endothelial Dysfunction and Organ Failure in Critically Ill Coronavirus Disease 2019 Patients. Clin Infect Dis 2021; 72:1834-1837Dupont V, Kanagaratnam L, Goury A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32672790 9. Differential Cytokine Signatures of SARS-CoV-2 and Influenza Infection Highlight Key Differences in Pathobiology. Clin Infect Dis 2021; Karaba AH, Zhou W, Hsieh LL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013339 10. Antibody Responses and Clinical Outcomes in Adults Hospitalized With Severe Coronavirus Disease 2019 (COVID-19): A Post hoc Analysis of LOTUS China Trial. Clin Infect Dis 2021; 72:e545-e551Ren L, Fan G, Wu W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32840287 11. Serum Antibody Profile of a Patient With Coronavirus Disease 2019 Reinfection. Clin Infect Dis 2021; 72:e659-e662To KK, Hung IF, Chan KH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32966566 12. Non-occupational and occupational factors associated with specific SARS- CoV-2 antibodies among hospital workers - A multicentre cross-sectional study. Clin Microbiol Infect 2021; Kahlert CR, Persi R, Güsewell S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020033 13. Mysterious multisystem inflammatory syndrome: Life-threatening disease in young people after SARS-CoV-2 infection causes concern. Deutsche Apotheker Zeitung 2021; 161Stahl V. 14. Persistence of SARS-CoV-2-Specific IgG in Children 6 Months After Infection, Australia. Emerg Infect Dis 2021; 27Toh ZQ, Higgins RA, Do LAH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016252 15. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020(1). Emerg Infect Dis 2021; 27:1598-1606Wiens KE, Mawien PN, Rumunu J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013872 16. Positron emission tomography in the COVID-19 pandemic era. Eur J Nucl Med Mol Imaging 2021:1-15Jin C, Luo X, Qian S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013405 17. Serum IgG levels in children 6 months after SARS-CoV-2 infection and comparison with adults. Eur. J. Pediatr. 2021; Bloise S, Marcellino A, Testa A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023936 18. Evaluation of Th1 and Th2 mediated cellular and humoral immunity in patients with COVID-19 following the use of melatonin as an adjunctive treatment. Eur. J. Pharmacol. 2021; 904:174193Hosseini A, Esmaeili Gouvarchin Ghaleh H, Aghamollaei H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015316 19. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives. Expert Rev. Clin. Immunol. 2021; Ruggeri RM, Campennì A, Deandreis D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015983 20. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration. Front. Immunol. 2021; 12:589095Chen R, Lan Z, Ye J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995341 21. Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1). Front. Immunol. 2021; 12:593595Choreño-Parra JA, Jiménez-Álvarez LA, Cruz-Lagunas A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33995342 22. Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients. Front. Immunol. 2021; 12:659018Martín-Sánchez E, Garcés JJ, Maia C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012444 23. A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain. Front. Immunol. 2021; 12:647934Niu L, Wittrock KN, Clabaugh GC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995366 24. CD4(+) T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein. Front. Immunol. 2021; 12:629102Taborska P, Strizova Z, Stakheev D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012431 25. SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs. Front. Immunol. 2021; 12:661052Xiang Q, Feng Z, Diao B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995382 26. Cellular Immune Response to COVID-19 and Potential Immune Modulators. Front. Immunol. 2021; 12:646333Zhou X, Ye Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995364 27. Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient. Hum Vaccin Immunother 2021:1- 3Etemadifar M, Sigari AA, Sedaghat N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34015240 28. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets. Immunity 2021; Dugan HL, Stamper CT, Li L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022127 29. Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection. Int J Infect Dis 2021; Vicenti I, Gatti F, Scaggiante R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34022329 30. Functional characterization of CD4+ T cell receptors crossreactive for SARS- CoV-2 and endemic coronaviruses. J. Clin. Invest. 2021; 131Dykema AG, Zhang B, Woldemeskel BA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33830946 31. Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease. J Clin Transl Hepatol 2021; 9:256-264Premkumar M, Kedarisetty CK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007808 32. Ultra-precise label-free nanosensor based on integrated graphene with Au nanostars toward direct detection of IgG antibodies of SARS-CoV-2 in blood. J Electroanal Chem (Lausanne) 2021; 894:115341Alireza Hashemi S, Bahrani S, Mojtaba Mousavi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994897 33. An immune-centric investigation of Coronavirus in the women with cancers; A review article. J Family Med Prim Care 2021; 10:56-61Yousefi Sharami SR, Yousefnezhad A, Nokhostin F. http://www.ncbi.nlm.nih.gov/pubmed/? term=34017703 34. Rapid COVID-19 antigenic tests: Usefulness of a modified method for diagnosis. J Med Virol 2021; Reza S, Corentin D, Te-Din H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009649 35. Immunological map in COVID-19. J Microbiol Immunol Infect 2021; Li CH, Chiou HC, Lin MH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023234 36. COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2. J. Neurol. 2021:1-31Sriwastava S, Tandon M, Podury S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009454 37. A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection-SARS-CoV-2 as a Proof of Concept. mBio 2021; 12Rusanen J, Kareinen L, Szirovicza L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006662 38. Attenuation of antibody response to SARS-CoV-2 infection in patients with multiple sclerosis on ocrelizumab: A case-control study. Mult Scler Relat Disord 2021; 52:103014Conte WL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000684 39. The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients. New Microbes New Infect 2021:100899Caruana G, Lebrun LL, Aebischer O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007453 40. SARS-CoV-2 IgG response in symptomatic and asymptomatic COVID-19- infected healthcare workers. Occup. Med. (Lond.) 2021; Cordova E, Bacelar B, Nieto F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008016 41. Implementation of integrated supportive supervision in the context of coronavirus 19 pandemic: its effects on routine immunization and vaccine preventable surveillance diseases indicators in the East and Southern African countries. Pan Afr. Med. J. 2021; 38:164Bello IM, Lebo E, Shibeshi ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995771 42. Multisystem inflammatory syndrome associated with SARS-CoV-2 in a Japanese girl. Pediatr. Int. 2021; Baba T, Maruyama T, Katsuragi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009707 43. [COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult]. Rev. Esp. Anestesiol. Reanim. 2020; Elouardi Y, Houssam R, Zarrouki Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994586 44. A recently explored aspect of the iceberg named COVID-19: multisystem inflammatory syndrome in children (MIS-C). Turk Arch Pediatr 2021; 56:3- 9Haslak F, Yıldız M, Adrovic A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34013222

Management miscellaneous diseases (1-3 articles)

1. Impact of COVID-19 on motor vehicle injuries and fatalities in older adults in Ontario, Canada. Accid. Anal. Prev. 2021; 157:106195Rapoport MJ, Chee JN, Aljenabi N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020183 2. [Management of the ENT consultation during the COVID-19 pandemic alert. Are ENT telephone consultations useful?]. Acta Otorrinolaringol. Esp. 2021; 72:190-194Gómez González MDR, Piqueras Pérez FM, Guillamón Vivancos L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017146 3. [Strategies for the practice of otolaryngology and head and neck surgery during the monitoring phase of COVID-19]. Acta Otorrinolaringol. Esp. 2020; 71:367-378Maza-Solano JM, Plaza-Mayor G, Jiménez-Luna A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017144 4. Patch Testing During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC). Actas Dermosifiliogr. 2020; 111:650-654Carrascosa JM, Pastor-Nieto MA, Ruiz-González I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012155 5. Estimated Effect of COVID-19 Lockdown on Skin Tumor Size and Survival: An Exponential Growth Model. Actas Dermosifiliogr. 2020; 111:629-638Tejera- Vaquerizo A, Cañueto J, Toll A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34012154 6. RF - Organization of a Dermatology Department During the COVID-19 Pandemic. Actas Dermosifiliogr (Engl Ed) 2020; 111:781-782Cerro PA, Palma AM, Navarro-Bielsa A, Gilaberte Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994550 7. [Changes in the ambulatory care of prostate cancer patients during the SARS- CoV-2 pandemic. Literature review and contribution of our group in telematic care.]. Actas Urol Esp (Engl Ed) 2021; García Rodríguez J, de León CGR, Sacristán González R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994612 8. [Impact of COVID-19 outbreak on urology surgical waiting lists and waiting lists prioritization strategies in the Post-COVID-19 era]. Actas Urol Esp (Engl Ed) 2021; 45:207-214García-Rojo E, Manfredi C, Santos-Pérez-de-la-Blanca R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017152 9. Medical Mistrust and Stigma Associated with COVID-19 Among People Living with HIV in South Africa. AIDS Behav. 2021:1-11Jarolimova J, Yan J, Govere S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999300 10. Exploring the Social Impacts of the COVID-19 Pandemic on People Living with HIV (PLHIV): A Scoping Review. AIDS Behav. 2021:1-16Winwood JJ, Fitzgerald L, Gardiner B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019203 11. Why COVID-19 strengthens the case to scale up assault on non- communicable diseases: role of health professionals including physical therapists in mitigating pandemic waves. AIMS Public Health 2021; 8:369- 375Dean E, Skinner M, Yu HP et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34017898 12. Pandemics of COVID-19 and racism: how HBCUs are coping. AIMS Public Health 2021; 8:333-351Murty KS, Payne TB. http://www.ncbi.nlm.nih.gov/pubmed/? term=34017896 13. Corneal transplantation during COVID-19 pandemic: need for special considerations-A live review. AIMS Public Health 2021; 8:186-195Pandey AK, Mudgil N, Wadgave Y, Mishra SS. http://www.ncbi.nlm.nih.gov/pubmed/? term=34017884 14. Analysis of the dispatch of physician staffed-helicopters in the COVID-19 pandemic. Am J Emerg Med 2021; Ota S, Jitsuiki K, Muramatsu KI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001427 15. The impact of COVID-19 on anaesthesia and critical care services in the UK: a serial service evaluation. Anaesthesia 2021; Kursumovic E, Cook TM, Vindrola- Padros C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34005837 16. Skin Prick Test Practice In Allergy Clinics During Covid-19 Pandemic. Ann. Allergy. Asthma. Immunol. 2021; Kendirlinan R, Cerci P, Mungan D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020010 17. Home epinephrine-treated reactions in food allergy oral immunotherapy: Lessons from COVID-19 lockdown. Ann. Allergy. Asthma. Immunol. 2021; Nachshon L, Goldberg MR, Levy MB et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34010698 18. Increased orthopaedic presentations as a result of COVID-19-related social restrictions in a regional setting, despite local and global trends. ANZ J Surg 2021; Woo E, Smith AJ, Mah D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34013547 19. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study. BMC Cancer 2021; 21:578van Marcke C, Honoré N, van der Elst A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016086 20. Reorganisation of GP surgeries during the COVID-19 outbreak: analysis of guidelines from 15 countries. BMC Fam. Pract. 2021; 22:96Tsopra R, Frappe P, Streit S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000985 21. Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales. BMC Med 2021; 19:124Alsallakh MA, Sivakumaran S, Kennedy S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33993870 22. Opioid use, motivation to quit, and treatment status related to COVID-19: a cross-sectional study. BMC Res. Notes 2021; 14:195Parker MA, Agley J, Adams ZW, Villanti AC. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016167 23. Impact of the COVID-19 pandemic and related control measures on cancer diagnosis in Catalonia: a time-series analysis of primary care electronic health records covering about five million people. BMJ Open 2021; 11:e047567Coma E, Guiriguet C, Mora N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006554 24. Assessment of the impact of the COVID-19 pandemic on Sexual Assault Treatment Unit activity. BMJ Sex Reprod Health 2021; Kane D, Maher N, Eogan M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016667 25. Morbidity and mortality in patients undergoing lower limb arthroplasty surgery during the initial surge of the COVID-19 pandemic in the UK at a single- speciality orthopaedic hospital. Bone Jt Open 2021; 2:323-329Agrawal Y, Vasudev A, Sharma A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003027 26. Early mortality outcomes of patients with fragility hip fracture and concurrent SARS-CoV-2 infection : a systematic review and meta-analysis. Bone Jt Open 2021; 2:314-322Alcock H, Moppett EA, Moppett IK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003031 27. Impact of COVID-19 pandemic on the management of glioma patients around the world. An evidence-based review. Brain Disord 2021; 2:100012Azab MA, Azzam AY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997826 28. Diagnosis and Management of Osteoporosis During COVID-19: Systematic Review and Practical Guidance. Calcif. Tissue Int. 2021:1-12Hampson G, Stone M, Lindsay JR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003337 29. Impact of nonpharmaceutical interventions on laboratory detections of influenza A and B in Canada. Can. Commun. Dis. Rep. 2021; 47:142-148Lagacé- Wiens P, Sevenhuysen C, Lee L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34012338 30. Risk factors and clinical outcomes of systemic cancer treatment delays in Filipino patients with solid tumor malignancy during the COVID-19 pandemic: A single tertiary center study. Cancer Rep (Hoboken) 2021:e1426Pandy JG, Maaño O, Balolong-Garcia JC, Datukan JTY. http://www.ncbi.nlm.nih.gov/pubmed/? term=34021716 31. [Consensus of the ambulatory surgery commite section of the spanish association of surgeons on the role of ambulatory surgery in the sars-cov-2 pandemic.]. Cir Esp (Engl Ed) 2021; Morales-García D, Durantez FD, Capitán Vallvey J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994557 32. Antimicrobial Stewardship in a Pandemic: Picking Up the Pieces. Clin Infect Dis 2021; 72:e542-e544Furukawa D, Graber CJ. http://www.ncbi.nlm.nih.gov/pubmed/? term=32857832 33. A comparison of emergency department presentations for medically unexplained symptoms in frequent attenders during COVID-19. Clin Med (Lond) 2021; Daniels NF, Ridwan R, Barnard EBG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016583 34. Saving time in the radiotherapy procedures for COVID-19 pneumonia treatment. A single-institution experience. Clin. Transl. Oncol. 2021:1-6Bonet M, Vázquez S, García E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013493 35. Analysis of Road Traffic Accident Fatalities in Karachi, Pakistan: An Autopsy- Based Study. Cureus 2021; 13:e14459Khurshid A, Sohail A, Khurshid M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996319 36. Using the Decrease in Trauma Admissions During the COVID-19 Pandemic to Evaluate Compliance With Stay-at-Home and Social Distancing Guidelines. Cureus 2021; 13:e14444Savla P, Wiginton Jt, Taka TM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996308 37. Trauma trends during COVID-19 alcohol prohibition at a South African regional hospital. Drug Alcohol Rev 2021; Chu KM, Marco JL, Owolabi EO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998731 38. Reflections on 40 Years of AIDS. Emerg Infect Dis 2021; 27:1553-1560De Cock KM, Jaffe HW, Curran JW. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013858 39. Trends in Viral Respiratory Infections During COVID-19 Pandemic, South Korea. Emerg Infect Dis 2021; 27:1685-1688Yum S, Hong K, Sohn S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013875 40. Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles. Epma j 2021:1-22Liskova A, Samec M, Koklesova L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025826 41. Impact of the COVID-19 pandemic on the care of cancer patients in Spain. ESMO Open 2021; 6:100157Amador M, Matias-Guiu X, Sancho-Pardo G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015642 42. Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review. Eur. J. Clin. Invest. 2021:e13604Spagnolo F, Boutros A, Croce E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021591 43. Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection. Eur J Hosp Pharm 2021; Fernández-Oliveira C, Rotea- Salvo S, Fernández-Docampo M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34011555 44. Impact of COVID-19 on a paediatric emergency service. Eur. J. Pediatr. 2021:1- 9Paiva R, Martins C, Rodrigues F, Domingues M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003356 45. The Impact of Coronavirus Disease 2019 on the Disease Pattern of Oral and Maxillofacial Surgery Inpatients: A Comparative Study. Front Med (Lausanne) 2021; 8:613663Pu JJ, McGrath CP, Leung YY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996845 46. Mortality and Life-Sustaining Therapy Decisions in Patients With Cancer and Acute Respiratory Failure Due to COVID-19 or Other Causes: An Observational Study. Front Med (Lausanne) 2021; 8:620818Testa RS, Praça APA, Nassar Junior AP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012970 47. The Impact of Coronavirus Disease 2019 Epidemic on Dizziness/Vertigo Outpatients in a Neurological Clinic in China. Front. Neurol. 2021; 12:663173Li C, Guo D, Ma X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995259 48. Patients With Epilepsy Who Underwent Epilepsy Surgery During the COVID-19 Pandemic Showed Less Depressive Tendencies. Front. Neurol. 2021; 12:677828Niimi K, Fujimoto A, Sato K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34017309 49. Survey on the Progression of Myopia in Children and Adolescents in Chongqing During COVID-19 Pandemic. Front Public Health 2021; 9:646770Wang W, Zhu L, Zheng S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33996724 50. Impact of COVID-19 related national lockdown on care of corneal transplantation patients at a tertiary eye care centre in India. Indian J Ophthalmol 2021; 69:1569-1574Bhalerao SA, Vuyyuru S, Mohamed A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011743 51. Immediate sequential bilateral cataract surgery and its relevance in COVID-19 era. Indian J Ophthalmol 2021; 69:1587-1591Bhalla JS, Zakai MU, Mehtani A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011747 52. Resident-performed immediate sequential bilateral cataract surgery during the COVID-19 pandemic. Indian J Ophthalmol 2021; 69:1579-1584Chen TA, Chen SP, Ahmad TR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011745 53. A graft-free scleral sleeve technique of Ahmed Glaucoma Valve implantation in refractory glaucoma- Rising to the challenge of COVID-19 pandemic. Indian J Ophthalmol 2021; 69:1623-1625Gupta R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34011756 54. Lessons Learnt from Managing Orthopaedic Trauma During the First Wave of the COVID-19 Pandemic at a UK District General Hospital. Indian J. Orthop. 2021:1-9Patel BA, Green SF, Henessy C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34024932 55. COVID-19 Stage Migration (CSM): a New Phenomenon in Oncology? Indian J Surg Oncol 2021:1-2Are C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994722 56. Pre-Anesthesia Re-Evaluation in Post COVID-19 Patients Posted for Elective Surgeries: an Online, Cross-Sectional Survey. Indian J Surg Oncol 2021:1- 6Wajekar AS, Solanki SL, Divatia JV. http://www.ncbi.nlm.nih.gov/pubmed/? term=34025062 57. The Pharmacist's Missing Role in the COVID-19 Pandemic. Innov Pharm 2020; 11Ahjel SW, Al-Jumaili AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007609 58. Effective operating room (OR) utilization by performing low-complex surgical procedures during the 2020 corona pandemic. Int. J. Comput. Assist. Radiol. Surg. 2021:1-3Vogel T, Schippers D, Aldarweesh B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999336 59. The changing influenza activity in the Southern hemisphere countries during the COVID-19 pandemic. Int J Infect Dis 2021; Kim J, Gómez REG, Hong K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022335 60. Ophthalmic practice during COVID-19 pandemic. Int J Ophthalmol 2021; 14:639- 642Soleimani M, Mehrpour M, Mohammad-Rabei H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012876 61. Prevention of infective complications in systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements. Int J Rheum Dis 2021; Oku K, Hamijoyo L, Kasitanon N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999518 62. Contradictory Responses to the COVID-19 Pandemic in Amyotrophic Lateral Sclerosis Patients and Their Families and Caregivers in Japan. Intern Med 2021; 60:1519-1524Yanagihashi M, Sugisawa T, Fuchimoto M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994445 63. Inequities in Hypertension Control in the United States Exposed and Exacerbated by COVID-19 and the Role of Home Blood Pressure and Virtual Health Care During and After the COVID-19 Pandemic. J Am Heart Assoc 2021:e020997Bress AP, Cohen JB, Anstey DE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006116 64. Airway Surgery for Laryngotracheal Stenosis During the COVID-19 Pandemic: Institutional Guidelines. J Cardiothorac Vasc Anesth 2021; Elsayed HH, Moharram AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994316 65. Comparing pattern of musculoskeletal injuries prior to and during COVID-19 lockdown: A time-trend case study from a tertiary level Trauma Center of Northern India. J Family Med Prim Care 2021; 10:427-431Dahuja A, Bansal K, Gupta N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017765 66. Dental practice in the era of COVID-19: A review of literature. J Family Med Prim Care 2021; 10:41-47Razmara F, Khayamzadeh M, Shabankare G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017701 67. Oral manifestations and dental practice recommendations during COVID-19 pandemic. J Family Med Prim Care 2021; 10:102-109Singh G, Priya H, Mishra D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017710 68. An immune-centric investigation of Coronavirus in the women with cancers; A review article. J Family Med Prim Care 2021; 10:56-61Yousefi Sharami SR, Yousefnezhad A, Nokhostin F. http://www.ncbi.nlm.nih.gov/pubmed/? term=34017703 69. Omission of adjuvant radiotherapy for older adults with early-stage breast cancer particularly in the COVID era: A literature review (on the behalf of Italian Association of Radiotherapy and Clinical Oncology). J. Geriatr. Oncol. 2021; Palumbo I, Borghesi S, Gregucci F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020908 70. Patient Perceptions of COVID-19 Precautions and Their Effects on Experiences With Hand Surgery. J Hand Surg Glob Online 2021; Tawfik AM, Silver JM, Katt BM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997725 71. The impact of COVID-19 pandemic on headache symptoms and drug withdrawal among patients with medication overuse headache: a cross- sectional study. J. Headache Pain 2021; 22:41Li C, Li Y, Ma M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020588 72. How Myanmar Is Working to Maintain Essential Services for People Living With HIV and Key Populations During the Covid-19 Pandemic. J Int Assoc Provid AIDS Care 2021; 20:23259582211017742Htun Nyunt O, Wan NMA, Soan P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013809 73. Navigating migraine care through the COVID-19 pandemic: an update. J. Neurol. 2021:1-8Angus-Leppan H, Guiloff AE, Benson K, Guiloff RJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002281 74. Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review. J. Neurol. 2021:1-14García-Azorín D, Seeher KM, Newton CR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021772 75. Sleep disturbances in children with cystic fibrosis, primary ciliary dyskinesia and typically developing children during COVID-19 pandemic. J. Paediatr. Child Health 2021; Sismanlar Eyuboglu T, Aslan AT, Ramaslı Gursoy T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004018 76. Resumption of Cosmetic Surgery During COVID - Experience of a Specialised Cosmetic Surgery Day-case Hospital. J. Plast. Reconstr. Aesthet. Surg. 2021; Imam SZ, Karanasios G, Khatib M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34006470 77. How emergency department visits for substance use disorders have evolved during the early COVID-19 pandemic. J. Subst. Abuse Treat. 2021; 129:108391Pines JM, Zocchi MS, Black BS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994360 78. Perioperative management invited expert opinions in 2020 and 2021: Synopsis of 9 "must read" articles. J. Thorac. Cardiovasc. Surg. 2021; Geube M, Whitman GJR, Arora RC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020802 79. Impact of COVID-19 and ICU capacity on vaccination support: Evidence from a two-leg representative survey in the UK. J Virus Erad 2021:100044Blanchard- Rohner G, Caprettini B, Rohner D, Voth HJ. http://www.ncbi.nlm.nih.gov/pubmed/? term=34026244 80. Both younger and elderly patients in pain are willing to undergo knee replacement despite the COVID-19 pandemic: a study on surgical waiting lists. Knee Surg. Sports Traumatol. Arthrosc. 2021:1-8Gómez-Barrena E, Rubio-Saez I, Padilla-Eguiluz NG, Hernandez-Esteban P. http://www.ncbi.nlm.nih.gov/pubmed/? term=34014339 81. Impact of COVID-19 on the management of patients with thoracic cancers in a tertiary referral center. Lung Cancer 2021; Basse C, Daniel C, Livartowski A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994016 82. Lung cancer patients with COVID-19 in Spain: GRAVID study. Lung Cancer 2021; Provencio M, Mazarico Gallego JM, Calles A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016490 83. [Endoscopic endonasal surgery during COVID-19 pandemic: management guideline]. Neurocirugia (Astur : Engl Ed) 2021; Mañas DM, Gómez PL, Artiles JV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994775 84. Impact of COVID-19 on chronic migraine treated with erenumab: a case report. Neurol Sci 2021; Grassini A, Marcinnò A, Roveta F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021438 85. The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment. Neurooncol Adv 2021; 3:vdab035Mrugala MM, Ostrom QT, Pressley SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007966 86. Knowledge about coronavirus disease 2019: Implication for dentists in Saudi Arabia. Niger. J. Clin. Pract. 2021; 24:747-752Nassar AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018985 87. Evaluation of coronavirus disease (COVID-19) awareness of patients undergoing dental interventions in Turkey. Niger. J. Clin. Pract. 2021; 24:753- 761Yilmaz B, Somay E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018986 88. Recommendations of the Laparoscopic Surgery Society of Nigeria on the Conduct of Minimal Access Surgeries during and after the COVID-19 Pandemic in Nigeria. Niger J Surg 2021; 27:1-4Adisa AO, Balogun OS, Osinowo A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012233 89. Effect of COVID-19 pandemic on global Bariatric surgery PRActiceS - The COBRAS study. Obes. Res. Clin. Pract. 2021; Singhal R, Tahrani AA, Sakran N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994148 90. Changes in Pediatric Sports Injury Presentation During the COVID-19 Pandemic: A Multicenter Analysis. Orthop J Sports Med 2021; 9:23259671211010826Johnson MA, Halloran K, Carpenter C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997072 91. Development and Assessment of an Otolaryngology-Specific Surgical Priority Scoring System. OTO Open 2021; 5:2473974x211012664Sharma A, Matos S, Ettema SL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017936 92. Practice of Telehealth in Otolaryngology: A Scoping Review in the Era of COVID-19. Otolaryngol Head Neck Surg 2021:1945998211013751Gonzalez JN, Axiotakis LG, Jr., Yu VX et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003046 93. Pain during and after coronavirus disease 2019: Chinese perspectives. Pain Rep 2021; 6:e931Jiang F, Yang WL, Wang JW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997586 94. Mortality and morbidity in COVID-19 orthopedic trauma patients: is early surgery the keystone? Pan Afr. Med. J. 2021; 38:163Giorgi PD, Gallazzi E, Capitani P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995770 95. [CME Rheumatology 23/Answers: Rheumatoid Arthritis Following COVID- 19/SARS-CoV-2 Infection]. Praxis (Bern 1994) 2021; 110:375-376Tamborrini G, Micheroli R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019443 96. Leveraging vertical COVID-19 investments to improve monitoring of cancer screening programme - A case study from Bangladesh. Prev. Med. 2021:106624Basu P, Lucas E, Zhang L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34023359 97. Predictors of screening for cervical and colorectal cancer in women 50- 65 years old in a multi-ethnic population. Prev Med Rep 2021; 22:101375Harper DM, Plegue M, Sen A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996388 98. Interruption of cancer screening services due to COVID-19 pandemic: lessons from previous disasters. Prev Med Rep 2021:101399Puricelli Perin DM, Christensen T, Burón A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34026465 99. [Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy]. Rev. Rhum. Ed. Fr. 2021; Quartuccio L, Valent F, Pasut E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34007141 100. A review on recipients of hematopoietic stem cell transplantation patients with COVID-19 infection. Ther Adv Infect Dis 2021; 8:20499361211013252Sahu KK, Siddiqui AD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996075 101. Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection. Ther. Adv. Med. Oncol. 2021; 13:17588359211011455Ottaiano A, Scala S, D'Alterio C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995596 102. Changes in pediatric healthcare utilization in Hunan Province, China, during the COVID-19 pandemic: a multi-center cross-sectional study. Transl Pediatr 2021; 10:870-881Yan H, Li X, Lu X et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34012836 103. Oncology Services for Patients with Head Neck Cancer during Corona-Times - Patients' Perspective. Tumor Diagnostik und Therapie 2021; 42:277-283Büntzel J, Walter S, Hellmund H et al.

Management (59 articles)

1. Implementing the medically necessary, time-sensitive surgical scoring system during the COVID-19 pandemic. Am. J. Surg. 2021; Zaifman JM, Sugalski GS, Tank LK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001331 2. Human factors and ergonomics to improve performance in intensive care units during the COVID-19 pandemic. Anaesthesiol Intensive Ther 2021; Della Torre V, F EN, Rosseel P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34006054 3. Noninvasive ventilation and positional therapy in COVID-19: Case report and literature review. Anaesthesist 2021; Sellmann T, Maurer C, Thal SC. 4. Repurposing of antibiotics for clinical management of COVID-19: a narrative review. Ann. Clin. Microbiol. Antimicrob. 2021; 20:37Yacouba A, Olowo-Okere A, Yunusa I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020659 5. Clinical characteristics of COVID-19 infection in polyhandicapped persons in France. Arch. Pediatr. 2021; Rousseau MC, Hully M, Milh M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994267 6. Can trace element supplementations (Cu, Se, and Zn) enhance human immunity against COVID-19 and its new variants? Beni Suef Univ J Basic Appl Sci 2021; 10:33Nedjimi B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34026905 7. The repurposed use of anesthesia machines to ventilate critically ill patients with coronavirus disease 2019 (COVID-19). BMC Anesthesiol. 2021; 21:155Bottiroli M, Calini A, Pinciroli R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34016056 8. Prediction of hospital bed capacity during the COVID- 19 pandemic. BMC Health Serv. Res. 2021; 21:468Deschepper M, Eeckloo K, Malfait S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006279 9. Factors influencing risk perception and nosocomial infection prevention practices of frontline nurses during the COVID-19 pandemic. BMC Nurs. 2021; 20:78Lyu X, Hu J, Xu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001128 10. The health policy response to COVID-19 in Malawi. BMJ Glob Health 2021; 6Mzumara GW, Chawani M, Sakala M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34006521 11. How patients with COVID-19 managed the disease at home during the first wave in Spain: a cross-sectional study. BMJ Open 2021; 11:e048702Romay- Barja M, Pascual-Carrasco M, De Tena-Dávila MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016666 12. Outpatient Management of Patients With COVID-19: Multicenter Prospective Validation of the HOME-CoV Rule to safely discharge patients. Chest 2021; Douillet D, Penaloza A, Mahieu R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34004154 13. Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi- hospital Cohort Study. Clin Infect Dis 2021; 72:e533-e541Vaughn VM, Gandhi TN, Petty LA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32820807 14. The Nazareth Community Oncology Unit: The Oncology Nurse's Role to Provide Care in the Environment of COVID-19. Clin. J. Oncol. Nurs. 2021; 25:347-350Dayan M, Zgairy S, Agbarya A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34019021 15. 'Food for thought': The importance of nutrition to patient care and the role of the junior doctor. Clin Med (Lond) 2021; 21:e272-e274Frost JC, Baldwin AJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001584 16. Family Caregivers' Experiences and Changes in Caregiving Tasks During the COVID-19 Pandemic. Clin. Nurs. Res. 2021:10547738211014211Irani E, Niyomyart A, Hickman RL, Jr. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998836 17. Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity. Comput. Biol. Med. 2021; 134:104459Das D, Podder S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020127 18. Non-intubated COVID-19 patients despite high levels of supplemental oxygen. Crit Care 2021; 25:170Chosidow S, Plantefève G, Fraissé M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001221 19. How can an emergency department be strengthened against a pandemic? Deutsche Medizinische Wochenschrift 2021; 146:657-666Schmid B, Lang CN, Danner T et al. 20. Edible and Herbal Plants for the Prevention and Management of COVID-19. Front. Pharmacol. 2021; 12:656103Li S, Cheng CS, Zhang C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995078 21. Global Healthcare Resource Efficiency in the Management of COVID-19 Death and Infection Prevalence Rates. Front Public Health 2021; 9:638481Breitenbach MC, Ngobeni V, Aye GC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996718 22. Acute-care hospital reencounters in COVID-19 patients. Geroscience 2021:1- 13Clark JR, Batra A, Shlobin NA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34019232 23. Long-term care at home and female work during the COVID-19 pandemic. Health Policy 2021; Sugawara S, Nakamura J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994215 24. Saffron: A potential drug-supplement for severe acute respiratory syndrome coronavirus (COVID) management. Heliyon 2021; 7:e07068Husaini AM, Jan KN, Wani GA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007917 25. Intensive Care Unit Built Environments: A Comprehensive Literature Review (2005-2020). Herd 2021:19375867211009273Verderber S, Gray S, Suresh-Kumar S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000842 26. Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: an open- label randomized clinical trial. Indian J Otolaryngol Head Neck Surg 2021:1- 5Arefin MK, Rumi S, Uddin A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34026595 27. Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic. Inflamm. Bowel Dis. 2021; 27:940-946Grossberg LB, Pellish RS, Cheifetz AS, Feuerstein JD. http://www.ncbi.nlm.nih.gov/pubmed/?term=32619010 28. A commentary on the value of hospital data for covid-19 pandemic surveillance and planning. Int J Popul Data Sci 2021; 5:1393Manuel DG, van Walraven C, Forster AJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007891 29. Length of Stay in ICU of Covid-19 patients in England, March - May 2020. Int J Popul Data Sci 2021; 5:1411Shryane N, Pampaka M, Aparicio-Castro A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007893 30. COVID-19 impact on nurses in Spain: a considered opinion survey. Int Nurs Rev 2021; Pérez-Raya F, Cobos-Serrano JL, Ayuso-Murillo D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004014 31. Could Isotretinoin be a protective agent against COVID-19?:A dermatologist perspective. J Cosmet Dermatol 2021; Abdelmaksoud A, Patil A, Dursun R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008285 32. Logistical Challenge With Prehospital Use of High-Flow Nasal Oxygen Therapy in COVID-19-Induced Respiratory Distress: A Case Report. J. Emerg. Med. 2021; Kedzierewicz R, Derkenne C, Fraudin A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994257 33. Harnessing the potential of the primary healthcare facilities in India to respond COVID-19 pandemic: A scoping evidence-based research synthesis. J Family Med Prim Care 2021; 10:116-121Royal A, Mali MA, Kumar V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017712 34. The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study. J Infect 2021; Zarif A, Joy M, Sherlock J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004222 35. Clinical outcomes of patients hospitalized for COVID-19 and evidence-based on the pharmacological management reduce mortality in a region of the Colombian Caribbean. J Infect Public Health 2021; 14:696-701García-Posada M, Aruachan-Vesga S, Mestra D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020208 36. Pulmonary Barotrauma in COVID-19 Patients With ARDS on Invasive and Non- Invasive Positive Pressure Ventilation. J. Intensive Care Med. 2021:8850666211019719Rajdev K, Spanel AJ, McMillan S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013825 37. The Development and Operation of a Home Management System during the COVID-19 Pandemic: Experience of the Local Government Gyeonggi-do in Korea. J Korean Med Sci 2021; 36:e134Lee Y, Han JO, Lee H, Lim S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002552 38. Delayed access to care and late presentations in children during the COVID-19 pandemic New Zealand-wide lockdown: A New Zealand Paediatric Surveillance Unit study. J. Paediatr. Child Health 2021; Duncanson M, Wheeler BJ, Jelleyman T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003540 39. Emerging Adults' Adherence to Preventative Health Guidelines in Response to COVID-19. J. Pediatr. Psychol. 2021; Feldman ECH, Balistreri KA, Lampert S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010417 40. Interventions targeting non-symptomatic cases can be important to prevent local outbreaks: SARS-CoV-2 as a case study. J R Soc Interface 2021; 18:20201014Lovell-Read FA, Funk S, Obolski U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006127 41. Ventilated COVID-19 patients: A call to action. Laryngo- Rhino- Otologie 2021; 100:342Kessing R. 42. An Overview of Human Resources and Capacity in Health Care Institutions in the Federation of Bosnia and Herzegovina in the Context of Responding to the COVID 19 Pandemic. Mater Sociomed 2021; 33:56-59Cilovic-Lagarija S, Hasanica N, Mulic M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012352 43. Practical Recommendations for the Management of Patients with ITP During the COVID-19 Pandemic. Mediterr. J. Hematol. Infect. Dis. 2021; 13:e2021032Rodeghiero F, Cantoni S, Carli G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007420 44. Change management in a maximum care hospital during a pandemic: A personal story. Nervenheilkunde 2021; 40:348-358Moskopp D. 45. Illness uncertainty among patients with COVID-19 in the Mobile Cabin Hospital. Nurs Open 2021; Dong L, Chen L, Ding S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000092 46. The impact of vitamin D supplementation on body fat mass in elite male collegiate athletes. Nutr. Metab. (Lond.) 2021; 18:51Kawashima I, Tsukahara T, Kawai R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020679 47. [General palliative care during the pandemic]. Onkologe (Berl) 2021:1-5Schwartz J, Reuters MC, Schallenburger M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994676 48. Impact of non-pharmacological initiatives for COVID-19 on hospital admissions due to pediatric acute respiratory illnesses. Paediatr. Respir. Rev. 2021; Chiapinotto S, Sarria EE, Mocelin HT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016531 49. Health and social care professionals' experiences of providing end of life care during the COVID-19 pandemic: A qualitative study. Palliat. Med. 2021:2692163211017808Hanna JR, Rapa E, Dalton LJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006159 50. Probiotics potentials in mitigating coronavirus disease (COVID-19) pandemic. Pan Afr. Med. J. 2021; 38:186Reuben RC, Makut MD, Adogo LY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995792 51. "I'm fine." "It's fine." "We are not fine!" - Providing behavioral health service to families in rural Appalachia during COVID-19. Patient Educ. Couns. 2021; Newhouse A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001395 52. Weaning from Mechanical Ventilation in Patients with SARS-CoV-2 Infection after Prolonged Mechanical Ventilation: First Experience. Pneumologie 2021; 75:261-267Schäfer H, Michels IC, Bucher B et al. 53. Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort study. Res Pract Thromb Haemost 2021; 5:e12521Weeks LD, Sylvester KW, Connors JM, Connell NT. http://www.ncbi.nlm.nih.gov/pubmed/? term=34013153 54. Prediction of Extubation Failure in COVID-19. Respir. Care 2021; de Andrade Filho PH, de Assis Brasil ES, Costa LG et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34006593 55. Comparative and quantitative analysis of COVID-19 epidemic interventions in Chinese provinces. Results Phys 2021; 25:104305Liu H, Rong Z, Qi X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002128 56. Simple hemogram to support the decision-making of COVID-19 diagnosis using clusters analysis with self-organizing maps neural network. Soft comput 2021:1-12Souza AA, Almeida DC, Barcelos TS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025211 57. [The role of micronutrients in the comprehensive rehabilitation of patients with the novel coronavirus infection COVID-19]. Vopr. Pitan. 2021; 90:40- 49Marchenkova LA, Makarova EV, Yurova OV. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019347 58. Reusable Elastomeric Respirators in HealthCare. Workplace Health Saf. 2021; 69:291-292Pompeii L, Hines SE. http://www.ncbi.nlm.nih.gov/pubmed/? term=33998347 59. Treatment refractive hypernatremia with mild COVID-19. Zeitschrift fur Gerontologie und Geriatrie 2021; Künzler T, Münzer T.

Mental – public health (148 articles)

1. Prevalence of Depression and Anxiety Among Medical Students and House Staff During the COVID-19 Health-Care Crisis. Acad. Psychiatry 2021:1-6Gupta P, B KA, Ramakrishna K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018165 2. A review on the COVID-19-related psychological impact on older adults: vulnerable or not? Aging Clin. Exp. Res. 2021:1-15Parlapani E, Holeva V, Nikopoulou VA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999378 3. Resilience, Anxiety, Stress, and Substance Use Patterns During COVID-19 Pandemic in the Miami Adult Studies on HIV (MASH) Cohort. AIDS Behav. 2021:1-11Diaz-Martinez J, Tamargo JA, Delgado-Enciso I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009479 4. COVID-19 among LGBTQ+ individuals living with HIV/AIDS: psycho-social challenges and care options. AIMS Public Health 2021; 8:303-308Tomar A, Spadine MN, Graves-Boswell T, Wigfall LT. http://www.ncbi.nlm.nih.gov/pubmed/? term=34017893 5. The need for psychological, caregiver-centered intervention in the time of COVID-19. Alzheimers Dement (N Y) 2021; 7:e12166Ortelli P, Ferrazzoli D, Versace V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013019 6. A rapid scoping review of COVID-19 and vulnerable workers: Intersecting occupational and public health issues. Am. J. Ind. Med. 2021; Côté D, Durant S, MacEachen E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003502 7. The Role of Hope and Resilience in Protecting Against Suicidal thoughts and Behaviors During the COVID-19 Pandemic. Arch Suicide Res 2021:1-18Knowles JRP, Gray NS, O'Connor C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33999758 8. Small Amounts of Physical Activity During the COVID-19 Pandemic May Contribute to Improve Empathy in Young Adults: An Observational Study. Asia Pac. J. Public Health 2021:10105395211016333Shima T, Jesmin S, Nakao H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000841 9. Testing Invariance of Measures of Internalizing Symptoms Before and After a Major Life Stressor: The Impact of COVID-19 in an Adolescent and Young Adult Sample. Assessment 2021:10731911211015315Olino TM, Case JAC, Hawes MT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013771 10. The mental health of Australian medical practitioners during Covid-19. Australas Psychiatry 2021:10398562211010807Adams MA, Brazel M, Thomson R, Lake H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010578 11. COVID-19 and ECT - a Victorian perspective. Australas Psychiatry 2021:10398562211014224Jagadheesan K, Walker F, Danivas V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33993747 12. Mental health among pregnant women with COVID-19-related stressors and worries in the United States. Birth 2021; Liu J, Hung P, Alberg AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008216 13. Psychological distress among people with probable COVID-19 infection: analysis of the UK Household Longitudinal Study. BJPsych Open 2021; 7:e104Niedzwiedz CL, Benzeval M, Hainey K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001295 14. The health-related quality of life in Iranian patients with COVID-19. BMC Infect. Dis. 2021; 21:459Alinia C, Yaghmaei S, Abdullah FZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016041 15. An investigation of the association between religious coping, fatigue, anxiety and depressive symptoms during the COVID-19 pandemic in Morocco: a web- based cross-sectional survey. BMC Psychiatry 2021; 21:264Zarrouq B, Abbas N, Hilaly JE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022849 16. Early life predictors of positive change during the coronavirus disease pandemic. BMC Psychol 2021; 9:83Bleil ME, Appelhans BM, Thomas AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006314 17. Mental health and its relationship with social support in Iranian students during the COVID-19 pandemic. BMC Psychol 2021; 9:81Ghafari R, Mirghafourvand M, Rouhi M, Osouli Tabrizi S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34001232 18. Worry and mental health in the Covid-19 pandemic: vulnerability factors in the general Norwegian population. BMC Public Health 2021; 21:928Blix I, Birkeland MS, Thoresen S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001071 19. Knowledge, attitude, and acceptance of healthcare workers and the public regarding the COVID-19 vaccine: a cross-sectional study. BMC Public Health 2021; 21:955Elhadi M, Alsoufi A, Alhadi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016073 20. Differential impact of non-pharmaceutical public health interventions on COVID-19 epidemics in the United States. BMC Public Health 2021; 21:965Liu X, Xu X, Li G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020613 21. Addressing the psychological impact of COVID-19 on healthcare workers: learning from a systematic review of early interventions for frontline responders. BMJ Open 2021; 11:e044134Hooper JJ, Saulsman L, Hall T, Waters F. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020974 22. Critical care work during COVID-19: a qualitative study of staff experiences in the UK. BMJ Open 2021; 11:e048124Montgomery CM, Humphreys S, McCulloch C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006556 23. COVID-19 health and social care access for autistic people: European policy review. BMJ Open 2021; 11:e045341Oakley B, Tillmann J, Ruigrok A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001500 24. How do the UK public interpret COVID-19 test results? Comparing the impact of official information about results and reliability used in the UK, USA and New Zealand: a randomised controlled trial. BMJ Open 2021; 11:e047731Recchia G, Schneider CR, Freeman AL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016665 25. Anxiety and depression levels of the general population during the rapid progressing stage in the coronavirus disease 2019 outbreak: a cross-sectional online investigation in China. BMJ Open 2021; 11:e050084Shi Z, Qin Y, Chair SY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011604 26. Knowledge brokering on infectious diseases for public health. Can. Commun. Dis. Rep. 2021; 47:160-164Haworth-Brockman M, Keynan Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012340 27. Suicide Deaths in British Columbia during the First Wave of the COVID-19 Pandemic. Can. J. Psychiatry. 2021:7067437211018398Barbic D, Scheuermeyer FX, Barbic SP, Honer WG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998835 28. Mental Health and Wellness of Service Providers Working with People Experiencing Homelessness in Canada: A National Survey from the Second Wave of the COVID-19 Pandemic: Santé Mentale et Bien-Être Des Prestataires de Services Qui Travaillent Avec Des Personnes en Situation D'itinérance au Canada : un Sondage National sur la Deuxième Vague de la Pandémie COVID- 19. Can. J. Psychiatry. 2021:7067437211018782Kerman N, Ecker J, Gaetz S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013774 29. Coronavirus Disease 2019 (COVID-19) Response in Zimbabwe: A Call for Urgent Scale-up of Testing to meet National Capacity. Clin Infect Dis 2021; 72:e667-e674Dzinamarira T, Mukwenha S, Eghtessadi R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32865204 30. A Psychological Perspective on the Association Between Critical Care Resource Availability and Emotional Wellness During the Coronavirus Disease 2019 Pandemic. Clin Infect Dis 2021; 72:e577-e579Kaslow NJ, White DT, Cook SC. http://www.ncbi.nlm.nih.gov/pubmed/?term=32929462 31. Concomitant Marked Decline in Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Other Respiratory Viruses Among Symptomatic Patients Following Public Health Interventions in Australia: Data from St Vincent's Hospital and Associated Screening Clinics, Sydney, NSW. Clin Infect Dis 2021; 72:e649-e651Marriott D, Beresford R, Mirdad F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32841316 32. Health-care Professionals' Perceptions of Critical Care Resource Availability and Factors Associated With Mental Well-being During Coronavirus Disease 2019 (COVID-19): Results from a US Survey. Clin Infect Dis 2021; 72:e566- e576Sharma M, Creutzfeldt CJ, Lewis A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32877508 33. Post-Traumatic Growth Experiences among COVID-19 Confirmed Cases in China: A Qualitative Study. Clin. Nurs. Res. 2021:10547738211016951Sun W, Chen WT, Zhang Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018405 34. The Impact of COVID-19 on mental health. Cogn. Behav. Ther. 2021; 50:185- 190Hofmann SG. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018470 35. Social Distancing During A COVID-19 Lockdown Contributes to The Maintenance of Social Anxiety: A Natural Experiment. Cognit. Ther. Res. 2021:1-7Arad G, Shamai-Leshem D, Bar-Haim Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007091 36. The Implementation of COVID-19 Social Distancing Measures Changed the Frequency and the Characteristics of Facial Injury: The Newcastle (Australia) Experience. Craniomaxillofac. Trauma Reconstr. 2021; 14:150-156Wang CJ, Hoffman GR, Walton GM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995836 37. The coping strategies followed by university students to mitigate the COVID- 19 quarantine psychological impact. Curr. Psychol. 2021:1-10Almomani EY, Qablan AM, Almomany AM, Atrooz FY. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994758 38. Exploring anxiety levels in healthcare workers during COVID-19 pandemic: Turkey sample. Curr. Psychol. 2021:1-8Şahin CU, Kulakaç N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994761 39. Subjective experience of time in dementia with Lewy bodies during COVID-19 lockdown. Curr. Psychol. 2021:1-10Torboli D, Mioni G, Bussé C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994757 40. Data set on impact of COVID-19 on mental health of internal migrant workers in India: Corona Virus Anxiety Scale (CAS) approach. Data Brief 2021; 36:107052Raghavendra NK, Gopal S, Munuswamy J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013004 41. Evaluation of perceived fears of COVID-19 virus infection and its relationship to health-related quality of life among patients with diabetes mellitus in Egypt during pandemic: a developing country single-center study. Diabetol Int 2021:1- 9Abdelghani M, Hamed MG, Said A, Fouad E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996370 42. COVID-19 and the Well-Being of the Homeless Population. Disaster Med Public Health Prep 2021:1Del Castillo FA, Del Castillo CDB, Corpuz JC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998436 43. The impact of COVID-19 on the well-being and cognition of older adults living in the United States and Latin America. EClinicalMedicine 2021; 35:100848Babulal GM, Torres VL, Acosta D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997742 44. COVID-19 Infection Stigma Scale: psychometric properties. Egypt J Neurol Psychiatr Neurosurg 2021; 57:61Elgohari HM, Bassiony MM, Sehlo MG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025114 45. The COVID-19-designated hospitals in China: Preparing for public health emergencies. Emerg Microbes Infect 2021:1-9Li Q, Wang L, Wang B, Lu H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33993856 46. Bio-psychosocial study on the impact of the COVID-19 lockdown on depression and anxiety in a sample of 1753 French-speaking subjects. Encephale 2021; Gouvernet B, Bonierbale M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994159 47. Two-stage mental health survey of first-line medical staff after ending COVID- 19 epidemic assistance and isolation. Eur. Arch. Psychiatry Clin. Neurosci. 2021:1-13Xu L, You D, Li C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34008059 48. A suicide attempt on a left ventricular assist device patient during COVID-19 pandemic: can we only blame the virus? A case report. Eur Heart J Case Rep 2021; 5:ytab144Jiménez-Blanco Bravo M, Zamorano Gómez JL, Del Prado Díaz S, Alonso Salinas GL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013162 49. Governing by Polling Public Opinion: A Potentially Dangerous Idea for Our Healthcare System. Eval. Health Prof. 2021:1632787211018240Gugiu PC. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008444 50. Health-Related Quality of Life in Italian Adolescents During Covid-19 Outbreak. Front Pediatr 2021; 9:611136Mastorci F, Piaggi P, Doveri C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996676 51. Coping Strategies in the Spanish Population: The Role in Consequences of COVID-19 on Mental Health. Front Psychiatry 2021; 12:606621Molero Jurado MDM, Pérez-Fuentes MDC, Fernández-Martínez E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995138 52. Cyberchondria Amidst COVID-19 Pandemic: Challenges and Management Strategies. Front Psychiatry 2021; 12:618508Varma R, Das S, Singh T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995143 53. Psychological Health Issues of Medical Staff During the COVID-19 Outbreak. Front Psychiatry 2021; 12:611223Xie J, Liu Q, Jiang X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995140 54. Physical Activity, Boredom and Fear of COVID-19 Among Adolescents in Germany. Front. Psychol. 2021; 12:624206Bösselmann V, Amatriain-Fernández S, Gronwald T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012413 55. Psychological Predictors of Precautionary Behaviors in Response to COVID- 19: A Structural Model. Front. Psychol. 2021; 12:559289Frías-Armenta M, Corral- Frías NS, Corral-Verdugo V, Lucas MY. http://www.ncbi.nlm.nih.gov/pubmed/? term=33995161 56. The Impact of COVID-19 Home Confinement on Mexican University Students: Emotions, Coping Strategies, and Self-Regulated Learning. Front. Psychol. 2021; 12:642823Gaeta ML, Gaeta L, Rodriguez MDS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995197 57. The Relationship Between Quarantine Length and Negative Affect During the COVID-19 Epidemic Among the General Population in China: The Roles of Negative Cognition and Protective Factors. Front. Psychol. 2021; 12:575684Hou L, Long F, Meng Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995168 58. Do Islanders Have a More Reactive Behavioral Immune System? Social Cognitions and Preferred Interpersonal Distances During the COVID-19 Pandemic. Front. Psychol. 2021; 12:647586Hromatko I, Grus A, Kolđeraj G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995203 59. The Contagion of Donation Behaviors Changes Along With the Abatement of the COVID-19 Pandemic: An Intertemporal Survey Experiment. Front. Psychol. 2021; 12:585128Li S, Liu X, Li J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33995171 60. The Prevalence of Psychological Status During the COVID-19 Epidemic in China: A Systemic Review and Meta-Analysis. Front. Psychol. 2021; 12:614964Li W, Zhang H, Zhang C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017278 61. Navigating the Same Storm but Not in the Same Boat: Mental Health Vulnerability and Coping in Women University Students During the First COVID-19 Lockdown in the UK. Front. Psychol. 2021; 12:648533Misca G, Thornton G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995205 62. Stress, Coping, and Resilience Before and After COVID-19: A Predictive Model Based on Artificial Intelligence in the University Environment. Front. Psychol. 2021; 12:647964Morales-Rodríguez FM, Martínez-Ramón JP, Méndez I, Ruiz- Esteban C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017287 63. Exploratory Study of the Relationship Between Happiness and the Rise of Media Consumption During COVID-19 Confinement. Front. Psychol. 2021; 12:566517Muñiz-Velázquez JA, Gómez-Baya D, Lozano Delmar J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995163 64. Authenticity as a Resilience Factor Against CV-19 Threat Among Those With Chronic Pain and Posttraumatic Stress Disorder. Front. Psychol. 2021; 12:643869Reed DE, 2nd, Lehinger E, Cobos B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995199 65. Psychological Impact of COVID-19 on College Students After School Reopening: A Cross-Sectional Study Based on Machine Learning. Front. Psychol. 2021; 12:641806Ren Z, Xin Y, Ge J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995195 66. Predicting the Severity of Symptoms of the COVID Stress Syndrome From Personality Traits: A Prospective Network Analysis. Front. Psychol. 2021; 12:632227Taylor S, Fong A, Asmundson GJG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995185 67. Clearing the Pathways to Self-Transcendence. Front. Psychol. 2021; 12:648381Worth P, Smith MD. http://www.ncbi.nlm.nih.gov/pubmed/? term=33995204 68. Mental Health Outcomes Among Civil Servants Aiding in Coronavirus Disease 2019 Control. Front Public Health 2021; 9:601791Hu Q, Hu X, Zheng B, Li L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996707 69. Perceived Social Norms as Determinants of Adherence to Public Health Measures Related to COVID-19 in Bali, Indonesia. Front Public Health 2021; 9:646764Indrayathi PA, Januraga PP, Pradnyani PE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996723 70. Utilization of Inpatient Mental Health Care in the Rhineland During the COVID- 19 Pandemic. Front Public Health 2021; 9:593307Zielasek J, Vrinssen J, Gouzoulis- Mayfrank E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996706 71. Rituals of Containment: Many Pandemics, Body Politics, and Social Dramas During COVID-19 in Pakistan. Front Sociol 2021; 6:648149Ali I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996992 72. Perceptions and Experiences of Frontline Urban Indian Organization Healthcare Workers With Infection Prevention and Control During the COVID- 19 Pandemic. Front Sociol 2021; 6:611961Collins N, Crowder J, Ishcomer-Aazami J, Apedjihoun D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996989 73. Evolution of the emotional impact in patients with early Inflammatory Bowel Disease during and after Covid-19 lockdown. Gastroenterol. Hepatol. 2021; Sempere L, Bernabeu P, Cameo J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34023470 74. Effects of social isolation on a long-term care resident with dementia and depression during the COVID-19 pandemic. Geriatr. Nurs. 2021; LeVasseur AL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001377 75. The need to incorporate the impact of population ageing into the post-COVID- 19 policy and planning reset in Low and Middle Income Countries. Glob Health Action 2021; 14:1921351Solanki G, Kelly G, Cornell J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013832 76. Impact of Pediatric COVID-19 on Family Health-Related Quality of Life: A Qualitative Study from Latvia. Glob Pediatr Health 2021; 8:2333794x211012394Stars I, Smane L, Pucuka Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997124 77. Emotional Disorders During the COVID-19 Outbreak in Spain: The Role of Sociodemographic Risk Factors and Cognitive Emotion Regulation Strategies. Health Educ. Behav. 2021:10901981211014101Muñoz-Navarro R, Cano Vindel A, Schmitz F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008452 78. The first 100 days: how has COVID-19 affected poor and vulnerable groups in India? Health Promot. Int. 2021; Johri M, Agarwal S, Khullar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002217 79. Covid-19 Mental Health Disparities. Health Secur 2021; Saltzman LY, Lesen AE, Henry V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014118 80. COVID-19 Resilience in the Third Sector. Health Serv Insights 2021; 14:11786329211013547Cottom S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34017180 81. Satisfied as professionals, but also exhausted and worried!!: The role of job demands, resources and emotional experiences of Spanish nursing home workers during the COVID-19 pandemic. Health Soc Care Community 2021; Blanco-Donoso LM, Moreno-Jiménez J, Gallego-Alberto L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013986 82. Depression, coping skills, and quality of life among Jordanian adults during the initial outbreak of COVID-19 pandemic: cross sectional study. Heliyon 2021; 7:e06873Al-Shannaq Y, Mohammad AA, Aldalaykeh M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997404 83. Occupational stress assessment of health care workers (HCWs) facing COVID- 19 patients in Kerman province hospitals in Iran. Heliyon 2021; 7:e07035Zare S, Mohammadi Dameneh M, Esmaeili R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33997362 84. Mindfulness-based online intervention on mental health and quality of life among COVID-19 patients in China: an intervention design. Infect Dis Poverty 2021; 10:69Si MY, Xiao WJ, Pan C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34001277 85. Examining the Mediating Effects of Stress on Fear of COVID-19 and Well-being Using Structural Equation Modeling. Int J Ment Health Addict 2021:1- 9Lathabhavan R, Vispute S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025306 86. Psychometric Validation of the Persian Version of the COVID-19-Related Psychological Distress Scale and Association with COVID-19 Fear, COVID-19 Anxiety, Optimism, and Lack of Resilience. Int J Ment Health Addict 2021:1- 16Nazari N, Zekiy AO, Feng LS, Griffiths MD. http://www.ncbi.nlm.nih.gov/pubmed/? term=34007255 87. COVID-19 and family violence: Is this a perfect storm? Int. J. Ment. Health Nurs. 2021; Usher K, Bradbury Jones C, Bhullar N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008291 88. Effects of the COVID-19 pandemic on acute stress disorder and career planning among healthcare students. Int. J. Ment. Health Nurs. 2021; Zhang L, Qi H, Wang L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002465 89. Context, design and conduct of the longitudinal COVID-19 psychological research consortium study-wave 3. Int. J. Methods Psychiatr. Res. 2021:e1880McBride O, Butter S, Murphy J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021946 90. A commentary on the value of hospital data for covid-19 pandemic surveillance and planning. Int J Popul Data Sci 2021; 5:1393Manuel DG, van Walraven C, Forster AJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007891 91. Associations between demographic characteristics, perceived threat, perceived stress, coping responses and adherence to COVID-19 prevention measures among Chinese healthcare students. J. Adv. Nurs. 2021; Tang ACY, Kwong EW, Chen L, Cheng WLS. http://www.ncbi.nlm.nih.gov/pubmed/? term=34008883 92. Association among income loss, financial strain and depressive symptoms during COVID-19: Evidence from two longitudinal studies. J. Affect. Disord. 2021; 291:1-8Hertz-Palmor N, Moore TM, Gothelf D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022550 93. Impact of the COVID-19 pandemic on mental health service use among psychiatric outpatients in a tertiary hospital. J. Affect. Disord. 2021; 290:279- 283Seo JH, Kim SJ, Lee M, Kang JI. http://www.ncbi.nlm.nih.gov/pubmed/? term=34015622 94. Dental trainees' mental health and intention to leave their programs during the COVID-19 pandemic. J. Am. Dent. Assoc. 2021; Chi DL, Randall CL, Hill CM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023094 95. Predictors of worker mental health in intellectual disability services during COVID-19. J Appl Res Intellect Disabil 2021; Lunsky Y, Bobbette N, Chacra MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998117 96. Physical Activity, Sleep and Quality of Life of Patients with Asthma during the COVID-19 Pandemic. J. Asthma 2021:1-11Daşdemir KA, Suner Keklik S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000956 97. Problematic Internet use among residential college students during the COVID-19 lockdown: A social network analysis approach. J Behav Addict 2021; Xia Y, Fan Y, Liu TH, Ma Z. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019485 98. Validation of the Mental Health Checklist (MHCL) during COVID-19 lockdown. J. Community Psychol. 2021; So CJ, Kim J, Cifre AB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999434 99. Psychophysical condition of adolescents in coronavirus disease 2019. J Exerc Rehabil 2021; 17:112-119Min SK, Son WH, Choi BH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012937 100. Gambling by Young Adults in the UK During COVID-19 Lockdown. J. Gambl. Stud. 2021:1-13Emond A, Nairn A, Collard S, Hollén L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997939 101. Intolerance of uncertainty and reactions to the COVID-19 pandemic. J. Gen. Psychol. 2021:1-28Bavolar J, Kacmar P, Hricova M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006200 102. Factors Influencing Anxiety Among WeChat Users During the Early Stages of the COVID-19 Pandemic in Mainland China: Cross-sectional Survey Study. J Med Internet Res 2021; 23:e24412Zou C, Zhang W, Sznajder K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878025 103. Toward understanding the mental health of nigerian residents during lockdown: the influence of age and vulnerability to COVID-19. J Ment Health 2021:1-6Lawal AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006187 104. The Mental Health of Healthcare Staff Working During the COVID-19 Crisis: Their Working Hours as a Boundary Condition. J Multidiscip Healthc 2021; 14:1073-1081Gong H, Zhang SX, Nawaser K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007182 105. Health Communication, Knowledge, Perception and Behavioral Responses to COVID-19 Outbreak in Dessie, Kombolcha and Kemissie Towns, Amhara Region, Northeast Ethiopia: A Mixed-Method Study. J Multidiscip Healthc 2021; 14:1083-1099Yalew ZM, Yitayew YA, Mohammed ES, Gezihagne TB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007183 106. Pandemic Fatigue And Clinical Nurses' Mental Health, Sleep Quality And Job Contentment During The COVID-19 Pandemic: The Mediating Role Of Resilience. J. Nurs. Manag. 2021; Labrague LJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018270 107. Sleep disturbances in children with cystic fibrosis, primary ciliary dyskinesia and typically developing children during COVID-19 pandemic. J. Paediatr. Child Health 2021; Sismanlar Eyuboglu T, Aslan AT, Ramaslı Gursoy T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004018 108. Likely Exacerbation of Psychological Disorders from Covid-19 Response. J. Prim. Care Community Health 2021; 12:21501327211016739Zolnikov TR, Clark T, Zolnikov T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998328 109. Prevalence of depression, anxiety, and insomnia symptoms among patients with COVID-19: A meta-analysis of quality effects model. J. Psychosom. Res. 2021; 147:110516Liu C, Pan W, Li L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34023580 110. Mental health and legal education in the time of pandemic. J Public Health (Oxf) 2021; Macaraan MC. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018546 111. The Impact of COVID-19 and Religious Restrictions on the Well-Being of Ghanaian Christians: The Perspectives of Religious Leaders. J Relig Health 2021:1-18Osei-Tutu A, Affram AA, Mensah-Sarbah C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014473 112. Cognitive Outcomes During COVID-19 Confinement Among Older People and Their Caregivers Using Technologies for Dementia: Protocol for an Observational Cohort Study. JMIR Res Protoc 2021; 10:e26431Goodman- Casanova JM, Dura-Perez E, Guerrero-Pertiñez G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909588 113. Suicide Prevention Among College Students Before and During the COVID-19 Pandemic: Protocol for a Systematic Review and Meta-analysis. JMIR Res Protoc 2021; 10:e26948Xiao Y, Hinrichs R, Johnson N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878016 114. The role of individual factors on corona-induced hypochondriasis and job stress: A case study in workplace. Med. J. Islam. Repub. Iran 2021; 35:11Mousavi SM, Yazdanirad S, Jahadi Naeini M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996662 115. Violence against healthcare personnel in India: Covid-19 prompts stricter laws. Med. Leg. J. 2021:258172211006276Manoj MA, Padubidri JR, Saran J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013804 116. Feasibility of a Brief Online Mindfulness and Compassion-Based Intervention to Promote Mental Health Among University Students During the COVID-19 Pandemic. Mindfulness (N Y) 2021:1-11González-García M, Álvarez JC, Pérez EZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025814 117. Psychiatric complications of COVID-19: The unknown disease (Long Covid). MMW-Fortschritte der Medizin 2021; 163:48-50Jebrini T, Reinhard MA, Ortmann M et al. 118. "corona und Du" : A web-based information portal on mental health for children, adolescents and parents. Nervenheilkunde 2021; 40:333-340Elisabeth Piechaczek C, Primbs R, Comanns PM et al. 119. Burden and mental health problems of children and adolescents in Hamburg during the COVID-19 pandemic: Results of the COPSY study Hamburg. Nervenheilkunde 2021; 40:319-326Kaman A, Otto C, Adedeji A et al. 120. Child protection in times of Covid-19 pandemic: Empirical results of a nationwide survey of children and youth welfare authorities. Nervenheilkunde 2021; 40:312-318Mairhofer A, Peucker C, Pluto L, Van Santen E. 121. Mental Health Adverse Effects of COVID-19 Pandemic on Health Care Workers in North West Ethiopia: A Multicenter Cross-Sectional Study. Neuropsychiatr. Dis. Treat. 2021; 17:1375-1384Asnakew S, Amha H, Kassew T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994787 122. Psychological Impact of COVID-19, Isolation, and Quarantine: A Cross- Sectional Study. Neuropsychiatr. Dis. Treat. 2021; 17:1413-1421Jassim G, Jameel M, Brennan E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007180 123. Examining the effects of COVID-19 on mental health services, service users and nurses. Nurs. Stand. 2021; Chuttoo V, Ramharakh SB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998202 124. Confirmatory Factor Analysis, Internal Consistency, Gender Differential Item Functioning and Discriminant Validity of the Fear of COVID-5 Scale Amidst Emerging Adult University Students in Mexico. Omega (Westport) 2021:302228211016216Campo-Arias A, Tirado-Otálvaro AF, Álvarez-Solorza I, Cassiani-Miranda CA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000883 125. Commentary on: A Call to Action: Facing the Shadow Pandemic of Complicated Forms of Grief. Omega (Westport) 2021:302228211016227Eisma MC, Boelen PA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018437 126. The need for a balanced hospital-based care (HBC) and home- and community-based care (HCBC) approach for mitigating COVID-19 pandemic in sub-Saharan Africa. Pan Afr. Med. J. 2021; 38:196Onywera H, Mwapagha LM, Hsiao NY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995802 127. Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato- Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19. Patient Prefer Adherence 2021; 15:945-952Sarid N, Mann S, Herishanu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007160 128. The effect of the COVID-19 pandemic on health anxiety and cyberchondria levels of university students. Perspect. Psychiatr. Care 2021; Kurcer MA, Erdogan Z, Cakir Kardes V. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018194 129. Anxiety and fear of COVID-19 among nursing students during the COVID-19 pandemic: A descriptive correlation study. Perspect. Psychiatr. Care 2021; Kuru Alici N, Ozturk Copur E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018195 130. Comparison of anxiety levels of hospitalized COVID-19 patients, individuals under quarantine, and individuals in society. Perspect. Psychiatr. Care 2021; Tokur Kesgin M, Hançer Tok H, Uzun LN, Pehlivan Ş. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018193 131. Does suicidal ideation increase during the second COVID-19 lockdown? Psychiatry Res 2021; 301:113990Efstathiou V, Michopoulos I, Yotsidi V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020218 132. Perceived Stress Among Chinese Medical Students Engaging in Online Learning in Light of COVID-19. Psychol. Res. Behav. Manag. 2021; 14:549- 562Wang J, Liu W, Zhang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34017205 133. Was a forced lockdown adequate for a country in conflict? A psychological perspective from the Syrian population. Qatar Med J 2021; 2021:17Kakaje A, Mansour S, Ghareeb A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996528 134. Clinical outcomes and quality of life of COVID-19 survivors: A follow-up of 3 months post hospital discharge. Respir. Med. 2021; 184:106453Todt BC, Szlejf C, Duim E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010740 135. [Scale of concern about COVID-19 infection in Peruvian health care workers]. Rev Colomb Psiquiatr 2021; Esteban RFC, Mamani-Benito OJ, Rodriguez-Alarcon JF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994584 136. COVID-19 pandemic and mental health in Spain: an analysis of their relationship using Google Trends. Rev Psiquiatr Salud Ment 2021; Becerra- García JA, Sánchez-Gutiérrez T, Barbeito S, Calvo A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004379 137. The Role of Social Media in the Advent of COVID-19 Pandemic: Crisis Management, Mental Health Challenges and Implications. Risk Manag. Healthc. Policy 2021; 14:1917-1932Abbas J, Wang D, Su Z, Ziapour A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012304 138. Magnitude and determinants of the psychological impact of COVID-19 among health care workers: A systematic review. SAGE Open Med 2021; 9:20503121211012512Bekele F, Hajure M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33996083 139. COVID-19 healthcare policies in Ireland: A rapid review of the initial pandemic response. Scand J Public Health 2021:14034948211008371O'Leary N, Kingston L, Griffin A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011221 140. Depression and anxiety symptoms in pregnant women in Denmark during COVID-19. Scand J Public Health 2021:14034948211013271Overbeck G, Rasmussen IS, Siersma V et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34011216 141. Towards a Theory of Digital Well-Being: Reimagining Online Life After Lockdown. Sci Eng Ethics 2021; 27:32Dennis MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013496 142. Acute Psychosis in COVID-19: Is It Due to Favipiravir Treatment or Acute Viral Illness? SN Compr Clin Med 2021:1-3Duyan M, Ozturan IU. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997622 143. Rates and predictors of uptake of mental health support during the COVID-19 pandemic: an analysis of 26,720 adults in the UK in lockdown. Soc. Psychiatry Psychiatr. Epidemiol. 2021:1-11Bu F, Mak HW, Fancourt D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003305 144. Understanding at-the-moment stress for parents during COVID-19 stay-at- home restrictions. Soc. Sci. Med. 2021; 279:114025Freisthler B, Gruenewald PJ, Tebben E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004571 145. The socio-economic determinants of COVID-19: A spatial analysis of German county level data. Socioecon. Plann. Sci. 2021:101083Ehlert A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007090 146. Associations of the COVID-19 pandemic with the economic status and mental health of people affected by the Fukushima disaster using the difference-in- differences method: The Fukushima Health Management Survey. SSM Popul Health 2021; 14:100801Murakami M, Kobayashi T, Oikawa Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997248 147. Impact of public health interventions to curb SARS-CoV-2 spread assessed by an evidence-educated Delphi panel and tailored SEIR model. Z Gesundh Wiss 2021:1-14Brüggenjürgen B, Stricker HP, Krist L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34026423 148. Knowledge, beliefs, mental health, substance use, and behaviors related to the COVID-19 pandemic among US adults: a national online survey. Z Gesundh Wiss 2021:1-11DiClemente RJ, Capasso A, Ali SH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996384

Meta-analyses - systematic reviews (17 articles)

1. Early mortality outcomes of patients with fragility hip fracture and concurrent SARS-CoV-2 infection : a systematic review and meta-analysis. Bone Jt Open 2021; 2:314-322Alcock H, Moppett EA, Moppett IK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003031 2. Hypothermia is Associated With Poor Prognosis in Hospitalized Patients With Severe COVID-19 Symptoms. Cureus 2021; 13:e14526Maait Y, El Khoury M, McKinley L, El Khoury A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007774 3. Where There Is (No) Smoke, There Is Still Fire: a Review of Trends, Reasons for Use, Preferences and Harm Perceptions of Adolescent and Young Adult Electronic Cigarette Use. Curr Pediatr Rep 2021:1-5Gupta PS, Kalagher KM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996271 4. Impact of pre-infection HbA1c levels on COVID-19 prognosis:systematic review and meta-analysis. Diabetes Metab Res Rev 2021:e3476Prattichizzo F, de Candia P, Nicolucci A, Ceriello A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34018307 5. Response to letter entitled: Re: A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19. Eur. J. Cancer 2021; Yekedüz E, Utkan G, Ürün Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016491 6. Role of High Resolution Computed Tomography chest in the diagnosis and evaluation of COVID -19 patients -A systematic review and meta-analysis. Eur J Radiol Open 2021; 8:100350Ishfaq A, Yousaf Farooq SM, Goraya A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007865 7. Comparative Effectiveness of Pharmacological Interventions for Covid-19: A Systematic Review and Network Meta-Analysis. Front. Pharmacol. 2021; 12:649472De Crescenzo F, Amato L, Cruciani F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012398 8. The Prevalence of Psychological Status During the COVID-19 Epidemic in China: A Systemic Review and Meta-Analysis. Front. Psychol. 2021; 12:614964Li W, Zhang H, Zhang C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017278 9. Tocilizumab treatment for COVID-19 patients: a systematic review and meta- analysis. Infect Dis Poverty 2021; 10:71Wei Q, Lin H, Wei RG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001244 10. Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as per November 20, 2020. Int J Infect Dis 2021; Hayer J, Kasapic D, Zemmrich C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015523 11. Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta- regression of randomized-controlled trials. Intensive Care Med 2021; Snow TAC, Saleem N, Ambler G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019122 12. Prevalence of depression, anxiety, and insomnia symptoms among patients with COVID-19: A meta-analysis of quality effects model. J. Psychosom. Res. 2021; 147:110516Liu C, Pan W, Li L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34023580 13. Suicide Prevention Among College Students Before and During the COVID-19 Pandemic: Protocol for a Systematic Review and Meta-analysis. JMIR Res Protoc 2021; 10:e26948Xiao Y, Hinrichs R, Johnson N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878016 14. Anakinra in hospitalized non-intubated patients with coronavirus disease 2019: a systematic review and meta-analysis. Rheumatology (Oxford) 2021; Barkas F, Ntekouan SF, Kosmidou M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33999135 15. Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis. Thromb J 2021; 19:32Xiong X, Chi J, Gao Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011381 16. Efficacy and Safety of Azithromycin for the Treatment of COVID-19: A Systematic Review and Meta-analysis. Tuberc Respir Dis (Seoul) 2021; Mangkuliguna G, Glenardi, Susanto N, Pramono LA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015868 17. Malignancy is a risk factor for higher COVID-19 severity:A meta-analysis. Turk J Med Sci 2021; Liu GE, Cai W, Liu H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34022777

Mortality (24 articles)

1. Association between fatality rate of COVID-19 and selenium deficiency in China. BMC Infect. Dis. 2021; 21:452Zhang HY, Zhang AR, Lu QB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011281 2. Using excess deaths and testing statistics to determine COVID-19 mortalities. Eur. J. Epidemiol. 2021:1-14Böttcher L, D'Orsogna MR, Chou T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002294 3. Multiple House Occupancy is Associated with Mortality in Hospitalised Patients with Covid-19. Eur. J. Public Health 2021; Bruce E, Carter B, Quinn TJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999142 4. Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients. Front. Immunol. 2021; 12:659018Martín-Sánchez E, Garcés JJ, Maia C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012444 5. Prediction of COVID-19 Hospital Length of Stay and Risk of Death Using Artificial Intelligence-Based Modeling. Front Med (Lausanne) 2021; 8:592336Mahboub B, Bataineh MTA, Alshraideh H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017839 6. Clinical presentation, outcomes and factors associated with mortality: a prospective study from three COVID-19 referral care centers in West Africa. Int J Infect Dis 2021; Jaspard M, Sow MS, Juchet S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000419 7. Radiologically Undetectable Latent Pulmonary Lymphocyte Infiltration Suggesting the Need for Early Glucocorticoid Therapy: An Autopsy Case of Rapidly Progressive COVID-19 Pneumonia with Lymphopenia. Intern Med 2021; Tanomogi N, Otani T, Araki J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994439 8. Environmental and climatic impact on the infection and mortality of SARS- CoV-2 in Peru. J. Basic Clin. Physiol. Pharmacol. 2021; Samillan VJ, Flores-León D, Rojas E, Zutta BR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018379 9. Cancer, transplant, and immunocompromising conditions were not significantly associated with severe illness or death in hospitalized COVID-19 patients. J Clin Virol 2021; 140:104850Krasnow MR, Litt HK, Lehmann CJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022753 10. Prevalence and cross states comparison of case fatality rate and recovery rate of COVID 19/SARS-COV-2 in India. J Family Med Prim Care 2021; 10:475-480AA ZA, Desai HD, Sharma K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34017773 11. MuLBSTA score in COVID-19 pneumonia and prediction of 14-day mortality risk: A study in an Indian cohort. J Family Med Prim Care 2021; 10:223- 227Preetam M, Anurag A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017730 12. Predictors of mortality and the need of mechanical ventilation in confirmed COVID-19 patients presenting to the emergency department in North India. J Family Med Prim Care 2021; 10:542-549Suresh S, Tiwari A, Mathew R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017785 13. The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study. J Infect 2021; Zarif A, Joy M, Sherlock J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004222 14. Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study. J Infect Public Health 2021; 14:726-733Alrashed AA, Khan TM, Alhusseini NK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020213 15. Prevalence and predictors of in-hospital mortality of patients hospitalized with COVID-19 infection. J Infect Public Health 2021; 14:759-765Khamis F, Memish Z, Bahrani MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022734 16. Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet Reg Health Eur 2021; 6:100109Bhaskaran K, Bacon S, Evans SJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997835 17. Small-scale spatial distribution of COVID-19-related excess mortality. MethodsX 2021; 8:101257Gibertoni D, Sanmarchi F, Adja KYC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996519 18. Tocilizumab could lower mortality in patients with severe COVID-19. Pneumologie 2021; 75Ruchalla E. 19. Demographic factors associated with COVID-19-related death in Palestine. Public Health Pract (Oxf) 2021; 2:100145Maraqa B, Al-Shakhra K, Alawneh M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34027510 20. SARS-CoV-2-associated deaths in adult persons up to 50 years of age: A retrospective evaluation of COVID-19-associated deaths in 2020 at the Institute of Legal Medicine in Hamburg, Germany. Rechtsmedizin 2021; Lohner L, Fröb D, Edler C et al. 21. Predictability of COVID-19 worldwide lethality using permutation-information theory quantifiers. Results Phys 2021; 26:104306Fernandes LHS, Araujo FHA, Silva MAR, Acioli-Santos B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002129 22. A population-based study on mortality among Belgian immigrants during the first COVID-19 wave in Belgium. Can demographic and socioeconomic indicators explain differential mortality? SSM Popul Health 2021; 14:100797Vanthomme K, Gadeyne S, Lusyne P, Vandenheede H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997246 23. [Clinical and anatomical analysis of mortality from COVID-19 in sudden death and in those who died in health care facilities]. Sud. Med. Ekspert. 2021; 64:5- 10Savchenko SV, Gritsinger VA, Tikhonov VV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013687 24. How many more? Under-reporting of the COVID-19 deaths in Brazil in 2020. Trop Med Int Health 2021; Kupek E. http://www.ncbi.nlm.nih.gov/pubmed/? term=34008266

Online – IT – Apps (72 articles)

1. University Students Perception of Online Education: Is Engagement Enough? Acta Inform Med 2021; 29:4-9Fyllos A, Kanellopoulos A, Kitixis P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012206 2. [Management of the ENT consultation during the COVID-19 pandemic alert. Are ENT telephone consultations useful?]. Acta Otorrinolaringol. Esp. 2021; 72:190-194Gómez González MDR, Piqueras Pérez FM, Guillamón Vivancos L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017146 3. Direct-to-Patient Teledermatology During COVID-19 Lockdown in a Health District in Madrid, Spain: The EVIDE-19 Pilot Study. Actas Dermosifiliogr. 2021; 112:345-353Sendagorta E, Servera G, Nuño A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012166 4. Validation and implementation of telephone-administered version of the Multidimensional Prognostic Index (TELE-MPI) for remote monitoring of community-dwelling older adults. Aging Clin. Exp. Res. 2021:1-7Custodero C, Senesi B, Pinna A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002336 5. Telemedicine-assisted care of an older patient with COVID-19 and dementia: bridging the gap between hospital and home. Aging Clin. Exp. Res. 2021:1- 4Marinello R, Brunetti E, Luppi C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34003476 6. Automatic COVID-19 disease diagnosis using 1D convolutional neural network and augmentation with human respiratory sound based on parameters: cough, breath, and voice. AIMS Public Health 2021; 8:240-264Lella KK, Pja A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017889 7. Current and future use of telemedicine in surgical clinics during and beyond COVID-19: A narrative review. Ann Med Surg (Lond) 2021; 66:102378McMaster T, Wright T, Mori K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996071 8. Working from home and dietary changes during the COVID-19 pandemic: A longitudinal study of health app (CALO mama) users. Appetite 2021:105323Sato K, Kobayashi S, Yamaguchi M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34004241 9. Patient Perspectives in the Era of Remote Medical Visits During the Coronavirus Disease (COVID-19) Pandemic - Insights From Outpatient Care of Cardiovascular Disease. Circ Rep 2021; 3:300-303Kitakata H, Katsumata Y, Kohsaka S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007945 10. Live teleophthalmology avoids escalation of referrals to secondary care during COVID-19 lockdown. Clin. Exp. Optom. 2021:1-6Ghazala FR, Hamilton R, Giardini ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016025 11. 'Face time' for the first time: Video communication between relatives and junior doctors in the COVID-19 pandemic. Clin Med (Lond) 2021; 21:211- 214White HL, Tuck AA, Pyrke BC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34001572 12. Therapist Experiences and Attitudes About Implementing Internet-Delivered Parent-Child Interaction Therapy During COVID-19. Cogn. Behav. Pract. 2021; Barnett ML, Sigal M, Green Rosas Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994769 13. Remote management of dental problems in children during and post the COVID-19 pandemic outbreak: A teledentistry approach. Dent Med Probl 2021; Nuvvula S, Mallineni SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019745 14. M-learning in the COVID-19 era: physical vs digital class. Educ Inf Technol (Dordr) 2021:1-21Matzavela V, Alepis E. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994833 15. Technology-mediated teaching and learning process: A conceptual study of educators' response amidst the Covid-19 pandemic. Educ Inf Technol (Dordr) 2021:1-33Okoye K, Rodriguez-Tort JA, Escamilla J, Hosseini S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025205 16. Perceptions and lessons from web-based interviews for the reproductive endocrinology and infertility fellowship application cycle. Fertil. Steril. 2021; Hariton E, Raker CA, Frishman GN, Feinberg EC. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016437 17. Prediction of COVID-19 Hospital Length of Stay and Risk of Death Using Artificial Intelligence-Based Modeling. Front Med (Lausanne) 2021; 8:592336Mahboub B, Bataineh MTA, Alshraideh H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017839 18. The Challenge of Reorganizing Rehabilitation Services at the Time of COVID- 19 Pandemic: A New Digital and Artificial Intelligence Platform to Support Team Work in Planning and Delivering Safe and High Quality Care. Front. Neurol. 2021; 12:643251Saverino A, Baiardi P, Galata G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995247 19. Cyberchondria Amidst COVID-19 Pandemic: Challenges and Management Strategies. Front Psychiatry 2021; 12:618508Varma R, Das S, Singh T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995143 20. Exploratory Study of the Relationship Between Happiness and the Rise of Media Consumption During COVID-19 Confinement. Front. Psychol. 2021; 12:566517Muñiz-Velázquez JA, Gómez-Baya D, Lozano Delmar J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995163 21. COVID-19 and future pandemics: a global systems approach and relevance to SDGs. Global Health 2021; 17:59Thoradeniya T, Jayasinghe S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020654 22. Virtual visits among gynecologic oncology patients during the COVID-19 pandemic are accessible across the social vulnerability spectrum. Gynecol. Oncol. 2021; McAlarnen LA, Tsaih SW, Aliani R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994014 23. Users' Beliefs Toward Physical Distancing in Facebook Pages of Public Health Authorities During COVID-19 Pandemic in Early 2020. Health Educ. Behav. 2021:10901981211014428Tan SG, Sesagiri Raamkumar A, Wee HL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014114 24. Social inequalities in mobility during and following the COVID-19 associated lockdown of the Madrid metropolitan area in Spain. Health Place 2021; 70:102580Glodeanu A, Gullón P, Bilal U. http://www.ncbi.nlm.nih.gov/pubmed/? term=34022543 25. Ideological representation of fear and hope in online newspaper reports on COVID-19 in Saudi Arabia. Heliyon 2021; 7:e06864Al-Ghamdi NA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997397 26. Using online information technology for deaf students during COVID-19: A closer look from experience. Heliyon 2021; 7:e06915Alshawabkeh AA, Woolsey ML, Kharbat FF. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013080 27. IoT based wearable device to monitor the signs of quarantined remote patients of COVID-19. Inform Med Unlocked 2021; 24:100588Al Bassam N, Hussain SA, Al Qaraghuli A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33997262 28. A Comprehensive Study of Artificial Intelligence and Machine Learning Approaches in Confronting the Coronavirus (COVID-19) Pandemic. Int J Health Serv 2021:207314211017469Rahman MM, Khatun F, Uzzaman A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999732 29. COVID-19 compliant and cost effective teaching model for King Abdulaziz University. Int J Inf Technol 2021:1-14Bardesi H, Al-Mashaikhi A, Basahel A, Yamin M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997602 30. From telehealth to virtual primary care in Australia? A Rapid scoping review. Int. J. Med. Inform. 2021; 151:104470Jonnagaddala J, Godinho MA, Liaw ST. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000481 31. Teaching Effective Informed Consent Communication Skills in the Virtual Surgical Clerkship. J Am Coll Surg 2021; Pang JH, Finlay E, Fortner S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015451 32. Usability, inclusivity, and content evaluation of COVID-19 contact tracing apps in the United States. J Am Med Inform Assoc 2021; Blacklow SO, Lisker S, Ng MY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022053 33. Rising to the Challenges of the Pandemic: Telehealth Innovations in U.S. Emergency Departments. J Am Med Inform Assoc 2021; Uscher-Pines L, Sousa J, Mehrotra A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022045 34. Problematic Internet use among residential college students during the COVID-19 lockdown: A social network analysis approach. J Behav Addict 2021; Xia Y, Fan Y, Liu TH, Ma Z. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019485 35. Dynamic deformable attention network (DDANet) for COVID-19 lesions semantic segmentation. J. Biomed. Inform. 2021:103816Rajamani KT, Siebert H, Heinrich MP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022421 36. Feasibility of a virtual Facebook community platform for engagement on health research. J Clin Transl Sci 2021; 5:e85Patten CA, Balls-Berry JJE, Cohen EL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007468 37. The impact of public health messaging and personal experience on the acceptance of mask wearing during the COVID-19 pandemic. J Econ Behav Organ 2021; 187:415-430Cherry TL, James AG, Murphy J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994606 38. Digital health: A panacea in COVID-19 crisis. J Family Med Prim Care 2021; 10:62-65Rani R, Kumar R, Mishra R, Sharma SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017704 39. Sensational media reporting is common when describing COVID-19 therapies, detection methods, and vaccines. J. Investig. Med. 2021; Ottwell R, Puckett M, Rogers T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021053 40. Understanding Public Perceptions of COVID-19 Contact Tracing Apps: Artificial Intelligence-Enabled Social Media Analysis. J Med Internet Res 2021; 23:e26618Cresswell K, Tahir A, Sheikh Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33939622 41. Factors Influencing Anxiety Among WeChat Users During the Early Stages of the COVID-19 Pandemic in Mainland China: Cross-sectional Survey Study. J Med Internet Res 2021; 23:e24412Zou C, Zhang W, Sznajder K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878025 42. Virtual Mega-Meetings: Here to Stay? J. Pathol. Inform. 2021; 12:11Hassell LA, Hassell HJG. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012715 43. Love at First Click: Surgery Residency Websites in the Virtual Era. J Surg Educ 2021; Chinedozi I, Martin O, Hays N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34011477 44. Video consultations during the coronavirus disease 2019 pandemic are associated with high satisfaction for both doctors and patients. JGH Open 2021; 5:542-548Zorron Cheng Tao Pu L, Raval M, Terbah R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013052 45. Changes in Perceptions and Use of Mobile Technology and Health Communication in South Africa During the COVID-19 Lockdown: Cross- sectional Survey Study. JMIR Form Res 2021; 5:e25273Fischer AE, Van Tonder T, Gumede SB, Lalla-Edward ST. http://www.ncbi.nlm.nih.gov/pubmed/? term=33956640 46. A Mobile Phone-Based Intervention to Reduce Mental Health Problems in Health Care Workers During the COVID-19 Pandemic (PsyCovidApp): Randomized Controlled Trial. JMIR Mhealth Uhealth 2021; 9:e27039Fiol-DeRoque MA, Serrano-Ripoll MJ, Jiménez R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33909587 47. Use of the Instagram Hashtags #winemom and #momjuice Among Mothers During the COVID-19 Pandemic: Descriptive, Cross-sectional Study. JMIR Pediatr Parent 2021; 4:e28991Basch CH, Meleo-Erwin ZC, Mohlman J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33848257 48. Otolaryngology Residency Program Rankings and Social Media Usage: A Longitudinal Analysis. Laryngoscope 2021; Patro A, Carr S, Stevens MN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000091 49. Exploring the Influential Factors of Consumers' Willingness Toward Using COVID-19 Related Chatbots: An Empirical Study. Med Arch 2021; 75:50- 55Almalki M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012200 50. Developing a Hybrid Four-Prong Approach to Anatomical Education During the COVID-19 Pandemic. Med Sci Educ 2021:1-7Cheng H, Esmonde-White C, Kassay AD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34026305 51. Feasibility of a Brief Online Mindfulness and Compassion-Based Intervention to Promote Mental Health Among University Students During the COVID-19 Pandemic. Mindfulness (N Y) 2021:1-11González-García M, Álvarez JC, Pérez EZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025814 52. Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation. Nanomedicine (Lond) 2021; Singh P, Singh D, Sa P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998837 53. "corona und Du" : A web-based information portal on mental health for children, adolescents and parents. Nervenheilkunde 2021; 40:333-340Elisabeth Piechaczek C, Primbs R, Comanns PM et al. 54. 'Saying goodbye' during the COVID-19 pandemic: A document analysis of online newspapers with implications for end of life care. Palliat. Med. 2021:2692163211017023Selman LE, Sowden R, Borgstrom E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015978 55. Conspiracy beliefs and trust as determinants of COVID-19 vaccine acceptance in Bali, Indonesia: Cross-sectional study. Pers. Individ. Dif. 2021; 180:110995Wirawan GBS, Mahardani P, Cahyani MRK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007092 56. Artificial Intelligence and Machine Learning to Predict Student Performance during the COVID-19. Procedia Comput Sci 2021; 184:835-840Tarik A, Aissa H, Yousef F. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025824 57. Development and Application of an Interdisciplinary Rapid Message Testing Model for COVID-19 in North Carolina. Public Health Rep. 2021:333549211018676Bartels SM, Gora Combs K, Lazard AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011204 58. Artificial neural networks and statistical models for optimization studying COVID-19. Results Phys 2021; 25:104274Elhag AA, Aloafi TA, Jawa TM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996399 59. [Monitoring of COVID-19 patients by telemedicine with telemonitoring]. Rev Clin Esp 2020; 220:472-479Martínez-García M, Bal-Alvarado M, Santos Guerra F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994572 60. The result of the use of remote consultation in orthopaedic and trauma surgery during the COVID-19 pandemic. Rev Esp Cir Ortop Traumatol 2021; 65:54-62Zamora Navas P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995713 61. The Role of Social Media in the Advent of COVID-19 Pandemic: Crisis Management, Mental Health Challenges and Implications. Risk Manag. Healthc. Policy 2021; 14:1917-1932Abbas J, Wang D, Su Z, Ziapour A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012304 62. Characteristics of Misinformation Spreading on Social Media During the COVID-19 Outbreak in China: A Descriptive Analysis. Risk Manag. Healthc. Policy 2021; 14:1869-1879Chen K, Luo Y, Hu A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007225 63. Towards a Theory of Digital Well-Being: Reimagining Online Life After Lockdown. Sci Eng Ethics 2021; 27:32Dennis MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013496 64. Dynamic relationships between different types of conspiracy theories about COVID-19 and protective behaviour: A four-wave panel study in Poland. Soc. Sci. Med. 2021; 280:114028Oleksy T, Wnuk A, Gambin M, Łyś A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023709 65. Simple hemogram to support the decision-making of COVID-19 diagnosis using clusters analysis with self-organizing maps neural network. Soft comput 2021:1-12Souza AA, Almeida DC, Barcelos TS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025211 66. Showing Up Is Half the Battle: The Impact of Telehealth on Psychiatric Appointment Attendance for Hospital-Based Intensive Outpatient Services During COVID-19. Telemed J E Health 2021; Childs AW, Bacon SM, Klingensmith K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999738 67. Rapid Rise of Pediatric Telehealth During COVID-19 in a Large Multispecialty Health System. Telemed J E Health 2021; Howie F, Kreofsky BL, Ravi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999718 68. Utilization of Telemedicine by the Lebanese Physicians During Time of Pandemic. Telemed J E Health 2021; Shaarani I, Ghanem A, Jounblat M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999731 69. Telemedicine in Primary Care During the COVID-19 Pandemic: Provider and Patient Satisfaction Examined. Telemed J E Health 2021; Vosburg RW, Robinson KA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999740 70. COVID-19 Classification Based on Deep Convolution Neural Network Over a Wireless Network. Wirel Pers Commun 2021:1-21Shalaby WA, Saad W, Shokair M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994667 71. Telemedicine in the COVID-19 era: Taking care of children with obesity and diabetes mellitus. World J. Diabetes 2021; 12:651-657Umano GR, Di Sessa A, Guarino S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995852 72. Improving Neurosurgery Education Using Social Media Case-Based Discussions: A Pilot Study. World Neurosurg X 2021; 11:100103Newall N, Smith BG, Burton O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997763

Other – Miscellaneous (73 articles)

1. Resource Allocation During the COVID-19 Pandemic: Contributions to an Ethical Approach. Acta Med Port 2021; Sobral M, Santa Rosa B, Silvestre M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009115 2. Emission reduction of black carbon and polycyclic aromatic hydrocarbons during COVID-19 pandemic lockdown. Air Qual Atmos Health 2021:1-15Ambade B, Kurwadkar S, Sankar TK, Kumar A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33995690 3. Assessment of Coronavirus disease, the nose pollution filter, fermented spicy Kimchee, and peppery hot soup consumed in Korea. Air Qual Atmos Health 2021:1-7Chung YS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995691 4. Isolating the impact of COVID-19 lockdown measures on urban air quality in Canada. Air Qual Atmos Health 2021:1-22Mashayekhi R, Pavlovic R, Racine J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025821 5. Food purchase and eating behavior during the COVID-19 pandemic: A cross- sectional survey of Russian adults. Appetite 2021; 165:105309Ben Hassen T, El Bilali H, Allahyari MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015307 6. Mind the gap: an analysis of core capacities of the international health regulations (2005) to respond to outbreaks in Yemen. BMC Health Serv. Res. 2021; 21:477Noman H, Dureab F, Ahmed I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016124 7. Home food procurement impacts food security and diet quality during COVID- 19. BMC Public Health 2021; 21:945Niles MT, Wirkkala KB, Belarmino EH, Bertmann F. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006243 8. Why have so many African leaders died of COVID-19? BMJ Glob Health 2021; 6Falisse JB, Macdonald R, Molony T, Nugent P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001520 9. Myanmar's coup d'état and its impact on COVID-19 response: a collapsing healthcare system in a state of turmoil. BMJ Mil Health 2021; Rocha IC, Cedeño TD, Pelayo MG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021054 10. Change in time spent visiting and experiences of green space following restrictions on movement during the COVID-19 pandemic: a nationally representative cross-sectional study of UK adults. BMJ Open 2021; 11:e044067Burnett H, Olsen JR, Nicholls N, Mitchell R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006030 11. Clinical, behavioural and social factors associated with racial disparities in COVID-19 patients from an integrated healthcare system in Georgia: a retrospective cohort study. BMJ Open 2021; 11:e044052Lobelo F, Bienvenida A, Leung S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011589 12. Identifying ethical values for guiding triage decisions during the COVID-19 pandemic: an Italian ethical committee perspective using Delphi methodology. BMJ Open 2021; 11:e043239Zeneli A, Brandi G, Di Pasquale G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006543 13. Practical Utility of the Postal Service in Delivering a Self-Fitted, Wearable, Long-Term Electrocardiogram Monitoring Device for Outpatient Care. Circ Rep 2021; 3:294-299Takami M, Fukuzawa K, Kiuchi K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007944 14. Social Disadvantage, Politics, and Severe Acute Respiratory Syndrome Coronavirus 2 Trends: A County-level Analysis of United States Data. Clin Infect Dis 2021; 72:e604-e607Mourad A, Turner NA, Baker AW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32918071 15. Volcanic Ash as a precursor for SARS-CoV-2 infection among susceptible populations in Ecuador: A satellite Imaging and excess mortality-based analysis. Disaster Med Public Health Prep 2021:1-37Toulkeridis T, Seqqat R, Torres Arias M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006342 16. The behaviour of alcohol-dependent drinkers of spirits during level 4 COVID- 19 lockdown in Auckland, New Zealand. Drug Alcohol Rev 2021; Falkner C, Neave H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008272 17. Assessing the Optimality of a COVID Lockdown in the United States. Econ Disaster Clim Chang 2021:1-25Scherbina A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33997600 18. Remote-Working Carbon-Saving Footprint: Could COVID-19 Pandemic Establish a New Working Model with Positive Environmental Health Implications? Environ. Health Insights 2021; 15:11786302211013546Maipas S, Panayiotides IG, Kavantzas N. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994793 19. The willingness for dietary and behavioral changes in frontline epidemic prevention workers after experiencing the outbreak of COVID-19 in China: a cross-sectional study. Environ. Health Prev. Med. 2021; 26:58Yu W, Xu Y, Zhang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006222 20. Outdoor light pollution and COVID-19: The Italian case. Environ. Impact Assess. Rev. 2021; 90:106602Argentiero A, Cerqueti R, Maggi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994611 21. Effect of COVID-19 pandemic-induced lockdown (general holiday) on air quality of Dhaka City. Environ. Monit. Assess. 2021; 193:343Islam MS, Chowdhury TA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002266 22. Effects of short- and long-term exposure to atmospheric pollution on COVID- 19 risk and fatality: analysis of the first epidemic wave in northern Italy. Environ. Res. 2021; 199:111293Ho CC, Hung SC, Ho WC. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004167 23. Effect of meteorological factors and Air Quality Index on the COVID-19 epidemiological characteristics: an ecological study among 210 countries. Environ. Sci. Pollut. Res. Int. 2021; Vali M, Hassanzadeh J, Mirahmadizadeh A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34024000 24. Environmental risk assessment and comprehensive index model of disaster loss for COVID-19 transmission. Environ Technol Innov 2021:101597Pang S, Hu X, Wen Z. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997146 25. Impact of COVID-19 on a paediatric emergency service. Eur. J. Pediatr. 2021:1- 9Paiva R, Martins C, Rodrigues F, Domingues M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003356 26. Meteorological and human mobility data on predicting COVID-19 cases by a novel hybrid decomposition method with anomaly detection analysis: a case study in the capitals of Brazil. Expert Syst Appl 2021:115190da Silva TT, Francisquini R, MC VN. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025047 27. A Public Health Ethics Case for Mitigating Zoonotic Disease Risk in Food Production. Food Ethics 2021; 6:9Bernstein J, Dutkiewicz J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997264 28. Impact of the COVID-19 pandemic on agricultural production, livelihoods, and food security in India: baseline results of a phone survey. Food Secur 2021:1- 17Jaacks LM, Veluguri D, Serupally R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34002117 29. Entrepreneurial Self-Efficacy Mediates the Impact of the Post-pandemic Entrepreneurship Environment on College Students' Entrepreneurial Intention. Front. Psychol. 2021; 12:643184Zhang J, Huang J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995198 30. Effect of COVID-19 Lockdown on Young Egyptian Soccer Players. Glob Pediatr Health 2021; 8:2333794x211012980Nassar MF, Allam MF, Shata MO. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017905 31. How does globalization affect COVID-19 responses? Global Health 2021; 17:57Bickley SJ, Chan HF, Skali A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34016146 32. The socio-spatial determinants of COVID-19 diffusion: the impact of globalisation, settlement characteristics and population. Global Health 2021; 17:56Sigler T, Mahmuda S, Kimpton A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34016145 33. School-Based Health Center Operations During the COVID-19 Pandemic: A Preliminary Study. Health Promot Pract 2021:15248399211016471Sullivan E, Brey L, Soleimanpour S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002646 34. National identification, a social cure for COVID-19? Evidence from 67 countries. Int J Soc Psychiatry 2021:207640211020036Bonetto E, Delouvée S, Mahfud Y, Adam-Troian J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015976 35. Disaster Management and School Nutrition: A Qualitative Study of Emergency Feeding During the COVID-19 Pandemic. J. Acad. Nutr. Diet. 2021; Patten EV, Spruance L, Vaterlaus JM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994141 36. Real versus illusory personal growth in response to COVID-19 pandemic stressors. J. Anxiety Disord. 2021; 81:102418Asmundson GJG, Paluszek MM, Taylor S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004367 37. Can virus-virus interactions impact the dynamics of the covid-19 pandemic? J Biomol Struct Dyn 2021:1-5Hendaus MA, Jomha FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998968 38. Transmission modes of COVID-19 disease pandemic in the light of ancient wisdom of Ayurveda medicine: a review. J Complement Integr Med 2021; Joshi N, Dash MK, Jayakumar R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002582 39. Emerging role of air pollution and meteorological parameters in COVID-19. J Evid Based Med 2021; Zhao C, Fang X, Feng Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003571 40. COVID-19 and Violence against doctors - Why a law is needed? J Family Med Prim Care 2021; 10:35-40Kuppuswamy G, Warrier U. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017700 41. COVID-19 pandemic-Environmental perspective of COVID-19 and a primer for all of us. J Family Med Prim Care 2021; 10:48-55Shaki O, Gupta TP, Rai SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017702 42. COVID-19 discarded disposable gloves as a source and a vector of pollutants in the environment. J. Hazard. Mater. 2021; 417:125938Jędruchniewicz K, Ok YS, Oleszczuk P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010776 43. Plastic waste associated with the COVID-19 pandemic: Crisis or opportunity? J. Hazard. Mater. 2021; 417:126108Khoo KS, Ho LY, Lim HR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020352 44. Ethical decision making during a healthcare crisis: a resource allocation framework and tool. J. Med. Ethics 2021; Guidolin K, Catton J, Rubin B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021059 45. A cross-sectional study of socioeconomic status and treatment interruption among Japanese workers during the COVID-19 pandemic. J Occup Health 2021; 63:e12232Fujimoto K, Ishimaru T, Tateishi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998105 46. Close Encounters of the First Kind: An interdisciplinary ethics of care approach mitigates moral injury and family division in the midst of COVID-19. J Pain Symptom Manage 2021; Berlin A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34022390 47. Policing pain: A qualitative study of non-criminal justice approaches to managing opioid overdose during the COVID-19 pandemic. J Prev Interv Community 2021:1-16Trappen SL, McLean KJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998397 48. From leisure to isolation: a call to explore hotel sectors' role during COVID-19 pandemic. J Public Health (Oxf) 2021; Aquino JA, Banal JT, Pablo FB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018563 49. Science, religion and state: a multidimensional perspective. J Public Health (Oxf) 2021; Corpuz JCG. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018562 50. Coping with COVID-19: An Examination of the Role of (Non)Religiousness/(Non)Spirituality. J Relig Health 2021:1-16Abbott DM, Franks AS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021846 51. The Impact of COVID-19 on Pre-Veterinary Opportunities and Recommendations for DVM Admissions. J. Vet. Med. Educ. 2021:e20200145Trivedi S, Clark JC, Royal KD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003737 52. Study commentary. Laryngo- Rhino- Otologie 2021; 100:341Didczuneit-Sandhop B. 53. Infectious disease, human capital, and the BRICS economy in the time of COVID-19. MethodsX 2021; 8:101202Dash DP, Sethi N, Dash AK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996518 54. Do gene-environment interactions play a role in COVID-19 distribution? The case of Alpha-1 Antitrypsin, air pollution and COVID-19. Multidiscip Respir Med 2021; 16:741Murgia N, Corsico AG, D'Amato G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012547 55. Rethinking the Paradigm and Practice of Occupational Health in a World Without Decent Work: A Perspective From East and Southern Africa. New Solut. 2021:10482911211017106Loewenson R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000888 56. Flattening the Latent Growth Curve? Explaining Within-Person Changes in Employee Well-Being during the COVID-19 Pandemic. Occup Health Sci 2021:1- 29Michel JS, Rotch MA, Carson JE et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34007876 57. Integrated coastal zone management in the context of COVID-19. Ocean Coast Manag 2021; 210:105687Perillo GME, Botero CM, Milanes CB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007124 58. The impact of COVID-19 pandemic on nitrogen dioxide levels in Nigeria. PeerJ 2021; 9:e11387Olusola JA, Shote AA, Ouigmane A, Isaifan RJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012730 59. Personality correlates of COVID-19 infection proclivity: Extraversion kills. Pers. Individ. Dif. 2021; 180:110994Rolón V, Geher G, Link J, Mackiel A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012186 60. Working from home during the COVID-19 pandemic, its effects on health, and recommendations: The pandemic and beyond. Perspect. Psychiatr. Care 2021; Birimoglu Okuyan C, Begen MA. http://www.ncbi.nlm.nih.gov/pubmed/? term=34003489 61. COVID-19 in a New York City Behavioral Health Housing and Treatment System. Psychiatr. Serv. 2021:appips202000620Tse J, Kingman E, LaStella D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015948 62. Impacts of lockdown on dietary patterns among youths in China: the COVID- 19 Impact on Lifestyle Change Survey. Public Health Nutr. 2021:1-12Yu B, Zhang D, Yu W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33993895 63. Anticipating trajectories of exponential growth. R Soc Open Sci 2021; 8:201574Hutzler F, Richlan F, Leitner MC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007459 64. From bad to worse: airline boarding changes in response to COVID-19. R Soc Open Sci 2021; 8:201019Islam T, Lahijani MS, Srinivasan A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007455 65. [Not Available]. Rev. Esp. Anestesiol. Reanim. 2021; Errando CL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994592 66. [Not Available]. Rev. Esp. Anestesiol. Reanim. 2021; Gil MG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994589 67. Restarting "Normal" Life after Covid-19 and the Lockdown: Evidence from Spain, the United Kingdom, and Italy. Soc Indic Res 2021:1-25Codagnone C, Bogliacino F, Gómez C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994649 68. Identifying key indicators of job loss trends during COVID-19 and beyond. Soc Sci Humanit Open 2021; 4:100163Roy S, Dutta R, Ghosh P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997770 69. Associations of alcohol, marijuana, and polysubstance use with non- adherence to COVID-19 public health guidelines in a US sample. Subst. Abus. 2021; 42:220-226Fendrich M, Becker J, Park C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010118 70. A Eulogy for Dr. Francisco Miguel Marty Forero. Transpl Infect Dis 2021:e13645Koo S, Bold TD, Cheng MP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022099 71. Spatial distributive effects of public green space and COVID-19 infection in London. Urban For Urban Green 2021; 62:127182Pan J, Bardhan R, Jin Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002111 72. Biological risk assessment: A challenge for occupational health and safety practitioners during the COVID-19 (SARS-CoV-2) Pandemic. Work 2021; Carvalhais C, Querido M, Pereira CC, Santos J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998572 73. COVID-19: the relationship between perceptions of risk and behaviours during lockdown. Z Gesundh Wiss 2021:1-11Brown R, Coventry L, Pepper G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007783

Pathology (4 articles)

1. Lung histopathological findings in COVID-19 disease - a systematic review. Infect. Agent. Cancer 2021; 16:34Pannone G, Caponio VCA, De Stefano IS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001199 2. Radiologically Undetectable Latent Pulmonary Lymphocyte Infiltration Suggesting the Need for Early Glucocorticoid Therapy: An Autopsy Case of Rapidly Progressive COVID-19 Pneumonia with Lymphopenia. Intern Med 2021; Tanomogi N, Otani T, Araki J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994439 3. Not all that glitters is COVID-19: a case-series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection. J Eur Acad Dermatol Venereol 2021; Barrera-Godínez A, Méndez-Flores S, Gatica-Torres M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013600 4. On the sensitivity and specificity of post-mortem upper respiratory tract testing for SARS-CoV-2. J Infect Dis 2021; Hall JA, Harris RJ, Emmett HE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999152

Protection (29 articles)

1. The pragmatic use of industrial elastomeric facemasks in health care practice during the COVID-19 pandemic. Am J Emerg Med 2021; 48:273-275McMahon K, Jeanmonod D, Check R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022633 2. Healthcare workers' compliance and its potential determinants to prevent COVID-19 in public hospitals in Western Ethiopia. BMC Infect. Dis. 2021; 21:454Etafa W, Gadisa G, Jabessa S, Takele T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011263 3. SARS-CoV2 IgG antibody: Seroprevalence among health care workers. Clin Epidemiol Glob Health 2021; 11:100766Prakash O, Solanki B, Sheth J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997477 4. Droplets and Aerosols Generated by Singing and the Risk of Coronavirus Disease 2019 for Choirs. Clin Infect Dis 2021; 72:e639-e641Bahl P, de Silva C, Bhattacharjee S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32945338 5. Optimized and Non-Optimized Personal Protective Equipment Use during the COVID-19 Pandemic in Thailand: A National Cross-Sectional Survey in a Resource-Limited Setting. Environ. Health Insights 2021; 15:11786302211013545Moolasart V, Manosuthi W, Thienthong V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017177 6. Addressing COVID-19 contagion through the HVAC systems by reviewing indoor airborne nature of infectious microbes: Will an innovative air recirculation concept provide a practical solution? Environ. Res. 2021; 199:111329Sodiq A, Khan MA, Naas M, Amhamed A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004171 7. Electrolyzed Water Generated On-Site as a Promising Disinfectant in the Dental Office During the COVID-19 Pandemic. Front Public Health 2021; 9:629142Farah RI, Al-Haj Ali SN. http://www.ncbi.nlm.nih.gov/pubmed/? term=33996714 8. Nurses' Actions to Protect Their Families from COVID-19: A Descriptive Qualitative Study. Glob Qual Nurs Res 2021; 8:23333936211014851Widiasih R, Ermiati, Emaliyawati E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997120 9. Novel device to contain aerosols during phacoemulsification. Indian J Ophthalmol 2021; 69:1605-1608Fathima A, Shivkumar C, Meenakshi R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011751 10. Risk of SARS-CoV-2 virus transmission from donor corneal tissue: A review. Indian J Ophthalmol 2021; 69:1592-1597Salz AK, Acharya M, Hofmann N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011748 11. Prolonged face mask use might worsen dry eye symptoms. Indian J Ophthalmol 2021; 69:1508-1510Scalinci SZ, Pacella E, Battagliola ET. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011730 12. Hypothesis: SARS-CoV-2 transmission is predominated by the short-range airborne route and exacerbated by poor ventilation. Indoor Air 2021; Li Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002888 13. Addressing Personal Protective Equipment (PPE) Decontamination: Methylene Blue and Light Inactivates SARS-CoV-2 on N95 Respirators and Medical Masks with Maintenance of Integrity and Fit. Infect Control Hosp Epidemiol 2021:1- 83Lendvay TS, Chen J, Harcourt BH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34016200 14. Effect of nasal suction catheter use on aerosol generation during endoscopic sinus surgery. Int Forum Allergy Rhinol 2021; Murr AT, Bacon DR, Onuorah PC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021534 15. Preventing SARS-CoV-2 transmission in the emergency department by implementing a separate pathway for patients with respiratory conditions. J Complement Integr Med 2021; Alqahtani F, Alanazi M, Alassaf W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022123 16. COVID-19 pandemic and safety of taxi services: Looking beyond primary care. J Family Med Prim Care 2021; 10:27-30Baluja A, Ghosh A, Modi JN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017698 17. Institutional quarantine centres as a strategy in control of COVID-19 outbreak: An evolving model from Kerala, India. J Family Med Prim Care 2021; 10:527- 532Sudha RR, Sujatha C, Gopakumar S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017782 18. Significant physiological impact of wearing PPE inside operation theatre: A challenging scenario in this COVID-19 pandemic. J Family Med Prim Care 2021; 10:561-563Yunus M, Deb P, Das R, Bhattacharyya P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017790 19. Hand Hygiene Habits and Prevalence of Hand Eczema During the COVID-19 Pandemic. J. Prim. Care Community Health 2021; 12:21501327211018013Techasatian L, Thaowandee W, Chaiyarit J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009056 20. Adherence to Masking Requirement During the COVID-19 Pandemic by Early Elementary School Children. J. Sch. Health 2021; Mickells GE, Figueroa J, West KW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997986 21. Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China. J Virus Erad 2021; 7:100040Kong X, Liu F, Wang H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996143 22. A Narrative Review of Personal Protective Equipment Uses in Coronavirus Disease 2019 and Its Disposable Practices. Jma j 2021; 4:86-90Giri A, Sapkota B, Shrestha R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997441 23. Remote buddy monitoring of the donning and doffing of personal protective equipment. Med. J. Aust. 2021; Segal R, Bradley WP, Williams D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002372 24. Axillary Digital Thermometers uplifted a multidrug-susceptible Candida auris outbreak among COVID-19 patients in Brazil. Mycoses 2021; de Almeida JN, Jr., Brandão IB, Francisco EC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34009677 25. Modelling personal cautiousness during the COVID-19 pandemic: a case study for Turkey and Italy. Nonlinear Dyn 2021:1-13Bulut H, Gölgeli M, Atay FM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994665 26. A Novel Negative Pressure, Face-Mounted Antechamber to Minimize Aerosolization of Particles During Endoscopic Skull Base Surgery. Oper Neurosurg (Hagerstown) 2021; Kim M, Lee M, Schwarz J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017990 27. Collectivism predicts mask use during COVID-19. Proc Natl Acad Sci U S A 2021; 118Lu JG, Jin P, English AS. http://www.ncbi.nlm.nih.gov/pubmed/? term=34016707 28. Assessment of infection prevention and control measures adopted by eye care practitioners in Ghana and South Africa against COVID-19. Sci Afr 2021; 12:e00766Boadi-Kusi SB, Kyei S, Ocansey S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997540 29. Prolonged facemask use in the heat worsens dyspnea without compromising motor-cognitive performance. Temperature (Austin) 2020; 8:160-165Morris NB, Piil JF, Christiansen L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997114

Pulmonary disease (20 articles)

1. Judicious use of incentive spirometry in resource limited times of COVID-19 pandemic. Am J Emerg Med 2021; Sheth AR, Faraji M, Boparai S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023182 2. A portable triboelectric spirometer for wireless pulmonary function monitoring. Biosens. Bioelectron. 2021; 187:113329Xu Q, Fang Y, Jing Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020223 3. How Local SARS-CoV-2 Prevalence Shapes Pulmonary Function Testing Laboratory Protocols and Practices During the COVID-19 Pandemic. Chest 2021; Saunders MJ, Haynes JM, McCormack MC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004155 4. Respiratory follow-up after hospitalization for COVID-19: who and when? Eur. J. Clin. Invest. 2021:e13603Riou M, Marcot C, Oulehri W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998683 5. A note on the stability characteristics of the respiratory events. Eur J Mech B Fluids 2021; 89:15-20Vadivukkarasan M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994752 6. An Overview of Asthma and COVID-19: Protective Factors Against SARS-COV- 2 in Pediatric Patients. Front Pediatr 2021; 9:661206Liuzzo Scorpo M, Ferrante G, La Grutta S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996694 7. Lung histopathological findings in COVID-19 disease - a systematic review. Infect. Agent. Cancer 2021; 16:34Pannone G, Caponio VCA, De Stefano IS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001199 8. Differential host circRNA expression profiles in human lung epithelial cells infected with SARS-CoV-2. Infect Genet Evol 2021:104923Yang M, Qi M, Xu L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004360 9. Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020. J Cyst Fibros 2021; Naehrlich L, Orenti A, Dunlevy F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016559 10. Interventional pulmonology during COVID-19 pandemic: current evidence and future perspectives. J Thorac Dis 2021; 13:2495-2509Piro R, Casalini E, Livrieri F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012596 11. Typical Covid-19 case with primary pneumomediastinum in a 37 year old male. Radiol Case Rep 2021; Jafari R, Cegolon L, Dehghanpoor F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995745 12. Massive Emphysema Subcutis, pneumothorax, Pneumomediastinum and Pneumoperitoneum as Uncommon Complication of COVID-19 Pneumonia, a Rare Case. Radiol Case Rep 2021; Utomo SA, Notopuro F, Rosalina S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995744 13. Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study. Respir. Med. 2021; 184:106435Frija-Masson J, Debray MP, Boussouar S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020126 14. Pneumomediastinum in COVID-19: A series of three cases and review of literature. SAGE Open Med Case Rep 2021; 9:2050313x211011807Machiraju PK, Alex NM, Safinaaz, Baby NM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017591 15. Analysis of mycoplasma pneumoniae infection among children with respiratory tract infections in hospital in Chengdu from 2014 to 2020. Transl Pediatr 2021; 10:990-997Zhang L, Lai M, Ai T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012847

Renal disease (8 articles)

1. Comparative Incidence and Outcomes of COVID-19 in Kidney or Kidney- Pancreas Transplant Recipients Versus Kidney or Kidney-Pancreas Waitlisted Patients: A Single-Center Study. Clin. Transplant. 2021:e14362Santos CAQ, Rhee Y, Hollinger EF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998716 2. Myeloma Cast Nephropathy and COVID-19: A Case Report of Multiple Myeloma Presenting as Acute Kidney Injury in the Setting of COVID-19. Cureus 2021; 13:e14461Memon W, Popli K, Akram A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996321 3. Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease. Front. Immunol. 2021; 12:671052Medjeral-Thomas NR, Troldborg A, Hansen AG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995410 4. Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19. Int J Cardiol 2021; Li XT, Zhang MW, Zhang ZZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000358 5. COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report. J Nephrol 2021:1-4Cognard N, Gautier-Vargas G, Perrin P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33999392 6. Panic in the Pandemic: When Should Kidney Transplant Programs Close? Kidney Int Rep 2021; 6:1232-1241Vinson AJ, Kiberd BA, Tennankore KK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34013101 7. Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion. Kidney Med 2021; Robinson BM, Guedes M, Alghonaim M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34007963 8. [Not Available]. Nefrologia (Engl Ed) 2021; Gameiro J, Agapito Fonseca J, Oliveira J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007095

Reviews (38 articles)

1. Sampling Methods and Risk Stratification Regarding Environmental Contamination by SARS-CoV-2. Acta Med Port 2021; Mendes M, Andrade Oliveira A, Pires O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014160 2. Corneal transplantation during COVID-19 pandemic: need for special considerations-A live review. AIMS Public Health 2021; 8:186-195Pandey AK, Mudgil N, Wadgave Y, Mishra SS. http://www.ncbi.nlm.nih.gov/pubmed/? term=34017884 3. Chloroquine- and Hydroxychloroquine-Induced Cardiomyopathy: A Case Report and Brief Literature Review. Am J Clin Pathol 2021; 155:793-801Nadeem U, Raafey M, Kim G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33316045 4. A rapid scoping review of COVID-19 and vulnerable workers: Intersecting occupational and public health issues. Am. J. Ind. Med. 2021; Côté D, Durant S, MacEachen E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003502 5. A review of 92 obstetric patients with COVID-19 in the Bronx, New York and their peripartum anaesthetic management. Anaesthesiol Intensive Ther 2021:1- 11Chen S, Bernstein P, Nair S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34006045 6. Current status of the COVID - 19 and male reproduction: a review of the literature. Andrology 2021; Borges E, Jr., Setti AS, Iaconelli A, Jr., de Almeida Ferreira Braga DP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998143 7. Current and future use of telemedicine in surgical clinics during and beyond COVID-19: A narrative review. Ann Med Surg (Lond) 2021; 66:102378McMaster T, Wright T, Mori K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996071 8. Future developments in the prevention, diagnosis and treatment of COVID-19. Best Pract. Res. Clin. Obstet. Gynaecol. 2021; Coltart CEM, Collet-Fenson LB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016525 9. Diagnosis and Management of Osteoporosis During COVID-19: Systematic Review and Practical Guidance. Calcif. Tissue Int. 2021:1-12Hampson G, Stone M, Lindsay JR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003337 10. The COVID-19-Cancer Connection. Clin. J. Oncol. Nurs. 2021; 25:235-236Boyle DA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019020 11. The Impact of COVID-19 on mental health. Cogn. Behav. Ther. 2021; 50:185- 190Hofmann SG. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018470 12. Correlation of Severity of COVID-19 Disease With Gastrointestinal Manifestations and Liver Injury - A North Brooklyn Community Hospital Experience: A Retrospective Cohort Study. Cureus 2021; 13:e14543Deane K, Singh A, Sarfraz A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017658 13. Does Tocilizumab have a Role in Dermatology? A Review of Clinical Applications, its Adverse Side Effects and Practical Considerations. Dermatol Ther 2021:e14990Choong DJ, Tan E. http://www.ncbi.nlm.nih.gov/pubmed/? term=34004074 14. Corona ticker: News about SARS-CoV-2 in a nutshell. Deutsche Apotheker Zeitung 2021; 161. 15. Vitamin D in the Covid-19 era: a review with recommendations from a G.I.O.S.E.G. expert panel. Endocrine 2021:1-7Ulivieri FM, Banfi G, Camozzi V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999367 16. Clinical outcomes of coronavirus disease 2019 (COVID-19) amongst HIV patients: a systematic literature review. Epidemiol Health 2021:e2021036Massarvva T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015893 17. Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review. Eur. J. Clin. Invest. 2021:e13604Spagnolo F, Boutros A, Croce E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021591 18. Genetic susceptibility of COVID-19: a systematic review of current evidence. Eur. J. Med. Res. 2021; 26:46SeyedAlinaghi S, Mehrtak M, MohsseniPour M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016183 19. Review: Obesity and COVID-19: A Detrimental Intersection. Front. Endocrinol. (Lausanne) 2021; 12:652639Gammone MA, D'Orazio N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995281 20. A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain. Front. Immunol. 2021; 12:647934Niu L, Wittrock KN, Clabaugh GC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995366 21. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data. Front Med (Lausanne) 2021; 8:653516Salamanna F, Veronesi F, Martini L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017846 22. Intensive Care Unit Built Environments: A Comprehensive Literature Review (2005-2020). Herd 2021:19375867211009273Verderber S, Gray S, Suresh-Kumar S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000842 23. A review on monoclonal antibodies in COVID-19: Role in immunotherapy, vaccine development and viral detection. Hum. Antibodies 2021; Tabll AA, Shahein YE, Omran MM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33998533 24. COVID-19 and pregnancy: A scoping review on pregnancy characteristics and outcomes. Int. J. Nurs. Pract. 2021:e12956de Oliveira KF, de Oliveira JF, Wernet M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998110 25. Prevention of infective complications in systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements. Int J Rheum Dis 2021; Oku K, Hamijoyo L, Kasitanon N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999518 26. Report of the ACLP Task Force on Lessons Learned From the COVID-19 Pandemic, Nov. 19, 2020: Executive Summary. J Acad Consult Liaison Psychiatry 2021; Shapiro PA, Brahmbhatt K, Caravella R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000470 27. Echocardiographic Correlates of In-Hospital Death in Patients with Acute COVID-19 Infection: The World Alliance Societies of Echocardiography (WASE-COVID) Study. J. Am. Soc. Echocardiogr. 2021; Karagodin I, Singulane CC, Woodward GM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023454 28. Review of COVID-19 Vaccines Approved in the United States of America for Emergency Use. J. Clin. Med. Res. 2021; 13:204-213Vasireddy D, Atluri P, Malayala SV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007358 29. Frequent clinical and radiological manifestations of the Novel SARS-CoV-2: A review article. J Family Med Prim Care 2021; 10:122-126Alshoabi SA, Alhazmi FH, Abdulaal OM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017713 30. Dental practice in the era of COVID-19: A review of literature. J Family Med Prim Care 2021; 10:41-47Razmara F, Khayamzadeh M, Shabankare G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017701 31. COVID-19-A new normal Indian community. J Family Med Prim Care 2021; 10:15-18Rohisha IK, Jibin M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017695 32. Cutaneous manifestations associated with COVID-19 in children: A systematic review. J Family Med Prim Care 2021; 10:93-101Shah S, Akhade K, Ganguly S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017709 33. An immune-centric investigation of Coronavirus in the women with cancers; A review article. J Family Med Prim Care 2021; 10:56-61Yousefi Sharami SR, Yousefnezhad A, Nokhostin F. http://www.ncbi.nlm.nih.gov/pubmed/? term=34017703 34. Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials. J Infect Public Health 2021; 14:740-748Patel TK, Patel PB, Barvaliya M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020215 35. Effects of SARS-CoV-2 infection on human reproduction. J. Mol. Cell. Biol. 2021; Yang M, Wang J, Chen Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34003284 36. A Narrative Review of Personal Protective Equipment Uses in Coronavirus Disease 2019 and Its Disposable Practices. Jma j 2021; 4:86-90Giri A, Sapkota B, Shrestha R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997441 37. COVID-19 healthcare policies in Ireland: A rapid review of the initial pandemic response. Scand J Public Health 2021:14034948211008371O'Leary N, Kingston L, Griffin A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011221 38. A review on recipients of hematopoietic stem cell transplantation patients with COVID-19 infection. Ther Adv Infect Dis 2021; 8:20499361211013252Sahu KK, Siddiqui AD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996075

Risk factors (61 articles)

1. Sampling Methods and Risk Stratification Regarding Environmental Contamination by SARS-CoV-2. Acta Med Port 2021; Mendes M, Andrade Oliveira A, Pires O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014160 2. Influence of vitamin D status on hospital length of stay and prognosis in hospitalized patients with moderate to severe COVID-19: a multicenter prospective cohort study. Am. J. Clin. Nutr. 2021; Reis BZ, Fernandes AL, Sales LP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020451 3. Lack of association between vitamin D insufficiency and clinical outcomes of patients with COVID-19 infection. BMC Infect. Dis. 2021; 21:450Davoudi A, Najafi N, Aarabi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006228 4. Lymphocyte/mean platelet volume ratio, a new marker; is it effective in predicting the prognosis of COVID-19 cases? Bratisl. Lek. Listy 2021; 122:413- 417Eraybar S, Yuksel M, Aygun H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34002615 5. Can we estimate cytokine storm from initial computed tomography images of Coronavirus disease-2019 patients? Bratisl. Lek. Listy 2021; 122:405-412Ozturk C, Gungor O, Koc F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002614 6. Risk factors for illness severity among pregnant women with confirmed SARS- CoV-2 infection - Surveillance for Emerging Threats to Mothers and Babies Network, 22 state, local, and territorial health departments, March 29, 2020 - March 5, 2021. Clin Infect Dis 2021; Galang RR, Newton SM, Woodworth KR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021332 7. Correlation of Severity of COVID-19 Disease With Gastrointestinal Manifestations and Liver Injury - A North Brooklyn Community Hospital Experience: A Retrospective Cohort Study. Cureus 2021; 13:e14543Deane K, Singh A, Sarfraz A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017658 8. Gastrointestinal Symptoms in Association With Hypokalemia Can Be a Predictor of Inferior Outcomes in COVID-19. Cureus 2021; 13:e14466Wong Wai Cheong N, Meyyur Aravamudan V, Venkatachalam J, Kuthiah N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996325 9. Clinical features and prognostic factors in Covid-19: A prospective cohort study. EBioMedicine 2021; 67:103378de Bruin S, Bos LD, van Roon MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000622 10. Association between Thyroid Function and Prognosis of COVID-19: A Retrospective Observational Study. Endocr. Res. 2021:1-8Lang S, Liu Y, Qu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014139 11. Incident atrial fibrillation and its risk prediction in patients developing COVID- 19: A machine learning based algorithm approach. Eur J Intern Med 2021; Lip GYH, Genaidy A, Tran G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34023150 12. Genetic susceptibility of COVID-19: a systematic review of current evidence. Eur. J. Med. Res. 2021; 26:46SeyedAlinaghi S, Mehrtak M, MohsseniPour M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016183 13. Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation. Front. Immunol. 2021; 12:675678Della-Torre E, Lanzillotta M, Campochiaro C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995419 14. CD4(+) T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein. Front. Immunol. 2021; 12:629102Taborska P, Strizova Z, Stakheev D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012431 15. Prediction of COVID-19 Hospital Length of Stay and Risk of Death Using Artificial Intelligence-Based Modeling. Front Med (Lausanne) 2021; 8:592336Mahboub B, Bataineh MTA, Alshraideh H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017839 16. Impact of Smoking on Women During the Covid-19 Pandemic. Front Med (Lausanne) 2021; 8:584061Mihaltan FD, Rajnoveanu AG, Rajnoveanu RM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996840 17. Distinguishing Coronavirus Disease 2019 Patients From General Surgery Emergency Patients With the CIAAD Scale: Development and Validation of a Prediction Model Based on 822 Cases in China. Front Med (Lausanne) 2021; 8:601941Zhao B, Wei Y, Sun W et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33996842 18. Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential. Front. Physiol. 2021; 12:652799Suvarna K, Biswas D, Pai MGJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995121 19. Association between vitamin D level and prognostic factors among patients infected with SARS-CoV-2. Horm. Mol. Biol. Clin. Investig. 2021; Haghighi M, Ebadi SS, Soleimantabar H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34005841 20. Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients. Hum Genomics 2021; 15:29Wulandari L, Hamidah B, Pakpahan C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001248 21. Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19. Int J Cardiol 2021; Li XT, Zhang MW, Zhang ZZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000358 22. Correlation of Racial Effect with Severity of Disease and In-Hospital Outcome in Individuals Diagnosed with COVID-19. Int J Clin Pract 2021:e14383Alotaibi AR, Ezzeldin T, Siddiqui IA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022105 23. Risk of COVID-19 Infection and Associated Factors Among Healthcare Workers: A Cross-Sectional Study at Eka Kotebe Treatment Center in Ethiopia. Int. J. Gen. Med. 2021; 14:1763-1772Hussen H, Alemu ZA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994805 24. Clinical presentation, outcomes and factors associated with mortality: a prospective study from three COVID-19 referral care centers in West Africa. Int J Infect Dis 2021; Jaspard M, Sow MS, Juchet S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000419 25. Phenome-wide and eQTL Associations of COVID-19 Genetic Risk Loci. iScience 2021:102550Moon C, Schilder BM, Raj T, Huang KL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34027315 26. Environmental and climatic impact on the infection and mortality of SARS- CoV-2 in Peru. J. Basic Clin. Physiol. Pharmacol. 2021; Samillan VJ, Flores-León D, Rojas E, Zutta BR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018379 27. Severity of COVID-19 in Cancer patients versus patients without Cancer: A Propensity Score Matching Analysis. J. Cancer 2021; 12:3558-3565Liu C, Wang K, Li L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995633 28. A Simplified Comorbidity Evaluation Predicting Clinical Outcomes Among Patients With Coronavirus Disease 2019. J. Clin. Med. Res. 2021; 13:237- 244Kirby JJ, Shaikh S, Bryant DP et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34007362 29. Do Certain Biomarkers Predict Adverse Outcomes in Coronavirus Disease 2019? J. Clin. Med. Res. 2021; 13:195-203Narvel H, Sayed A, Narvel N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007357 30. Impact of Body Mass Index on COVID-19-Related In-Hospital Outcomes and Mortality. J. Clin. Med. Res. 2021; 13:230-236Ullah W, Roomi S, Nadeem N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007361 31. Cancer, transplant, and immunocompromising conditions were not significantly associated with severe illness or death in hospitalized COVID-19 patients. J Clin Virol 2021; 140:104850Krasnow MR, Litt HK, Lehmann CJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022753 32. Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020. J Cyst Fibros 2021; Naehrlich L, Orenti A, Dunlevy F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016559 33. MuLBSTA score in COVID-19 pneumonia and prediction of 14-day mortality risk: A study in an Indian cohort. J Family Med Prim Care 2021; 10:223- 227Preetam M, Anurag A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017730 34. Predictors of mortality and the need of mechanical ventilation in confirmed COVID-19 patients presenting to the emergency department in North India. J Family Med Prim Care 2021; 10:542-549Suresh S, Tiwari A, Mathew R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017785 35. ABO in Correlation to the Requirement of Mechanical Ventilation and Mortality in Critically Ill Patients With COVID-19. J Hematol 2021; 10:64-70Al-Ansari RY, Alshaer A, Al-Anazi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007367 36. Scoring system for identifying Japanese patients with COVID-19 at risk of requiring oxygen supply: A retrospective single-center study. J Infect Chemother 2021; Kitajima H, Hirashima T, Suzuki H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023221 37. Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study. J Infect Public Health 2021; 14:726-733Alrashed AA, Khan TM, Alhusseini NK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020213 38. Identifying the predictors of Covid-19 infection outcomes and development of prediction models. J Infect Public Health 2021; 14:751-756Ansari RM, Baker P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022732 39. Susceptibility to SARS-CoV-2 infection in patients undergoing chemotherapy and radiation therapy. J Infect Public Health 2021; 14:766-771Corso CR, Mulinari Turin de Oliveira N, Maria-Ferreira D. http://www.ncbi.nlm.nih.gov/pubmed/? term=34022735 40. Prevalence and predictors of in-hospital mortality of patients hospitalized with COVID-19 infection. J Infect Public Health 2021; 14:759-765Khamis F, Memish Z, Bahrani MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022734 41. Clinical Characteristics of COVID-19: Risk Factors for Early Oxygen Requirement after Hospitalization. J Korean Med Sci 2021; 36:e139Suh HJ, Lee E, Park SW. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002553 42. Evaluation of the prognostic role of NLR, LMR, PLR and LCR ratio in COVID-19 patients. J Med Virol 2021; Erdogan A, Can FE, Gönüllü H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019701 43. Genome-wide screening of SARS-CoV-2 infection-related genes based on the blood leucocytes sequencing dataset of patients with COVID-19. J Med Virol 2021; Gao X, Liu Y, Zou S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34009691 44. Evaluation of the relationship between KIM-1 and suPAR levels and clinical severity in COVID-19 patients: A different perspective on suPAR. J Med Virol 2021; Kerget B, Kerget F, Aksakal A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34019703 45. Glycosylation is a key in SARS-CoV-2 infection. J. Mol. Med. (Berl.) 2021; Reis CA, Tauber R, Blanchard V. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023935 46. The Essential Vulnerability of Human Cardiac Myocytes to SARS-CoV-2. JACC Basic Transl Sci 2021; 6:346-349Das M, Bristow MR, Chung MK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997520 47. Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis. JHEP Rep 2021:100303Kaur S, Hussain S, Kolhe K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997748 48. Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet Reg Health Eur 2021; 6:100109Bhaskaran K, Bacon S, Evans SJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997835 49. Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: A case-control study. Life Sci 2021; 277:119634Karsli E, Sabirli R, Altintas E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015287 50. Personalized Prediction of Hospital Mortality in COVID-19 positive patients. Mayo Clin Proc Innov Qual Outcomes 2021; Rozenbaum D, Shreve J, Radakovich N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002167 51. Evaluation of oxidative stress level: total antioxidant capacity, total oxidant status and glutathione activity in patients with Covid-19. New Microbes New Infect 2021:100897Karkhanei B, Ghane ET, Mehri F. http://www.ncbi.nlm.nih.gov/pubmed/?term=34026228 52. NSGA-II as feature selection technique and AdaBoost classifier for COVID-19 prediction using patient's symptoms. Nonlinear Dyn 2021:1-23Soui M, Mansouri N, Alhamad R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025034 53. Demographic factors associated with COVID-19-related death in Palestine. Public Health Pract (Oxf) 2021; 2:100145Maraqa B, Al-Shakhra K, Alawneh M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34027510 54. Communicating personalized risks from COVID-19: guidelines from an empirical study. R Soc Open Sci 2021; 8:201721Freeman ALJ, Kerr J, Recchia G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996117 55. Lung Ultrasound Score to Predict Outcomes in COVID-19. Respir. Care 2021; Trias-Sabrià P, Molina-Molina M, Aso S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34006594 56. An updated overview of e-cigarette impact on human health. Respir Res 2021; 22:151Marques P, Piqueras L, Sanz MJ. http://www.ncbi.nlm.nih.gov/pubmed/? term=34006276 57. Risk factors for persistent abnormality on chest radiographs at 12-weeks post hospitalisation with PCR confirmed COVID-19. Respir Res 2021; 22:157Wallis TJM, Heiden E, Horno J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020644 58. [C-Reactive protein and SOFA scale: a simple score as early predictor of critical care requirement in patients with COVID-19 pneumonia in Spain.]. Rev. Esp. Anestesiol. Reanim. 2021; Vaquero-Roncero LM, Sánchez-Barrado E, Escobar-Macias D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994585 59. Malignancy is a risk factor for higher COVID-19 severity:A meta-analysis. Turk J Med Sci 2021; Liu GE, Cai W, Liu H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34022777 60. Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients. World J. Diabetes 2021; 12:590- 602Rojas A, Lindner C, Gonzàlez I, Morales MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995847 61. Particulate matter exposure exacerbates susceptibility to SARS-CoV-2 infection in humanized ACE2 mice. Zool Res 2021; 42:335-338Zhu TY, Qiu H, Cao QQ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998180

Safety (27 articles)

1. SARS-CoV-2 vaccines are not free of neurological side effects. Acta Neurol. Scand. 2021; Finsterer J, Scorza FA. http://www.ncbi.nlm.nih.gov/pubmed/? term=34002379 2. COVID-19 Vaccination of Allergic Patients in Conjunction with allergen immunotherapy (AIT) – A position paper of the Association of German Allergists (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI). Allergologie 2021; 44:339-348Klimek L, Pfaar O, Hamelmann E et al. 3. Chloroquine- and Hydroxychloroquine-Induced Cardiomyopathy: A Case Report and Brief Literature Review. Am J Clin Pathol 2021; 155:793-801Nadeem U, Raafey M, Kim G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33316045 4. COVID-19 vaccine adverse reactions bring patients to emergency departments. Am J Emerg Med 2021; Fertel BS, Milk J, Simon EL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994051 5. [MANAGEMENT, DIAGNOSIS, AND TREATMENT OF SEVERE ALLERGIC REACTIONS INCLUDING ANAPHYLAXIS TO COVID-19 VACCINE]. Arerugi 2021; 70:215-223Asano K, Fujisawa T, Nakamura Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011777 6. Prognostic value of bilirubin and drug interactions. BMJ Open Gastroenterol 2021; 8Ng A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006605 7. Thrombotic Events in COVID-19: Inquires About the Deleterious Procoagulant Effect of Corticosteroid Therapy. Clin. Appl. Thromb. Hemost. 2021; 27:10760296211020139Crisan-Dabija R, Burlacu A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018412 8. Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA- 1273 Vaccine Recipients. Clin Infect Dis 2021; Ogata AF, Cheng CA, Desjardins M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015087 9. Modelling sudden cardiac death risks factors in patients with coronavirus disease of 2019: the hydroxychloroquine and azithromycin case. Europace 2021; Montnach J, Baró I, Charpentier F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34009333 10. Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice. Expert Rev. Anti Infect. Ther. 2021; Crisan Dabija R, Antohe I, Trofor A, Antoniu SA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015985 11. Covid-19 vaccine, acceptance, and concern of safety from public perspective in the state of Odisha, India. Hum Vaccin Immunother 2021:1-5Panda DS, Giri RK, Nagarajappa AK, Basha S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010097 12. Effect of vaccine effectiveness and safety on COVID-19 vaccine acceptance in Detroit, Michigan, July 2020. Hum Vaccin Immunother 2021:1-6Wagner AL, Sheinfeld Gorin S, Boulton ML et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33998949 13. Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights. Interdiscip Sci 2021:1-4Selvaraj G, Kaliamurthi S, Peslherbe GH, Wei DQ. http://www.ncbi.nlm.nih.gov/pubmed/? term=34021862 14. Perspectives on vaccine induced thrombotic thrombocytopenia. J Autoimmun 2021; 121:102663Dotan A, Shoenfeld Y. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020254 15. COVID-19 vector-based vaccine causing thrombosis. J Biomol Struct Dyn 2021:1-3Hendaus MA, Jomha FA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33998976 16. Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from North-East Italy. J Eur Acad Dermatol Venereol 2021; Farinazzo E, Ponis G, Zelin E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021625 17. Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution. J. Hematol. Oncol. 2021; 14:81Pimpinelli F, Marchesi F, Piaggio G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001183 18. Osmotic tubulopathy in a patient with COVID-19 treated with remdesivir. Kidney Int Rep 2021; Wongboonsin J, Shah SI, Marty FM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997535 19. COVID-19 swab-related skull base injury. Med. J. Aust. 2021; Mistry SG, Walker W, Earnshaw J, Cervin A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008200 20. [Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination]. Neurologia 2021; Avendaño-Solá C, Cámara R, Castellanos M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994625 21. [Vaccination against SARS-CoV-2 in cancer patients]. Onkologe (Berl) 2021:1- 6von Lilienfeld-Toal M, Rieger C, Giesen N, Wörmann B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025046 22. Favipiravir use in children with COVID-19 and acute kidney injury: is it safe? Pediatr. Nephrol. 2021:1-6Ozsurekci Y, Oygar PD, Gürlevik SL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021797 23. Risk of infection within 4 weeks of corticosteroid injection (CSI) in the management of chronic pain during a pandemic: a cohort study in 216 patients. Scand J Pain 2021; James A, Niraj S, Mittal M, Niraj G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010525 24. Acute Psychosis in COVID-19: Is It Due to Favipiravir Treatment or Acute Viral Illness? SN Compr Clin Med 2021:1-3Duyan M, Ozturan IU. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997622 25. Efficacy and Safety of Azithromycin for the Treatment of COVID-19: A Systematic Review and Meta-analysis. Tuberc Respir Dis (Seoul) 2021; Mangkuliguna G, Glenardi, Susanto N, Pramono LA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015868 26. Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines. Vaccine 2021; Somiya M, Mine S, Yasukawa K, Ikeda S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020815 27. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine 2021; Welsh KJ, Baumblatt J, Chege W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=3400640

Treatment options (76 articles)

1. Role of the early short-course corticosteroids treatment in ARDS caused by COVID-19: A single-center, retrospective analysis. Adv. Med. Sci. 2021; 66:262- 268Boglione L, Olivieri C, Rostagno R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34022675 2. Viral inhibitors derived from macroalgae, microalgae, and cyanobacteria: A review of antiviral potential throughout pathogenesis. Algal Res 2021; 57:102331Reynolds D, Huesemann M, Edmundson S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34026476 3. Chloroquine- and Hydroxychloroquine-Induced Cardiomyopathy: A Case Report and Brief Literature Review. Am J Clin Pathol 2021; 155:793-801Nadeem U, Raafey M, Kim G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33316045 4. Changes of clinical characteristics of asymptomatic patients with positive SARS-Cov-2 nucleic acid test during treatment cycle and related risk factors. Am J Transl Res 2021; 13:3650-3657Li S, Li J, Cao D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017547 5. Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro. Antiviral Res 2021:105089Paull JRA, Heery GP, Bobardt MD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010661 6. Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID- 19. Brief. Bioinform. 2021; Tomazou M, Bourdakou MM, Minadakis G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009288 7. Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19). Carbohydr. Res. 2021; 505:108326Andrew M, Jayaraman G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015720 8. Metal Complexes as Antiviral Agents for SARS-CoV-2. Chembiochem 2021; Karges J, Cohen SM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002456 9. Computational Approaches to Discover Novel Natural Compounds for SARS- CoV-2 Therapeutics. ChemistryOpen 2021; 10:593-599Rampogu S, Lee G, Kulkarni AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010501 10. Thrombotic Events in COVID-19: Inquires About the Deleterious Procoagulant Effect of Corticosteroid Therapy. Clin. Appl. Thromb. Hemost. 2021; 27:10760296211020139Crisan-Dabija R, Burlacu A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018412 11. The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors. Clin Epidemiol Glob Health 2021; 11:100763Wardhani SO, Fajar JK, Nurarifah N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997476 12. Operationalizing Human Immunodeficiency Virus Cure-related Trials with Analytic Treatment Interruptions During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Collaborative Approach. Clin Infect Dis 2021; 72:1843-1849Peluso MJ, Dee L, Shao S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32841311 13. Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multi-center study. Clin Microbiol Infect 2021; Liu J, Chen Y, Li R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020032 14. Therapeutic application of light and electromagnetic fields to reduce hyper- inflammation triggered by COVID-19. Commun. Integr. Biol. 2021; 14:66- 77Pooam M, Aguida B, Drahy S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33995820 15. Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking. Comput. Biol. Med. 2021; 134:104468Elghoneimy LK, Ismail MI, Boeckler FM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34015671 16. QSAR modeling and pharmacoinformatics of SARS coronavirus 3C-like protease inhibitors. Comput. Biol. Med. 2021; 134:104483Ishola AA, Adedirin O, Joshi T, Chandra S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020129 17. Does Tocilizumab have a Role in Dermatology? A Review of Clinical Applications, its Adverse Side Effects and Practical Considerations. Dermatol Ther 2021:e14990Choong DJ, Tan E. http://www.ncbi.nlm.nih.gov/pubmed/? term=34004074 18. Focal onset non-motor seizure following COVID-19 vaccination: A mere coincidence? Diabetes Metab Syndr 2021; 15:1023-1024Ghosh R, Dubey S, Roy D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000712 19. Converging global crises are forcing the rapid adoption of disruptive changes in drug discovery. Drug Discov Today 2021; Mark Treherne J, Langley GR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015541 20. Drug combination therapy for emerging viral diseases. Drug Discov Today 2021; Shyr ZA, Cheng YS, Lo DC, Zheng W. http://www.ncbi.nlm.nih.gov/pubmed/? term=34023496 21. Mouthrinses against SARS-CoV-2: anti-inflammatory effectivity and a clinical pilot study. Eur Arch Otorhinolaryngol 2021:1-9Schürmann M, Aljubeh M, Tiemann C, Sudhoff H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021807 22. Response to letter entitled: Re: A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19. Eur. J. Cancer 2021; Yekedüz E, Utkan G, Ürün Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016491 23. A cyclic peptide inhibitor of the SARS-CoV-2 main protease. Eur. J. Med. Chem. 2021; 221:113530Kreutzer AG, Krumberger M, Diessner EM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023738 24. Azithromycin: Immunomodulatory and Antiviral Properties for SARS-CoV-2 Infection. Eur. J. Pharmacol. 2021; 905:174191Khezri MR, Zolbanin NM, Ghasemnejad-Berenji M, Jafari R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34015317 25. Modelling sudden cardiac death risks factors in patients with coronavirus disease of 2019: the hydroxychloroquine and azithromycin case. Europace 2021; Montnach J, Baró I, Charpentier F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34009333 26. Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice. Expert Rev. Anti Infect. Ther. 2021; Crisan Dabija R, Antohe I, Trofor A, Antoniu SA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015985 27. Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations. Expert Rev Vaccines 2021; Focosi D, Franchini M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34015243 28. Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor. Front Chem 2021; 9:661230Al-Karmalawy AA, Dahab MA, Metwaly AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017819 29. Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs. Front Chem 2021; 9:638187Tito A, Colantuono A, Pirone L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996744 30. Commentary: Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID- 19 Treatment. Front. Immunol. 2021; 12:682195Carvalho JL, Silva-Carvalho AE, Garcez EM, Saldanha-Araujo F. http://www.ncbi.nlm.nih.gov/pubmed/? term=33995424 31. High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients. Front. Immunol. 2021; 12:675679Greenbaum U, Klein K, Martinez F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995420 32. Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm. Front. Immunol. 2021; 12:642860Kozma GT, Mészáros T, Bakos T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995361 33. Cellular Immune Response to COVID-19 and Potential Immune Modulators. Front. Immunol. 2021; 12:646333Zhou X, Ye Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995364 34. Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro. Front. Microbiol. 2021; 12:651403Shionoya K, Yamasaki M, Iwanami S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995308 35. Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies. Front. Pharmacol. 2021; 12:629935Abubakar MB, Usman D, El-Saber Batiha G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34012391 36. Comparative Effectiveness of Pharmacological Interventions for Covid-19: A Systematic Review and Network Meta-Analysis. Front. Pharmacol. 2021; 12:649472De Crescenzo F, Amato L, Cruciani F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012398 37. Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery. Front. Pharmacol. 2021; 12:660710Li X, Peng T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017257 38. Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential. Front. Physiol. 2021; 12:652799Suvarna K, Biswas D, Pai MGJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995121 39. A review on monoclonal antibodies in COVID-19: Role in immunotherapy, vaccine development and viral detection. Hum. Antibodies 2021; Tabll AA, Shahein YE, Omran MM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33998533 40. Chemotherapy vs. Immunotherapy in combating nCOVID19: An update. Hum. Immunol. 2021; Choudhury A, Mukherjee G, Mukherjee S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020832 41. Anti-IgE monoclonal antibodies as potential treatment in COVID-19. Immunopharmacol. Immunotoxicol. 2021:1-6Farmani AR, Mahdavinezhad F, Moslemi R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018464 42. Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19. Immunopharmacol. Immunotoxicol. 2021:1-12Saeedi-Boroujeni A, Mahmoudian-Sani MR, Nashibi R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34015982 43. Tocilizumab treatment for COVID-19 patients: a systematic review and meta- analysis. Infect Dis Poverty 2021; 10:71Wei Q, Lin H, Wei RG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001244 44. Insights on the mechanisms of action of ozone in the medical therapy against COVID-19. Int Immunopharmacol 2021; 96:107777Chirumbolo S, Valdenassi L, Simonetti V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020394 45. Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting. Int Immunopharmacol 2021; 96:107636Mokhtari M, Mohraz M, Gouya MM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015598 46. Intragastric and atomized administration of canagliflozin inhibit inflammatory cytokine storm in lipopolysaccharide-treated sepsis in mice: A potential COVID-19 treatment. Int Immunopharmacol 2021; 96:107773Niu Y, Chen Y, Sun P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020392 47. Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta- regression of randomized-controlled trials. Intensive Care Med 2021; Snow TAC, Saleem N, Ambler G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019122 48. A large-scale computational screen identifies strong potential inhibitors for disrupting SARS-CoV-2 S-protein and human ACE2 interaction. J Biomol Struct Dyn 2021:1-14Singh A, Dhar R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33998954 49. Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials. J Infect Public Health 2021; 14:740-748Patel TK, Patel PB, Barvaliya M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020215 50. The Effectiveness of Photobiomudulation Therapy (PBMT) in COVID-19 Infection. J Lasers Med Sci 2020; 11:S23-s29Jahani Sherafat S, Mokmeli S, Rostami-Nejad M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995965 51. Inhibition of SARS-CoV-2 reproduction using Boswellia carterii: A theoretical study. J. Mol. Liq. 2021; 337:116440Kadhim MM, Washeel Salman A, Mrebee Zarzoor A, Kadhum WR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994607 52. COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report. J Nephrol 2021:1-4Cognard N, Gautier-Vargas G, Perrin P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33999392 53. Calendulaglycoside A Showing Potential Activity Against SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics, and SAR Studies. J Tradit Complement Med 2021; Zaki AA, Ashour A, Elhady SS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34026584 54. Notes From the Field: The Combined Effects of Tocilizumab and Remdesivir in a Patient With Severe COVID-19 and Cytokine Release Syndrome. JMIR Public Health Surveill 2021; 7:e27609Ali S, Khalid S, Afridi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009133 55. Osmotic tubulopathy in a patient with COVID-19 treated with remdesivir. Kidney Int Rep 2021; Wongboonsin J, Shah SI, Marty FM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997535 56. Design of advanced siRNA therapeutics for the treatment of COVID-19. Meta Gene 2021; 29:100910Niktab I, Haghparast M, Beigi MH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996501 57. Favipiravir use in children with COVID-19 and acute kidney injury: is it safe? Pediatr. Nephrol. 2021:1-6Ozsurekci Y, Oygar PD, Gürlevik SL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021797 58. Selection bias, investment decisions and treatment effect distributions. Pharm. Stat. 2021; Wiklund SJ, Burman CF. http://www.ncbi.nlm.nih.gov/pubmed/? term=34002467 59. Photodynamic Therapy and Photobiomodulation on Oral Lesion in Patient with Coronavirus Disease 2019: A Case Report. Photobiomodul Photomed Laser Surg 2021; Garcez AS, Delgado MGT, Sperandio M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009028 60. Convalescent plasma: It comes down to the right time. Pneumologie 2021; 75:336Krome S. 61. Tocilizumab could lower mortality in patients with severe COVID-19. Pneumologie 2021; 75Ruchalla E. 62. Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID- 19. Pulm. Pharmacol. Ther. 2021:102039Maslennikov R, Ivashkin V, Vasilieva E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023513 63. METHYLENE BLUE FOR TREATMENT OF HOSPITALIZED COVID-19 PATIENTS: A RANDOMIZED, CONTROLLED, OPEN-LABEL CLINICAL TRIAL, PHASE 2. Rev Invest Clin 2021; 73:190-198Hamidi-Alamdari D, Hafizi-Lotfabadi S, Bagheri- Moghaddam A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019535 64. Anakinra in hospitalized non-intubated patients with coronavirus disease 2019: a systematic review and meta-analysis. Rheumatology (Oxford) 2021; Barkas F, Ntekouan SF, Kosmidou M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33999135 65. Risk of infection within 4 weeks of corticosteroid injection (CSI) in the management of chronic pain during a pandemic: a cohort study in 216 patients. Scand J Pain 2021; James A, Niraj S, Mittal M, Niraj G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010525 66. Acute Psychosis in COVID-19: Is It Due to Favipiravir Treatment or Acute Viral Illness? SN Compr Clin Med 2021:1-3Duyan M, Ozturan IU. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997622 67. Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report. Ther Adv Hematol 2021; 12:20406207211011353Gruden G, Beggiato E, Camerino E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995989 68. Efficacy of convalescent plasma therapy in severe COVID-19 patients. Transfus. Apher. Sci. 2021:103158Akay Cizmecioglu H, Goktepe MH, Demircioglu S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994106 69. Preparedness and activities of the anti-SARS-CoV-2 convalescent plasma bank in the Veneto region (Italy): An organizational model for future emergencies. Transfus. Apher. Sci. 2021:103154De Silvestro G, Gandini G, Fiorin F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994107 70. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Trials 2021; 22:343Keitel V, Jensen B, Feldt T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001215 71. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial. Trials 2021; 22:342Soto A, Krapp F, Vargas A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001174 72. Efficacy and Safety of Azithromycin for the Treatment of COVID-19: A Systematic Review and Meta-analysis. Tuberc Respir Dis (Seoul) 2021; Mangkuliguna G, Glenardi, Susanto N, Pramono LA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015868 73. Effect of aspirin on short-term outcomes in hospitalized patients with COVID- 19. Vasc. Med. 2021:1358863x211012754Sahai A, Bhandari R, Godwin M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010070 74. Exploring SARS-CoV-2 Spikes Glycoproteins for Designing Potential Antiviral Targets. Viral Immunol 2021; Kamel NA, El Wakeel LM, Aboshanab KM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018828 75. Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study. Virol J 2021; 18:101Hou X, Tian L, Zhou L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020680 76. Almitrine for COVID-19 critically ill patients - a vascular therapy for a pulmonary vascular disease: Three case reports. World J Clin Cases 2021; 9:3385-3393Huette P, Abou Arab O, Jounieaux V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=3400214

Trials (10 articles)

1. Prospective observational study of gender and ethnicity biases in respiratory protective equipment for healthcare workers in the COVID-19 pandemic. BMJ Open 2021; 11:e047716Carvalho CYM, Schumacher J, Greig PR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016664 2. Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multi-center study. Clin Microbiol Infect 2021; Liu J, Chen Y, Li R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020032 3. Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting. Int Immunopharmacol 2021; 96:107636Mokhtari M, Mohraz M, Gouya MM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015598 4. The COVID-19-Related Lockdown in Qatar: Associations Among Demographics, Social Distancing, Mood Changes, and Quality of Life. Int J Ment Health Addict 2021:1-17Megreya AM, Latzman RD, Al-Ahmadi AM, Al-Dosari NF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994887 5. EXPRESS: COVID-19 AND STROKE â UNDERSTANDING THE RELATIONSHIP AND ADAPTING SERVICES. A GLOBAL WORLD STROKE ORGANISATION PERSPECTIVE. Int. J. Stroke 2021:17474930211006435Markus HS, Martins SCO. http://www.ncbi.nlm.nih.gov/pubmed/?term=34003703 6. Assessment of salivary antibody response to BNT162b2 mRNA COVID-19 vaccination. J Med Virol 2021; Lapić I, Šegulja D, Rogić D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009653 7. Decentralized Clinical Trials: The Future of Medical Product Development?∗. JACC Basic Transl Sci 2021; 6:384-387Van Norman GA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997523 8. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 2021; 6:100122Augustin M, Schommers P, Stecher M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34027514 9. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Trials 2021; 22:343Keitel V, Jensen B, Feldt T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001215 10. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial. Trials 2021; 22:342Soto A, Krapp F, Vargas A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001174

Vaccines (74 articles)

1. Ethical reflections on Covid-19 vaccines. Acta Clin. Belg. 2021:1-6Raus K, Mortier E, Eeckloo K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008482 2. SARS-CoV-2 vaccines are not free of neurological side effects. Acta Neurol. Scand. 2021; Finsterer J, Scorza FA. http://www.ncbi.nlm.nih.gov/pubmed/? term=34002379 3. COVID-19 Vaccination of Allergic Patients in Conjunction with allergen immunotherapy (AIT) – A position paper of the Association of German Allergists (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI). Allergologie 2021; 44:339-348Klimek L, Pfaar O, Hamelmann E et al. 4. COVID-19 vaccine adverse reactions bring patients to emergency departments. Am J Emerg Med 2021; Fertel BS, Milk J, Simon EL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994051 5. [MANAGEMENT, DIAGNOSIS, AND TREATMENT OF SEVERE ALLERGIC REACTIONS INCLUDING ANAPHYLAXIS TO COVID-19 VACCINE]. Arerugi 2021; 70:215-223Asano K, Fujisawa T, Nakamura Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34011777 6. Acceptance of COVID-19 Vaccine in Sri Lanka: Applying the Health Belief Model to an Online Survey. Asia Pac. J. Public Health 2021:10105395211014975Wijesinghe MSD, Weerasinghe W, Gunawardana I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000877 7. Delivering routine immunisations in London during the Covid-19 pandemic: lessons for future vaccine delivery. BJGP Open 2021; Skirrow H, Flynn C, Heller A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006529 8. Bhutan's experience with COVID-19 vaccination in 2021. BMJ Glob Health 2021; 6Dorji T, Tamang ST. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006520 9. Flashing red lights: the global implications of COVID-19 vaccination passports. BMJ Glob Health 2021; 6Voigt K, Nahimana E, Rosenthal A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016580 10. The current second wave and COVID-19 vaccination status in India. Brain Behav Immun 2021; Chakraborty C, Ranjan A, Bhattacharya M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022371 11. BNT162b2 vaccination effectively prevents the rapid rise of SARS-CoV-2 variant B.1.1.7 in high-risk populations in Israel. Cell Rep Med 2021; 2:100264Munitz A, Yechezkel M, Dickstein Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899031 12. The effectiveness of the TWO-DOSE BNT162b2 vaccine: analysis of real-world data. Clin Infect Dis 2021; Chodick G, Tene L, Rotem RS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999127 13. Bacille Calmette-Guérin Vaccination in Infancy Does Not Protect Against Coronavirus Disease 2019 (COVID-19): Evidence From a Natural Experiment in Sweden. Clin Infect Dis 2021; 72:e501-e505de Chaisemartin C, de Chaisemartin L. http://www.ncbi.nlm.nih.gov/pubmed/?term=32829400 14. Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA- 1273 Vaccine Recipients. Clin Infect Dis 2021; Ogata AF, Cheng CA, Desjardins M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015087 15. BCG Scar Local Skin Inflammation as a Novel Reaction Following mRNA COVID-19 Vaccines in Two International Healthcare Workers. Cureus 2021; 13:e14453Lopatynsky-Reyes EZ, Acosta-Lazo H, Ulloa-Gutierrez R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996313 16. Impact of the COVID-19 Pandemic and Obstetrician and Gynecologist Workforce Distribution on Vaccine Deployment and Predicting Women's Healthcare Shortages. Cureus 2021; 13:e14545Shastri T, Rasendran C, Markwei M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017660 17. Focal onset non-motor seizure following COVID-19 vaccination: A mere coincidence? Diabetes Metab Syndr 2021; 15:1023-1024Ghosh R, Dubey S, Roy D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000712 18. Using structural equation modeling to predict Indian people's attitudes and intentions towards COVID-19 vaccination. Diabetes Metab Syndr 2021; 15:1017- 1022Mir HH, Parveen S, Mullick NH, Nabi S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34000711 19. Prime-boost vaccination of mice and Rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates. Emerg Microbes Infect 2021:1-59Luo S, Zhang P, Liu B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33993845 20. Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review. Eur. J. Clin. Invest. 2021:e13604Spagnolo F, Boutros A, Croce E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021591 21. EBCOG position statement on COVID-19 vaccination for pregnant and breastfeeding women. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021; Martins I, Louwen F, Ayres-de-Campos D, Mahmood T. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020833 22. Parents' intention to get vaccinated and to have their child vaccinated against COVID-19: cross-sectional analyses using data from the KUNO-Kids health study. Eur. J. Pediatr. 2021:1-6Brandstetter S, Böhmer MM, Pawellek M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999257 23. Acceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer: a cross-sectional study and the implications. Expert Rev. Pharmacoecon. Outcomes Res. 2021; Godói IPD, Sarmento TTR, Reis EA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33993823 24. Optimal Lockdown Policy for Vaccination during COVID-19 Pandemic. Financ Res Lett 2021:102123Fu Y, Jin H, Xiang H, Wang N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007250 25. A Survey Among Italian Physicians During COVID-19 Outbreak. Could Bacillus Calmette-Guérin Vaccine Be Effective Against SARS-CoV2? Front. Pharmacol. 2021; 12:646570Patella V, Sanduzzi A, Bruzzese D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012395 26. SARS-CoV-2 Vaccine Hesitancy in a Sample of US Adults: Role of Perceived Satisfaction With Health, Access to Healthcare, and Attention to COVID-19 News. Front Public Health 2021; 9:665724Bass SB, Wilson-Genderson M, Garcia DT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996731 27. Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries. Genomics 2021; 113:2158-2170Wang R, Chen J, Gao K, Wei GW. http://www.ncbi.nlm.nih.gov/pubmed/?term=34004284 28. Exploring perception and hesitancy toward COVID-19 vaccine: A study from Jordan. Hum Vaccin Immunother 2021:1-6Abu Farha RK, Alzoubi KH, Khabour OF, Alfaqih MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014128 29. Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient. Hum Vaccin Immunother 2021:1- 3Etemadifar M, Sigari AA, Sedaghat N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34015240 30. Alteration in vaccination rates and an evaluation of physicians' perceptions of the possible impact of the SARS-CoV-2 pandemic on childhood vaccinations in Ankara, Turkey. Hum Vaccin Immunother 2021:1-6Kara A, İlbay S, Topaç O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015237 31. COVID-19 vaccine delay: An examination of United States residents' intention to delay vaccine uptake. Hum Vaccin Immunother 2021:1-11Latkin C, Dayton L, Yi G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014130 32. Covid-19 vaccine, acceptance, and concern of safety from public perspective in the state of Odisha, India. Hum Vaccin Immunother 2021:1-5Panda DS, Giri RK, Nagarajappa AK, Basha S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34010097 33. Effect of vaccine effectiveness and safety on COVID-19 vaccine acceptance in Detroit, Michigan, July 2020. Hum Vaccin Immunother 2021:1-6Wagner AL, Sheinfeld Gorin S, Boulton ML et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33998949 34. Evaluation of COVID-19 vaccine acceptance of healthcare providers in a tertiary Pediatric hospital. Hum Vaccin Immunother 2021:1-5Yigit M, Ozkaya- Parlakay A, Senel E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018902 35. Knowledge About COVID-19, Beliefs and Vaccination Acceptance Against COVID-19 Among High-Risk People in Ho Chi Minh City, Vietnam. Infect Drug Resist 2021; 14:1773-1780Huynh G, Nguyen TV, Nguyen DD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34012276 36. Brief report: attitudes towards Covid-19 vaccination among hospital employees in a tertiary care university hospital in Germany in December 2020. Infection 2021:1-5Bauernfeind S, Hitzenbichler F, Huppertz G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014530 37. COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies. Inflamm. Bowel Dis. 2021; Squire JD, Gonzalez-Estrada A, Caldera F, Farraye FA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33999204 38. Genomic Variation, Origin Tracing and Vaccine Development of SARS-CoV-2: A Systematic Review. Innovation (N Y) 2021:100116Li T, Huang T, Guo C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997827 39. Parents' willingness and attitudes concerning the COVID-19 vaccine: A cross- sectional study. Int J Clin Pract 2021:e14364Yılmaz M, Sahin MK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998108 40. Effectiveness of Booster Measles-Mumps-Rubella Vaccination in Lower COVID-19 Infection Rates: A Retrospective Cohort Study in Turkish Adults. Int. J. Gen. Med. 2021; 14:1757-1762Yengil E, Onlen Y, Ozer C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994804 41. Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals. Int J Infect Dis 2021; Sasikala M, Shashidhar J, Deepika G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34022331 42. Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection. Int J Infect Dis 2021; Vicenti I, Gatti F, Scaggiante R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34022329 43. Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights. Interdiscip Sci 2021:1-4Selvaraj G, Kaliamurthi S, Peslherbe GH, Wei DQ. http://www.ncbi.nlm.nih.gov/pubmed/? term=34021862 44. Perspectives on vaccine induced thrombotic thrombocytopenia. J Autoimmun 2021; 121:102663Dotan A, Shoenfeld Y. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020254 45. COVID-19 vector-based vaccine causing thrombosis. J Biomol Struct Dyn 2021:1-3Hendaus MA, Jomha FA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33998976 46. Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine. J. Clin. Invest. 2021; Beharier O, Plitman Mayo R, Raz T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014840 47. Review of COVID-19 Vaccines Approved in the United States of America for Emergency Use. J. Clin. Med. Res. 2021; 13:204-213Vasireddy D, Atluri P, Malayala SV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007358 48. Knowledge and Attitudes Toward Covid-19 and Vaccines Among a New York Haredi-Orthodox Jewish Community. J. Community Health 2021:1-9Carmody ER, Zander D, Klein EJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33999317 49. Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from North-East Italy. J Eur Acad Dermatol Venereol 2021; Farinazzo E, Ponis G, Zelin E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021625 50. Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution. J. Hematol. Oncol. 2021; 14:81Pimpinelli F, Marchesi F, Piaggio G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001183 51. BNT162b2 mRNA Covid-19 vaccine effectiveness in the prevention of SARS- CoV-2 infection: a preliminary report. J Infect Dis 2021; Bianchi FP, Germinario CA, Migliore G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34007998 52. HIV vaccines beyond COVID-19: merits of trust. J Int AIDS Soc 2021; 24:e25742Kublin JG. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002544 53. COVID-19 vaccination in pregnancy and postpartum. J Matern Fetal Neonatal Med 2021:1-20Brillo E, Tosto V, Gerli S, Buonomo E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998379 54. Equal Access of COVID-19 Vaccine distribution in Africa: Challenges and Way Forward. J Med Virol 2021; Aborode AT, Olofinsao OA, Osmond E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009657 55. Expecto Patronum! Leveraging the positive force of COVID-19 Vaccines for Pregnant and Lactating Individuals. J. Obstet. Gynaecol. Can. 2021; Malinowski AK, Whittle W, Murphy K, Kingdom J. http://www.ncbi.nlm.nih.gov/pubmed/? term=34000442 56. Determining the Cutoff Points of the 5C Scale for Assessment of COVID-19 Vaccines Psychological Antecedents among the Arab Population: A Multinational Study. J. Prim. Care Community Health 2021; 12:21501327211018568Ghazy RM, Abd ElHafeez S, Shaaban R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018891 57. Building vaccine confidence through public participation. J Public Health (Oxf) 2021; Corpuz JCG. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018556 58. Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology. J Thromb Haemost 2021; Nazy I, Sachs UJ, Arnold DM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34018298 59. COVID-19 vaccine passport for a safe resumption of travel. J Travel Med 2021; Pavli A, Maltezou HC. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008004 60. Impact of COVID-19 and ICU capacity on vaccination support: Evidence from a two-leg representative survey in the UK. J Virus Erad 2021:100044Blanchard- Rohner G, Caprettini B, Rohner D, Voth HJ. http://www.ncbi.nlm.nih.gov/pubmed/? term=34026244 61. Prisons need to be included in global and national vaccinations effort against COVID-19. Lancet Reg Health Eur 2021; 4:100088Neufeld M, Alves da Costa F, Ferreira-Borges C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33997833 62. Development of leading first-generation vaccines against SARS-CoV-2. Microbes Infect 2021:104841Perera PY, Perera LP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34022375 63. [Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination]. Neurologia 2021; Avendaño-Solá C, Cámara R, Castellanos M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33994625 64. [Vaccination against SARS-CoV-2 in cancer patients]. Onkologe (Berl) 2021:1- 6von Lilienfeld-Toal M, Rieger C, Giesen N, Wörmann B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34025046 65. Implementation of integrated supportive supervision in the context of coronavirus 19 pandemic: its effects on routine immunization and vaccine preventable surveillance diseases indicators in the East and Southern African countries. Pan Afr. Med. J. 2021; 38:164Bello IM, Lebo E, Shibeshi ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995771 66. The Relationship between COVID-19 Severity and Bacillus Calmette-Guérin (BCG)/ Mycobacterium tuberculosis exposure history in healthcare workers: a multi-center study. Pathog Glob Health 2021:1-7Torun S, Ozkaya S, Şen N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014806 67. Vaccinating against SARS-CoV-2 at a snail's pace. Praxis 2021; 110:281Battegay E. 68. Role of Psychiatric Hospitals in the Equitable Distribution of COVID-19 Vaccines. Psychiatr. Serv. 2021:appips202000808Brown JD, Bell N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34015949 69. Perceptions and predictors of intention to receive the COVID-19 vaccine. Res Social Adm Pharm 2021; Coe AB, Elliott MH, Gatewood SBS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994325 70. Older adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for informing public health strategies. Vaccine 2021; Afifi TO, Salmon S, Taillieu T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023134 71. Childhood immunization during the COVID-19 pandemic in Texas. Vaccine 2021; Nuzhath T, Ajayi KV, Fan Q et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020814 72. Influenza and pneumococcal vaccinations are not associated to COVID-19 outcomes among patients admitted to a university hospital. Vaccine 2021; Pastorino R, Villani L, La Milia DI et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020813 73. Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines. Vaccine 2021; Somiya M, Mine S, Yasukawa K, Ikeda S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020815 74. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine 2021; Welsh KJ, Baumblatt J, Chege W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006408

Women – pregnancy (40 articles)

1. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. Am J Obstet Gynecol 2021; Gurol-Urganci I, Jardine JE, Carroll F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023315 2. Acceptance of COVID-19 vaccination in pregnancy: A survey study. Am J Obstet Gynecol MFM 2021:100399Levy AT, Singh S, Riley LE, Prabhu M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020098 3. A review of 92 obstetric patients with COVID-19 in the Bronx, New York and their peripartum anaesthetic management. Anaesthesiol Intensive Ther 2021:1- 11Chen S, Bernstein P, Nair S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34006045 4. Current status of the COVID - 19 and male reproduction: a review of the literature. Andrology 2021; Borges E, Jr., Setti AS, Iaconelli A, Jr., de Almeida Ferreira Braga DP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998143 5. Future developments in the prevention, diagnosis and treatment of COVID-19. Best Pract. Res. Clin. Obstet. Gynaecol. 2021; Coltart CEM, Collet-Fenson LB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016525 6. Mental health among pregnant women with COVID-19-related stressors and worries in the United States. Birth 2021; Liu J, Hung P, Alberg AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34008216 7. Impact of SARS-Cov-2 on ectopic pregnancies management in the United Kingdom: a multicentre observational study. Bjog 2021; Platts S, Ranawaka J, Oliver R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998125 8. Knowledge and practice to prevent COVID-19 and its associated factors among pregnant women in Debre Tabor Town Northwest Ethiopia, a community-based cross-sectional study. BMC Pregnancy Childbirth 2021; 21:397Ayele AD, Mihretie GN, Belay HG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020600 9. Characteristics, clinical and laboratory data and outcomes of pregnant women with confirmed SARS-CoV-2 infection admitted to Al-Zahra tertiary referral maternity center in Iran: a case series of 24 patients. BMC Pregnancy Childbirth 2021; 21:378Vaezi M, Mirghafourvand M, Hemmatzadeh S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34001013 10. Prospective observational study of gender and ethnicity biases in respiratory protective equipment for healthcare workers in the COVID-19 pandemic. BMJ Open 2021; 11:e047716Carvalho CYM, Schumacher J, Greig PR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34016664 11. Knowledge mobilization tool to promote, protect, and support breastfeeding during COVID-19. Can. J. Public Health. 2021; Hirani SAA, Pearce M, Lanoway A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34019282 12. Risk factors for illness severity among pregnant women with confirmed SARS- CoV-2 infection - Surveillance for Emerging Threats to Mothers and Babies Network, 22 state, local, and territorial health departments, March 29, 2020 - March 5, 2021. Clin Infect Dis 2021; Galang RR, Newton SM, Woodworth KR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34021332 13. Impact of the COVID-19 Pandemic and Obstetrician and Gynecologist Workforce Distribution on Vaccine Deployment and Predicting Women's Healthcare Shortages. Cureus 2021; 13:e14545Shastri T, Rasendran C, Markwei M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017660 14. EBCOG position statement on COVID-19 vaccination for pregnant and breastfeeding women. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021; Martins I, Louwen F, Ayres-de-Campos D, Mahmood T. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020833 15. Neurological consequences of neurovascular unit and brain vasculature damages: potential risks for pregnancy infections and COVID-19-babies. Febs j 2021; Rasile M, Lauranzano E, Mirabella F, Matteoli M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998773 16. Immune Response to COVID-19 During Pregnancy. Front. Immunol. 2021; 12:675476Chen G, Liao Q, Ai J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34012458 17. Impact of Smoking on Women During the Covid-19 Pandemic. Front Med (Lausanne) 2021; 8:584061Mihaltan FD, Rajnoveanu AG, Rajnoveanu RM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996840 18. Management of Follow-Up With Preterm Infants During the Outbreak in China. Front Pediatr 2021; 9:637275Li L, Li Z, Wan W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996687 19. Association of Stress-Related Factors With Anxiety Among Chinese Pregnant Participants in an Online Crisis Intervention During COVID-19 Epidemic. Front. Psychol. 2021; 12:633765Shangguan F, Wang R, Quan X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33995188 20. Fostering Resilience in Pregnancy and Early Childhood During the COVID-19 Pandemic: The HUGS/Abrazos Program Design and Implementation. Front Public Health 2021; 9:633285Liu M, Neri Mini F, Torres C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33996717 21. Novel Coronavirus Infection in an Infant with Intussusception. Glob Pediatr Health 2021; 8:2333794x211012978Osorno JF, Giraldo M, Marín AF, Figueroa LM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017904 22. "This choice does not just affect me." Attitudes of pregnant women toward COVID-19 vaccines: a mixed-methods study. Hum Vaccin Immunother 2021:1- 6Geoghegan S, Stephens LC, Feemster KA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009096 23. SARS-CoV-2 congenital infection and pre-eclampsia-like syndrome in dichorionic twins: A case report and review of the literature. Int J Gynaecol Obstet 2021; Abadía-Cuchí N, Ruiz-Martínez S, Fabre Estremera M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34009656 24. COVID-19 and pregnancy: A scoping review on pregnancy characteristics and outcomes. Int. J. Nurs. Pract. 2021:e12956de Oliveira KF, de Oliveira JF, Wernet M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998110 25. Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine. J. Clin. Invest. 2021; Beharier O, Plitman Mayo R, Raz T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34014840 26. Impact of COVID-19 pandemic on maternal and child health services in Uttar Pradesh, India. J Family Med Prim Care 2021; 10:509-513Singh AK, Jain PK, Singh NP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34017779 27. Clinical outcomes of maternal and neonate with COVID-19 infection - Multicenter study in Saudi Arabia. J Infect Public Health 2021; 14:702-708Al- Matary A, Almatari F, Al-Matary M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020209 28. COVID-19 vaccination in pregnancy and postpartum. J Matern Fetal Neonatal Med 2021:1-20Brillo E, Tosto V, Gerli S, Buonomo E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998379 29. Effects of SARS-CoV-2 infection on human reproduction. J. Mol. Cell. Biol. 2021; Yang M, Wang J, Chen Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34003284 30. Expecto Patronum! Leveraging the positive force of COVID-19 Vaccines for Pregnant and Lactating Individuals. J. Obstet. Gynaecol. Can. 2021; Malinowski AK, Whittle W, Murphy K, Kingdom J. http://www.ncbi.nlm.nih.gov/pubmed/? term=34000442 31. COVID-19 in Africa: an ovarian victory? J Ovarian Res 2021; 14:70Dufailu OA, Afriyie-Asante A, Gyan B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34020688 32. COVID-19: what about pregnant women during first lockdown in Italy? J. Reprod. Infant Psychol. 2021:1-13Ionio C, Gallese M, Fenaroli V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34000926 33. A study of breastfeeding practices, SARS-CoV-2 and its antibodies in the breast milk of mothers confirmed with COVID-19. Lancet Reg Health West Pac 2020; 4:100045Peng S, Zhu H, Yang L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34013217 34. Childbirth experience and practice changing during COVID-19 pandemic: A cross-sectional study. Nurs Open 2021; Inversetti A, Fumagalli S, Nespoli A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34002943 35. [Creating conditions for male partner involvement in birth in the Hungarian obstetric wards during the COVID-19 pandemic]. Orv. Hetil. 2021; 162:824- 829Lengyel IK, Ács N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34023816 36. The sex-related discrepancy in laboratory parameters of severe COVID-19 patients with diabetes: A retrospective cohort study. Prim. Care Diabetes 2021; Hammad MO, Alseoudy MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34006475 37. Does the maternal-fetal transmission of SARS-CoV-2 occur during pregnancy? Rev Clin Esp (Barc) 2021; 221:93-96Hijona Elósegui JJ, Carballo García AL, Fernández Risquez AC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33998494 38. Depression and anxiety symptoms in pregnant women in Denmark during COVID-19. Scand J Public Health 2021:14034948211013271Overbeck G, Rasmussen IS, Siersma V et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34011216 39. Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines. Vaccine 2021; Somiya M, Mine S, Yasukawa K, Ikeda S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34020815 40. The impact of COVID-19 on pregnant womens' experiences and perceptions of antenatal maternity care, social support, and stress-reduction strategies. Women Birth 2021; Meaney S, Leitao S, Olander EK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33994134

to subscribe click here

mailing address is: [email protected]

© P.J. Lansberg